{
    "total_result": {
        "total_samples": 456,
        "removed_samples": {
            "number": 14,
            "removed_samples list": [
                "CD006469",
                "CD000567",
                "CD002282",
                "CD009461",
                "CD002891",
                "CD004957",
                "CD006400",
                "CD002752",
                "CD009190",
                "CD001055",
                "CD002009",
                "CD002959",
                "CD003633",
                "CD003341"
            ]
        },
        "sample_errors": {
            "Completeness": {
                "Population_Mismatch": 66,
                "Intervention_Mismatch": 14,
                "Outcome_Mismatch": 5,
                "Omission_of_Key_Facts": 449
            },
            "Conciseness": {
                "Redundancy": 34,
                "Length": 245,
                "Lack_of_Focus": 414,
                "Excessive_Detail": 42
            },
            "Faithfulness": {
                "Intrinsic_Information": 44,
                "Extrinsic_Information": 264,
                "Ambiguity": 21,
                "Overgeneralization": 123,
                "Incorrect_Implication": 194,
                "Inaccurate_Emphasis": 67
            }
        },
        "total_errors": {
            "Completeness": {
                "Population_Mismatch": 70,
                "Intervention_Mismatch": 17,
                "Outcome_Mismatch": 5,
                "Omission_of_Key_Facts": 612
            },
            "Conciseness": {
                "Redundancy": 41,
                "Length": 293,
                "Lack_of_Focus": 499,
                "Excessive_Detail": 44
            },
            "Faithfulness": {
                "Intrinsic_Information": 46,
                "Extrinsic_Information": 267,
                "Ambiguity": 21,
                "Overgeneralization": 126,
                "Incorrect_Implication": 202,
                "Inaccurate_Emphasis": 67
            }
        }
    },
    "samples": [
        {
            "ReviewID": "CD000220",
            "ESE Summary": "There is <span class=Lack_of_Focus Length><span class=Incorrect_Implication>insufficient evidence to support or refute the routine use of metronidazole to prevent preterm birth</span> in women with trichomoniasis during pregnancy.</span>",
            "Target Summary": "Metronidazole, given as a single dose, is likely to provide parasitological cure for trichomoniasis, but it is not known whether this treatment will have any effect on pregnancy outcomes. The cure rate could probably be higher if more partners used the treatment.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008120",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information Overgeneralization>There is insufficient evidence to support the use of antidepressants in the treatment of GAD.</span></span></span> <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Incorrect_Implication>There is a need for well-designed, adequately powered randomised controlled trials with long-term follow-up.</span></span></span>",
            "Target Summary": "We identified eligible trials on quetiapine, risperidone and olanzapine. The available data on olanzapine and risperidone are too limited to draw any conclusions. Monotherapy with quetiapine seems to be efficacious in reducing symptoms of generalised anxiety disorder and this effect may be similar to that of antidepressants. However, quetiapine's efficacy must be weighed against its lower tolerability.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002968",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support or refute the use of exercise as a treatment for type 2 diabetes.</span></span></span> <span class=Omission_of_Key_Facts><span class=Length>Further research is needed.</span></span>",
            "Target Summary": "The meta-analysis shows that exercise significantly improves glycaemic control and reduces visceral adipose tissue and plasma triglycerides, but not plasma cholesterol, in people with type 2 diabetes, even without weight loss.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008472",
            "ESE Summary": "<span class=Lack_of_Focus>There is evidence that <span class=Extrinsic_Information>IP reduces the risk of renal injury</span> and <span class=Incorrect_Implication>perioperative renal impairment in patients with abdominal aortic aneurysm repair</span>.</span> However, <span class=Length><span class=Omission_of_Key_Facts>there is <span class=Overgeneralization>insufficient evidence to assess the effect of this intervention on renal impairment</span></span>.</span>",
            "Target Summary": "Based on current evidence from small pilot trials, there are too few data to be able to say whether remote ischaemic preconditioning has any beneficial or harmful effects. The safety of this technique needs to be confirmed in adequately powered trials. Therefore, further randomised trials on this technique are required.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006373",
            "ESE Summary": "<span class=Extrinsic_Information Overgeneralization>There is <span class=Omission_of_Key_Facts><span class=Length>limited evidence</span> to support the effectiveness of voice therapy for people with voice disorders.</span></span> <span class=Intrinsic_Information>There is a need for <span class=Omission_of_Key_Facts><span class=Length>well-designed, adequately powered randomised controlled trials with long-term follow-up.</span></span></span>",
            "Target Summary": "Evidence is available for the effectiveness of comprehensive voice therapy comprising both direct and indirect therapy elements. Effects are similar in patients and in teachers and student teachers screened for voice problems. Larger and methodologically better studies are needed with outcome measures that match treatment aims.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007033",
            "ESE Summary": "In patients with chronic obstructive pulmonary disease, the addition of <span class=Lack_of_Focus Length><span class=Omission_of_Key_Facts><span class=Extrinsic_Information>LABA</span></span> significantly improves lung function and reduces the risk of exacerbations.</span> In comparison with <span class=Redundancy><span class=Omission_of_Key_Facts><span class=Intrinsic_Information>monocomponent therapy</span></span>, LABA is significantly more effective in reducing the risk and severity of pulmonary exacerbations and the need for hospitalisation.</span> However, the <span class=Ambiguity>clinical significance of these results is not known</span>.",
            "Target Summary": "Placebo-controlled trials have established the benefits of both long-acting beta-agonist and inhaled corticosteroid therapy for COPD patients as individual therapies. This review, which included trials allowing comparisons between LABA and ICS, has shown that the two therapies confer similar benefits across the majority of outcomes, including the frequency of exacerbations and mortality. Use of long-acting beta-agonists appears to confer a small additional benefit in terms of improvements in lung function compared to inhaled corticosteroids. On the other hand, inhaled corticosteroid therapy shows a small advantage over long-acting beta-agonist therapy in terms of health-related quality of life, but inhaled corticosteroids also increase the risk of pneumonia. This review supports current guidelines advocating long-acting beta-agonists as frontline therapy for COPD, with regular inhaled corticosteroid therapy as an adjunct in patients experiencing frequent exacerbations.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 1,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004366",
            "ESE Summary": "<span class=Length>There is some evidence that <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>aerobic exercise may be beneficial for people with depression</span></span>.</span> However, <span class=Lack_of_Focus Length><span class=Omission_of_Key_Facts><span class=Overgeneralization>the evidence is not strong enough to support the use of aerobic exercise as an adjunctive treatment for depression</span></span>.</span>",
            "Target Summary": "Exercise seems to improve depressive symptoms in people with a diagnosis of depression when compared with no treatment or control intervention, however since analyses of methodologically robust trials show a much smaller effect in favour of exercise, some caution is required in interpreting these results.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD010256",
            "ESE Summary": "<span class=Incorrect_Implication>There is no evidence to support the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>intravenous aminophylline as an initial treatment for acute asthma.</span></span></span>",
            "Target Summary": "In the included RCTs there was no consistent evidence favouring either IV beta2-agonists or IV aminophylline for patients with acute asthma. The opportunity to draw clear conclusions is limited by the heterogeneity of outcomes evaluated and the small sample sizes in the included studies. It is recommended that these data should be viewed carefully alongside the conclusions from separate Cochrane reviews comparing IV beta2-agonists plus inhaled beta2-agonists versus inhaled beta2-agonists alone and IV aminophylline plus inhaled beta2-agonists versus inhaled beta2-agonists alone.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004409",
            "ESE Summary": "<span class=Extrinsic_Information>There is insufficient evidence from randomised controlled trials</span> to determine the effects of <span class=Intrinsic_Information><span class=Omission_of_Key_Facts><span class=Length>hostel care</span> on <span class=Excessive_Detail>long-term outcomes</span></span>.</span>",
            "Target Summary": "From the single, small and ill-reported, included study, the hostel ward type of facility appeared cheaper and positively effective. Currently, the value of this way of supporting people - which could be considerable - is unclear. Trials are needed. Any 24 hour care 'ward-in-a-house' is likely to be oversubscribed. We argue that the only equitable way of providing care in this way is to draw lots as to who is allocated a place from the eligible group of people with serious mental illness. With follow-up of all eligible for the placements - those who were lucky enough to be allocated a place as well as people in more standard type of care - real-world evaluation could take place. In the UK further randomised control trials are probably impossible, as many of these types of facilities have closed. The broader lesson of this review is to ensure early and rigorous evaluation of fashionable innovations before they are superseded by new approaches.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003075",
            "ESE Summary": "There is no evidence from randomised controlled trials to support the use of <span class=Lack_of_Focus><span class=Omission_of_Key_Facts><span class=Extrinsic_Information>ACE inhibitors</span></span> in patients with <span class=Population_Mismatch><span class=Overgeneralization>peripheral arterial disease</span></span>.</span>",
            "Target Summary": "Evidence on various anti-hypertensive drugs in people with PAD is poor so that it is unknown whether significant benefits or risks accrue from their use. Lack of data specifically examining outcomes in PAD patients should not detract from the compelling evidence of the benefit of treating hypertension and lowering blood pressure.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003225",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Incorrect_Implication><span class=Lack_of_Focus Length>insufficient evidence</span> to determine whether propranolol is superior to placebo</span></span> in the prophylactic treatment of migraine.",
            "Target Summary": "Although many trials have relevant methodological shortcomings, there is clear evidence that propranolol is more effective than placebo in the short-term interval treatment of migraine. Evidence on long-term effects is lacking. Propranolol seems to be as effective and safe as a variety of other drugs used for migraine prophylaxis.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008012",
            "ESE Summary": "<span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence to support the use of antidepressants in the treatment of depression in patients with MI or CHD.</span></span> Further research is needed to determine whether antidepressants are more effective than placebo in treating depression in these patients.\r\n<span class=Length>[Note: The four citations in the awaiting classification section of the review may alter the conclusions of the reviews once assessed.]</span>",
            "Target Summary": "Psychological interventions and pharmacological interventions with SSRIs may have a small yet clinically meaningful effect on depression outcomes in CAD patients. No beneficial effects on the reduction of mortality rates and cardiac events were found. Overall, however, the evidence is sparse due to the low number of high quality trials per outcome and the heterogeneity of examined populations and interventions.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000978",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>There is insufficient evidence to recommend the use of any of the agents in this review.</span></span></span> <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Overgeneralization>There is a need for further RCTs to evaluate the effects of these agents in patients with head and neck cancer.</span></span></span>",
            "Target Summary": "Ten interventions were found to have some benefit with regard to preventing or reducing the severity of mucositis associated with cancer treatment. The strength of the evidence was variable and implications for practice include consideration that benefits may be specific for certain cancer types and treatment. There is a need for further well designed, and conducted trials with sufficient numbers of participants to perform subgroup analyses by type of disease and chemotherapeutic agent.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003948",
            "ESE Summary": "There is <span class=Inaccurate_Emphasis>insufficient evidence</span> to determine whether <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Incorrect_Implication>miltefosine solution is an effective palliative treatment</span> for breast cancer.</span></span>",
            "Target Summary": "There is weak evidence from one small trial that 6% miltefosine solution applied topically to people with superficial fungating breast lesions (smaller than 1cm) who have received either previous radiotherapy, surgery, hormonal therapy or chemotherapy for their breast cancer, may slow disease progression. There is insufficient evidence in this review to give a clear direction for practice with regard to improving quality of life or managing wound symptoms associated with fungating wounds. More research is needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD006790",
            "ESE Summary": "<span class=Lack_of_Focus>Interferon beta-1a <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>appears to be effective in the induction of remission</span></span> in patients with active ulcerative colitis.</span>",
            "Target Summary": "The existing literature does not support the efficacy of type I IFNs for induction of remission in patients with UC. Given concerns regarding the tolerability of IFN therapy, we suggest that the results of two ongoing trials are evaluated for efficacy and safety prior to development or commencement of further randomised controlled trials of type I IFNs in UC.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006268",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to recommend the use of propofol or midazolam for colonoscopy.</span></span></span>",
            "Target Summary": "Propofol for sedation during colonoscopy for generally healthy individuals can lead to faster recovery and discharge times, increased patient satisfaction without an increase in side-effects. For the comparison of propofol administration by anaesthesiologists to that by non-anesthesiologists, we found insufficient high quality evidence. There is a need for better quality studies, with double blind randomizations, reporting of allocation concealment and more standardized reporting of outcomes.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000980",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Inaccurate_Emphasis>insufficient evidence</span></span></span> to support the use of vitamin C for the treatment of the common cold.",
            "Target Summary": "The failure of vitamin C supplementation to reduce the incidence of colds in the general population indicates that routine vitamin C supplementation is not justified, yet vitamin C may be useful for people exposed to brief periods of severe physical exercise. Regular supplementation trials have shown that vitamin C reduces the duration of colds, but this was not replicated in the few therapeutic trials that have been carried out. Nevertheless, given the consistent effect of vitamin C on the duration and severity of colds in the regular supplementation studies, and the low cost and safety, it may be worthwhile for common cold patients to test on an individual basis whether therapeutic vitamin C is beneficial for them. Further therapeutic RCTs are warranted.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD003687",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Excessive_Detail><span class=Intrinsic_Information>Eutrophic electrotherapy is more effective than uniform 10 Hz electrostimulation for the plastic adaptation of atrophied muscle in rheumatoid arthritic hands.</span></span></span>",
            "Target Summary": "ES was shown to have a clinically beneficial effect on grip strength and fatigue resistance for RA patients with muscle atrophy of the hand. However, these conclusions are limited by the low methodological quality of the trial included. More well-designed studies are therefore needed to provide further evidence of the benefits of ES in the management of RA.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001782",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Overgeneralization>insufficient evidence</span></span></span> to determine whether the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>CO2 or tretinoin</span></span></span> improves the appearance of photodamaged skin.",
            "Target Summary": "There is conclusive evidence that topical tretinoin improves the appearance of mild to moderate photodamage on the face and forearms, in the short-term. However erythema, scaling/dryness, burning/stinging and irritation may be experienced initially.\nThere is limited evidence that tazarotene and isotretinoin benefit patients with moderate photodamage on the face: both are associated with skin irritation and erythema. The effectiveness of other interventions remains uncertain.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006355",
            "ESE Summary": "There is currently <span class=Inaccurate_Emphasis>insufficient evidence</span> to recommend the use of <span class=Population_Mismatch Omission_of_Key_Facts><span class=Lack_of_Focus>topical glyceryl trinitrate as an adjunct to corticosteroids in the management of shoulder pain in patients with <span class=Incorrect_Implication>supraspinatus tendinitis</span>.</span></span>",
            "Target Summary": "There is some evidence from one study at high risk of bias that topical glyceryl trinitrate is more effective than placebo for rotator cuff disease among patients with acute symptoms (< seven-days duration), but there is insufficient evidence to be certain about their longer-term effects. Headache was a common side effect in one trial and any benefits of treatment need to be balanced against the risk of headache. Further high quality research is needed to determine the effectiveness and safety of this new therapy.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD003082",
            "ESE Summary": "<span class=Lack_of_Focus>Haloperidol <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>appears to be an effective antipsychotic drug for the treatment of schizophrenia.</span></span></span> However, <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Ambiguity>it is not clear whether it is superior to other antipsychotics.</span></span></span>",
            "Target Summary": "Haloperidol is a potent antipsychotic drug but has a high propensity to cause adverse effects. Where there is no treatment option, use of haloperidol to counter the damaging and potentially dangerous consequences of untreated schizophrenia is justified. However, where a choice of drug is available, people with schizophrenia and clinicians may wish to prescribe an alternative antipsychotic with less likelihood of adverse effects such as parkinsonism, akathisia and acute dystonias. Haloperidol should not be a control drug of choice for randomised trials of new antipsychotics.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 1,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001543",
            "ESE Summary": "There is <span class=Lack_of_Focus Length><span class=Extrinsic_Information>insufficient evidence from randomised controlled trials</span> to determine whether <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>Shouldice repair is superior to other types of inguinal hernia repair</span>.</span></span>",
            "Target Summary": "Shouldice herniorrhaphy is the best non-mesh technique in terms of recurrence, though it is more time consuming and needs a slightly longer post-operative hospital stay. The use of mesh is associated with a lower rate of recurrence. The quality of included studies, assessed with jaded scale, were low. Patients have similar characteristic in the treatment and control group but seems more healthy than in general population, this features may affect the dimension of effect in particularly recurrence rate could be higher in general population. Lost to follow-up were similar in the treatment and control group but the reasons were often not reported. The length of follow-up vary broadly among the studies from 1 year to 13.7 year.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000405",
            "ESE Summary": "<span class=Incorrect_Implication>There is insufficient evidence to support or refute the use of prophylactic oral antibiotics in the treatment of <span class=Lack_of_Focus><span class=Population_Mismatch Omission_of_Key_Facts>NEC in preterm or low-risk infants</span>.</span></span>",
            "Target Summary": "Evidence suggests that oral antibiotics reduce the incidence of NEC in low birth weight infants. However concerns about adverse outcomes persist, particularly related to the development of resistant bacteria. To address this question further, a large trial would be required with a sample size sufficient to examine all the important benefits and harms. Adverse outcomes associated with infection should be evaluated, and microbiological studies looking for the development of resistant bacteria should be undertaken",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005506",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Inaccurate_Emphasis>Oral ondansetron is effective in reducing the number of episodes of vomiting in children with acute gastroenteritis.</span></span></span> However, <span class=Omission_of_Key_Facts><span class=Length><span class=Ambiguity>it is not clear whether this effect is maintained in the long-term.</span></span></span>",
            "Target Summary": "Oral ondansetron increased the proportion of patients who had ceased vomiting and reduced the number needing intravenous rehydration and immediate hospital admission. Intravenous ondansetron and metoclopramide reduced the number of episodes of vomiting and hospital admission, and dimenhydrinate as a suppository reduced the duration of vomiting.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 1,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD005616",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Overgeneralization>There is insufficient evidence from randomised controlled trials to determine whether <span class=Omission_of_Key_Facts>splinting is beneficial or harmful for women with de Quervain's disease</span>.</span></span>",
            "Target Summary": "The efficacy of corticosteroid injections for de Quervain's tenosynovitis has been studied in only one small controlled clinical trial, which found steroid injections to be superior to thumb spica splinting. However, the applicability of our findings to daily clinical practice is limited, as they are based on only one trial with a small number of included participants, the methodological quality was poor and only pregnant and lactating women participated in the study. No adverse effects were observed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009404",
            "ESE Summary": "There is <span class=Incorrect_Implication>insufficient evidence to determine the effectiveness of <span class=Population_Mismatch Omission_of_Key_Facts>educational interventions for reducing the incidence of <span class=Lack_of_Focus>wrong-site tooth extraction in adults.</span></span></span>",
            "Target Summary": "The findings of this review identified one ITS study for a non-medical procedure conducted in a dental outpatient setting. The study suggested that the use of a specific educational intervention, in the above-mentioned context, which targets junior dental staff using a training session that included cases of wrong-site surgery, presentation of clinical guidelines and feedback by the instructor, was associated with a reduction in the incidence of wrong-site tooth extractions. Given the nature of the intervention in a very specific population, application of these results to a broader population undergoing other forms of surgery or invasive procedures should be undertaken cautiously.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003917",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of anthracycline-based chemotherapy regimens in patients with cancer.</span></span></span>",
            "Target Summary": "No definitive conclusions can be made about the efficacy of cardioprotective agents for which pooling of results was impossible. Dexrazoxane prevents heart damage and no evidence for a difference in response rate or survival between the dexrazoxane and control groups was identified. The evidence available did not allow us to reach any definite conclusions about adverse effects. We conclude that if the risk of cardiac damage is expected to be high, it might be justified to use dexrazoxane in patients with cancer treated with anthracyclines. However, clinicians should weigh the cardioprotective effect of dexrazoxane against the possible risk of adverse effects for each individual patient.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005522",
            "ESE Summary": "<span class=Omission_of_Key_Facts>Tramadol 200 mg as an add-on therapy for OA is <span class=Lack_of_Focus Length>more effective than placebo at reducing pain intensity and improving physical function</span> in patients with moderate to severe pain.</span>",
            "Target Summary": "Tramadol or tramadol/paracetamol decreases pain intensity, produces symptom relief and improves function, but these benefits are small. Adverse events, although reversible and not life threatening, often cause participants to stop taking the medication and could limit tramadol or tramadol plus paracetamol usefulness.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008838",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>Venom immunotherapy reduces the size and duration of insect stings and the frequency of systemic reactions.</span></span></span> However, <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Inaccurate_Emphasis>there is insufficient evidence to assess whether immunotherapy is beneficial or harmful.</span></span></span>",
            "Target Summary": "We found venom immunotherapy using extracted insect venom to be an effective therapy for preventing further allergic reactions to insect stings, which can improve quality of life. The treatment carries a small but significant risk of systemic adverse reaction.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD005463",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Intrinsic_Information>There is insufficient evidence to support or refute the use of parent training in the treatment of maltreating parents.</span></span></span>",
            "Target Summary": "There is insufficient evidence to support the use of parenting programmes to treat physical abuse or neglect. There is, however, limited evidence to show that some parenting programmes may be effective in improving some outcomes that are associated with physically abusive parenting. Further research is urgently needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006097",
            "ESE Summary": "<span class=Extrinsic_Information>Natalizumab is <span class=Lack_of_Focus Length><span class=Population_Mismatch Omission_of_Key_Facts>efficacious in improving remission rates in patients with mild to moderately active Crohn's disease</span>.</span></span> It is not clear whether this improvement is <span class=Lack_of_Focus Length>due to <span class=Ambiguity Overgeneralization><span class=Intervention_Mismatch Omission_of_Key_Facts>benefit from induction or maintenance of therapy</span>.</span></span>",
            "Target Summary": "Pooled data suggest that natalizumab is effective for induction of clinical response and remission in some patients with moderately to severely active Crohn's disease. The clinical benefit of induction therapy with natalizumab in Crohn's disease should be weighed against the potential risk of serious adverse events. Preliminary data from the retrospective investigation of adverse events associated with natalizumab suggest that it may be possible to identify patients at risk for PML by testing for the appearance of JC virus in plasma.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 1,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 1,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003709",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support the use of dopamine as a first-line vasopressin</span></span> in patients with hyperdynamic septic shock.</span>",
            "Target Summary": "There is some evidence of no difference in mortality between norepinephrine and dopamine. Dopamine appeared to increase the risk for arrhythmia. There is not sufficient evidence of any difference between any of the six vasopressors examined. Probably the choice of vasopressors in patients with shock does not influence the outcome, rather than any vasoactive effect per se. There is not sufficient evidence that any one of the investigated vasopressors is clearly superior over others.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008870",
            "ESE Summary": "<span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>no evidence to support the use of 5-ASA in the treatment of active Crohn's disease.</span></span></span>",
            "Target Summary": "Sulfasalazine has modest efficacy compared to placebo and is inferior to corticosteroids for the treatment of mild to moderately active Crohn's disease. Olsalazine and low dose mesalamine (1 to 2 g/day) are not superior to placebo. High dose mesalamine (3 to 4.5 g/day) is not more effective than placebo for inducing response or remission. High dose mesalamine was inferior to budesonide for inducing remission in a single trial. In conclusion, sulfasalazine shows modest efficacy for the treatment of active Crohn's disease. However, the existing data show little benefit for 5-aminosalicylates.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006194",
            "ESE Summary": "<span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>insufficient evidence</span> to recommend the use of external fixation for distal radial fractures.</span></span>",
            "Target Summary": "There is some evidence to support the use of external fixation for dorsally displaced fractures of the distal radius in adults. Though there is insufficient evidence to confirm a better functional outcome, external fixation reduces redisplacement, gives improved anatomical results and most of the excess surgically-related complications are minor.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005042",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Incorrect_Implication Overgeneralization>There is insufficient evidence to support or refute the use of <span class=Omission_of_Key_Facts>combined medication and ADHD treatment</span> for children with ADHD.</span></span> <span class=Redundancy><span class=Inaccurate_Emphasis><span class=Omission_of_Key_Facts>Additive effects of medication alone may be beneficial</span>, but the evidence is too weak to recommend the use either of these interventions alone or in combination with other treatments.</span></span>",
            "Target Summary": "Further research examining the effectiveness of family therapy versus a no-treatment control condition is needed to determine whether family therapy is an effective intervention for children with ADHD. There were no results available from studies investigating forms of family therapy other than behavioural family therapy.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD005413",
            "ESE Summary": "In patients with metastatic melanoma, the addition of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information Incorrect_Implication>IFN significantly improves OS, time to progression and quality of life</span></span></span> compared with chemotherapy alone.",
            "Target Summary": "We failed to find any clear evidence that the addition of immunotherapy to chemotherapy increases survival of people with metastatic melanoma. Further use of combined immunotherapy and chemotherapy should only be done in the context of clinical trials.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001983",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Omission_of_Key_Facts><span class=Extrinsic_Information>Salmon calcitonin is effective in the prevention of vertebral, hip, and wrist fractures</span> in patients with RA,</span> but <span class=Incorrect_Implication>there is no evidence of benefit in the lumbar spine</span>.</span> <span class=Omission_of_Key_Facts><span class=Length>There is a need for further <span class=Overgeneralization>randomised controlled trials</span>.</span></span>",
            "Target Summary": "Calcitonin appears to preserve bone mass in the first year of glucocorticoid therapy at the lumbar spine by about 3% compared to placebo, but not at the femoral neck. Our analysis suggests that the protective effect on bone mass may be greater for the treatment of patients who have been taking corticosteroids for more than three months. Efficacy of calcitonin for fracture prevention in steroid-induced osteoporosis remains to be established.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002988",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to determine whether the use of intravenous salbutamol is superior to the use use of nebulised beta2-agonists in patients with severe asthma.</span></span></span>",
            "Target Summary": "There is no evidence to support the use of IV beta2-agonists in patients with severe acute asthma. These drugs should be given by inhalation. No subgroups were identified in which the IV route should be considered.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006772",
            "ESE Summary": "<span class=Incorrect_Implication>There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>insufficient evidence to support the use of case method learning</span> to improve primary care outcomes in people with <span class=Lack_of_Focus>CHD</span>.</span></span>",
            "Target Summary": "There is weak evidence that regular planned recall of patients for appointments, structured monitoring of risk factors and prescribing, and education for patients can be effective in increasing the proportions of patients within target levels for cholesterol control and blood pressure. Further research in this area would benefit from greater standardisation of the outcomes measured.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007887",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to recommend the use of any drug for the treatment of post-puncture headache.</span></span></span>",
            "Target Summary": "Caffeine has shown effectiveness for treating PDPH, decreasing the proportion of participants with PDPH persistence and those requiring supplementary interventions, when compared with placebo. Gabapentin, theophylline and hydrocortisone have also shown a decrease in pain severity scores when compared with placebo or conventional care.\nThere is a lack of conclusive evidence for the other drugs assessed (sumatriptan and ACTH).\nThese conclusions should be interpreted with caution, due to the lack of information to allow correct appraisal of risk of bias, the small sample sizes of studies and also the limited generalisability, as most participants were post-partum women in their 30s.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007166",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is some evidence to support the use of <span class=Omission_of_Key_Facts>catechol-O-methyltransferase inhibitors</span> as an add-on therapy for Parkinson's disease.</span></span> <span class=Length>However, <span class=Incorrect_Implication>the evidence is not strong enough to recommend their use as an adjunctive therapy.</span></span>",
            "Target Summary": "Compared to placebo, adjuvant therapy reduces off-time, levodopa dose, and improves UPDRS scores in PD patients who develop motor complications on levodopa therapy. However, this is at the expense of increased dyskinesia and numerous other side-effects. Indirect comparisons suggest that dopamine agonist therapy may be more effective than COMTI and MAOBI therapy, which have comparable efficacy. However, as indirect comparisons should be interpreted with caution, direct head-to-head randomised trials assessing the impact of these different drug classes on overall patient-rated quality of life are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006956",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>no evidence to support the use of laparoscopic surgery for refractory Crohn's disease</span>.</span></span>",
            "Target Summary": "Laparoscopic surgery for small bowel CD may be as safe as the open operation. There was no significant difference in the perioperative outcomes and the long term reoperation rates for disease-related or non-disease related complications of CD.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003054",
            "ESE Summary": "<span class=Lack_of_Focus>Lifestyle interventions aimed at reducing the risk of type 2 diabetes, <span class=Extrinsic_Information>i.e. the incidence of diabetes</span>, have been shown to be effective in the short term.</span> <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>Lifestyle intervention aimed at preventing the development of <span class=Incorrect_Implication>type 1 diabetes</span> has not been shown in the long term.</span></span>",
            "Target Summary": "Interventions aimed at increasing exercise combined with diet are able to decrease the incidence of type 2 diabetes mellitus in high risk groups (people with impaired glucose tolerance or the metabolic syndrome). There is a need for studies exploring exercise only interventions and studies exploring the effect of exercise and diet on quality of life, morbidity and mortality, with special focus on cardiovascular outcomes.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001005",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Overgeneralization>There is insufficient evidence to support or refute the effectiveness of educational interventions for asthma control.</span></span></span> <span class=Omission_of_Key_Facts><span class=Length><span class=Inaccurate_Emphasis>There is a need for high-quality randomised controlled trials with long-term follow-up.</span></span></span>",
            "Target Summary": "Use of limited asthma education as it has been practiced does not appear to improve health outcomes in adults with asthma although perceived symptoms may improve. Provision of information in the emergency department may be effective, but this needs to be confirmed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD006829",
            "ESE Summary": "In the short term, the combination of <span class=Omission_of_Key_Facts><span class=Length><span class=Extrinsic_Information>salmeterol and fluticasone</span></span> significantly reduced the number of exacerbations per year, but <span class=Redundancy Length><span class=Incorrect_Implication>not the rate of pneumonia</span></span>.</span> In the longer term, <span class=Omission_of_Key_Facts>there was <span class=Lack_of_Focus Length><span class=Overgeneralization>no significant difference in FEV1, symptoms, or treatment-related quality of life</span></span>.</span>",
            "Target Summary": "Concerns over the analysis and availability of data from the studies bring into question the superiority of ICS/LABA over LABA alone in preventing exacerbations. The effects on hospitalisations were inconsistent and require further exploration. There was moderate quality evidence of an increased risk of pneumonia with ICS/LABA. There was moderate quality evidence that treatments had similar effects on mortality. Quality of life, symptoms score, rescue medication use and FEV1 improved more on ICS/LABA than on LABA, but the average differences were probably not clinically significant for these outcomes. To an individual patient the increased risk of pneumonia needs to be balanced against the possible reduction in exacerbations.\nMore information would be useful on the relative benefits and adverse event rates with combination inhalers using different doses of inhaled corticosteroids. Evidence from head-to-head comparisons is needed to assess the comparative risks and benefits of the different combination inhalers.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 3,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005646",
            "ESE Summary": "There is <span class=Incorrect_Implication>insufficient evidence to determine whether <span class=Lack_of_Focus Length><span class=Omission_of_Key_Facts>desensitization is more effective than rechallenge in preventing allergic reactions to TMP-SMX</span>.</span></span> This review highlights the need for <span class=Omission_of_Key_Facts><span class=Excessive_Detail>well-designed, conducted and reported randomised trials</span> to determine the efficacy of desensitized patients receiving PCP compared to other interventions</span>.",
            "Target Summary": "In the small trials included in this review, when compared to cotrimoxazole rechallenge for prophylaxis of opportunistic infections, cotrimoxazole desensitization resulted in fewer treatment discontinuations and overall adverse reactions in HIV-infected patients with a previous history of mild or moderate hypersensitivity to cotrimoxazole. Paediatric data and trials in resource-poor settings are urgently required. Further randomised controlled trials are also needed for the treatment of opportunistic infections, treating-through, adjunctive medications, and different desensitization-dosing schedules.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD007345",
            "ESE Summary": "Antibiotic prophylaxis in patients with ERCP reduces the risk of <span class=Omission_of_Key_Facts><span class=Redundancy Length><span class=Intrinsic_Information>pancreatitis, leukocytosis, and pancreatitis</span></span></span>. However, the absolute risk of <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>mortality</span></span> is small.",
            "Target Summary": "Prophylactic antibiotics reduce bacteriaemia and seem to prevent cholangitis and septicaemia in patients undergoing elective ERCP. In the subgroup of patients with uncomplicated ERCP, the effect of antibiotics may be less evident. Further research is required to determine whether antibiotics can be given during or after an ERCP if it becomes apparent that biliary obstruction cannot be relieved during that procedure.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD010292",
            "ESE Summary": "Duloxetine <span class=Lack_of_Focus Length><span class=Inaccurate_Emphasis>60 mg/day was an effective treatment for pain and fibromyalgia</span>, but was associated with adverse events.</span> <span class=Omission_of_Key_Facts>Milnacipran <span class=Lack_of_Focus Length><span class=Incorrect_Implication>was not significantly different from placebo in efficacy and safety</span>.</span></span>",
            "Target Summary": "The SNRIs duloxetine and milnacipran provided a small incremental benefit over placebo in reducing pain. The superiority of duloxetine and milnacipran over placebo in reducing fatigue and limitations of QOL was not substantial. Duloxetine and milnacipran were not superior to placebo in reducing sleep problems. The dropout rates due to adverse events were higher for duloxetine and milnacipran than for placebo. The most frequently reported symptoms leading to stopping medication were nausea, dry mouth, constipation, headache, somnolence/dizziness and insomnia. Rare complications of both drugs may include suicidality, liver damage, abnormal bleeding, elevated blood pressure and urinary hesitation.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD005203",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Overgeneralization>There is <span class=Omission_of_Key_Facts>insufficient evidence to support or refute the use of any specific dietary intervention</span> in the management of eczema.</span></span>",
            "Target Summary": "There may be some benefit in using an egg-free diet in infants with suspected egg allergy who have positive specific IgE to eggs. Little evidence supports the use of various exclusion diets in unselected people with atopic eczema, but that may be because they were not allergic to those substances in the first place. Lack of any benefit may also be because the studies were too small and poorly reported. Future studies should be appropriately powered focusing on participants with a proven food allergy. In addition a distinction should be made between young children whose food allergies improve with time and older children/adults.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003978",
            "ESE Summary": "<span class=Omission_of_Key_Facts>There is insufficient evidence from <span class=Length><span class=Extrinsic_Information>randomised controlled trials (RCTs)</span></span> to determine which type of prosthetic foot is the most appropriate for people with <span class=Lack_of_Focus><span class=Intrinsic_Information>below-knee amputation</span></span>.</span>",
            "Target Summary": "There is insufficient evidence from high quality comparative studies for the overall superiority of any individual type of prosthetic ankle-foot mechanism, although there is a small trend towards the Flex-foot in comparison with the SACH foot for greater stride length and lower energy cost in individuals with a transtibial amputation, and improved gait efficiency and lower energy cost in high activity individuals with a transfemoral amputation. In prescribing prosthetic-ankle foot mechanisms for individuals with a lower limb amputation, practitioners should take into account availability, patient functional needs, the type of knee mechanism to be prescribed and the inter-relationship with ankle-foot mechanisms, and cost.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009792",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of <span class=Population_Mismatch>misoprostol for labour induction in women with previous uterine incision</span>.</span></span> Further research is required to determine the optimal dose and route of administration for induction in this <span class=Population_Mismatch>population</span>.",
            "Target Summary": "There is insufficient information available from randomised controlled trials on which to base clinical decisions regarding the optimal method of induction of labour in women with a prior caesarean birth.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 2,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 0
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003422",
            "ESE Summary": "There is insufficient evidence from randomised controlled trials to determine the effectiveness of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>carbogen compared with placebo</span></span></span> in the treatment of <span class=Population_Mismatch>idiopathic sudden deafness</span>.",
            "Target Summary": "The effectiveness of vasodilators in the treatment of ISSHL remains unproven. The included studies were of relatively poor quality and the number of patients included was small. Moreover, there were differences in the type, dosage and duration of vasodilator used in each study. Due to the degree of heterogeneity the results could not be combined to reach a conclusion.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008351",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of ARP1 for bronchiectasis.</span></span></span> <span class=Omission_of_Key_Facts><span class=Length><span class=Incorrect_Implication>Further RCTs are needed.</span></span></span>",
            "Target Summary": "ACTs appear to be safe for individuals (adults and children) with stable bronchiectasis, where there may be improvements in sputum expectoration, selected measures of lung function and health-related quality of life. The role of these techniques in people with an acute exacerbation of bronchiectasis is unknown. In view of the chronic nature of bronchiectasis, more data are needed to establish the clinical value of ACTs over the short and long term on patient-important outcomes, including symptoms, on physiological outcomes which may clarify the rationale for each technique and on long-term parameters that impact on disease progression in individuals with stable bronchiectasis. This is necessary in order to provide further guidance of specific ACT prescription for people with bronchiectasis. It may also be important to establish the comparative effect of different types of ACTs in people with bronchiectasis.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003937",
            "ESE Summary": "Topical capsaicin <span class=Incorrect_Implication>appears to be effective in reducing the symptoms of <span class=Population_Mismatch Omission_of_Key_Facts><span class=Lack_of_Focus>HIV infection in asymptomatic patients with AIDS</span></span>.</span> However, the evidence is not strong enough to support its use in clinical practice. Further <span class=Excessive_Detail>well-designed, adequately powered and reported randomised controlled trials are needed</span>.",
            "Target Summary": "There is insufficient evidence to support the use of herbal medicines in HIV-infected individuals and AIDS patients. Potential beneficial effects need to be confirmed in large, rigorous trials.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005059",
            "ESE Summary": "Epidural analgesia <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>appears to reduce the risk of major complications</span></span></span> in patients undergoing abdominal surgery.",
            "Target Summary": "Epidural analgesia provides better pain relief (especially during movement) in the period up to three postoperative days. It reduces the duration of postoperative tracheal intubation by roughly half. The occurrence of prolonged postoperative mechanical ventilation, myocardial infarction, gastric complications and renal complications was reduced by epidural analgesia. However, current evidence does not confirm the beneficial effect of epidural analgesia on postoperative mortality and other types of complications.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003231",
            "ESE Summary": "<span class=Lack_of_Focus Length>Intravesical chemotherapy <span class=Overgeneralization>appears to be <span class=Population_Mismatch Omission_of_Key_Facts>more effective than placebo</span></span> in reducing recurrence of bladder cancer in patients with <span class=Population_Mismatch>pTA-pT1 bladder cancer</span>.</span> However, <span class=Lack_of_Focus Length>there is <span class=Omission_of_Key_Facts><span class=Ambiguity>insufficient evidence to determine whether intravesical therapy is more effective or not</span></span>.</span>",
            "Target Summary": "The data from the present meta-analysis indicate that tumour recurrence was significantly reduced with intravesical BCG compared to MMC only in the subgroup of patients at high risk of tumour recurrence. However, there was no difference in terms of disease progression or survival, and the decision to use either agent might be based on adverse events and cost.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 2,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 1,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003159",
            "ESE Summary": "Nicergoline appears to be of benefit in <span class=Omission_of_Key_Facts><span class=Overgeneralization>mild to moderate dementia</span></span>, but <span class=Lack_of_Focus Length>there is <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>insufficient evidence to determine whether it is beneficial in other demented patients</span></span>.</span>",
            "Target Summary": "The clinical studies on nicergoline were carried out with diverse criteria and modalities of evaluation. Despite this, the 14 studies included in this review, have presented generally consistent results. Results of this meta-analysis provide some evidence of positive effects of nicergoline on cognition and behaviour and these effects are supported by an effect on clinical global impression. There was some evidence that there were increased risk of adverse effects associated with nicergoline. These results were obtained on older patients with mild to moderate cognitive and behavioural impairment of various clinical origins, including chronic cerebrovascular disorders and Alzheimer's dementia. The few studies specifically performed on patients with Alzheimer's disease were performed with too few people to give a definitive answer to the questions concerning the use of nicergoline for this form of dementia.This drug has not been evaluated using current diagnostic categories such as MCI or in association with therapeutic agents of different nature such as cholinesterase or antioxidant drugs.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002224",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Overgeneralization>There is insufficient evidence from randomised controlled trials to determine whether groin dissection is better than radical vulvectomy for patients with vulval carcinoma.</span></span></span> <span class=Length><span class=Incorrect_Implication>Further randomised trials are needed.</span></span>",
            "Target Summary": "Primary radiotherapy to the groin results in less morbidity but may be associated with a higher risk of groin recurrence and decreased survival when compared with surgery. Due to the small numbers in this trial and criticisms regarding the depth of radiotherapy applied, corroboration of these findings by larger RCTs using a standardised radiotherapy method, is desirable. However, until better evidence is available, surgery should be considered the first choice treatment for the groin nodes in women with vulvar cancer. Individual patients not physically able to withstand surgery may be treated with primary radiotherapy.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004737",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Incorrect_Implication><span class=Lack_of_Focus>Manual placental removal of the placenta during cesarean section</span> is associated with a <span class=Lack_of_Focus>lower incidence of postoperative endometritis</span> and <span class=Lack_of_Focus>haemorrhage</span>.</span></span>",
            "Target Summary": "Delivery of the placenta with cord traction at caesarean section has more advantages compared to manual removal. These are less endometritis; less blood loss; less decrease in haematocrit levels postoperatively; and shorter duration of hospital stay. Future trials should provide information on interval between the delivery of the infant and of the placenta, change in lochia, blood splashing during placental removal and uterine pain after operation, as well as the effects of delayed cord clamping.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 3,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002964",
            "ESE Summary": "There is some evidence that using <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>culturally sensitive videotape to enhance parent-infant communication and infant cognitive development</span> among adolescents</span></span> is effective. However, this evidence is based on <span class=Overgeneralization>a <span class=Omission_of_Key_Facts><span class=Length>small number of small studies with limited sample sizes</span></span></span>. More research is needed.",
            "Target Summary": "Variation in the measures used, the included populations and interventions, and the risk of bias within the included studies limit the conclusions that can be reached. The findings provide some evidence to suggest that parenting programmes may be effective in improving a number of aspects of parent-child interaction both in the short- and long-term, but further research is now needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001487",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Extrinsic_Information>There is insufficient evidence to determine whether PTFE is superior to <span class=Omission_of_Key_Facts>HBD</span> in terms of <span class=Omission_of_Key_Facts>patency, function, and major complications</span>.</span> <span class=Overgeneralization>There is a need for <span class=Omission_of_Key_Facts>large well-designed RCTs to assess the effect of bypass grafts on major complications such as rest, rest, and diabetes</span>.</span></span>",
            "Target Summary": "There was a clear primary patency benefit for autologous vein when compared to synthetic materials for above knee bypasses. In the long term (five years) Dacron confers a small primary patency benefit over PTFE for above knee bypass. PTFE with a vein cuff improved primary patency when compared to PTFE alone for below knee bypasses. Further randomised data is needed to ascertain whether this information translates into improvement in limb survival.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 3
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008449",
            "ESE Summary": "<span class=Incorrect_Implication>There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>insufficient evidence to support the use of mirror therapy for people with acute stroke.</span></span></span>",
            "Target Summary": "The results indicate evidence for the effectiveness of mirror therapy for improving upper extremity motor function, activities of daily living and pain, at least as an adjunct to normal rehabilitation for patients after stroke. Limitations are due to small sample sizes of most included studies, control interventions that are not used routinely in stroke rehabilitation and some methodological limitations of the studies.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009109",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence from randomised controlled trials to determine whether the clinical outcome of endodontically treated teeth restored with fiber posts is equivalent to the same treatment used with metal-ceramic crowns.</span></span></span>\r\n\r\n[Note: The six citations in the awaiting classification section of the review may alter the conclusions of the study once assessed.]",
            "Target Summary": "There is insufficient evidence to support or refute the effectiveness of conventional fillings over crowns for the restoration of root filled teeth. Until more evidence becomes available clinicians should continue to base decisions on how to restore root filled teeth on their own clinical experience, whilst taking into consideration the individual circumstances and preferences of their patients.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001691",
            "ESE Summary": "Prophylactic <span class=Lack_of_Focus>phenobarbitone appears to <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>reduce the incidence of VLBW and EELBW</span></span> in preterm infants with low birth weight and high risk of developing IVH.</span> However, there is <span class=Redundancy><span class=Omission_of_Key_Facts><span class=Incorrect_Implication>no evidence to support its use in extremely preterm or low birthweight infants</span></span>.</span>",
            "Target Summary": "Postnatal administration of phenobarbital cannot be recommended as prophylaxis to prevent IVH in preterm infants and is associated with an increased need for mechanical ventilation.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001162",
            "ESE Summary": "<span class=Length>Sulpiride may be <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>more effective than other antipsychotic drugs for the maintenance of remission in people with schizophrenia</span></span>.</span> However, the evidence is <span class=Inaccurate_Emphasis>not strong enough to recommend its use</span>.",
            "Target Summary": "Sulpiride may be an effective antipsychotic drug but evidence is limited and data relating to claims for its value against negative symptoms is not trial-based.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD008862",
            "ESE Summary": "<span class=Extrinsic_Information>There is insufficient evidence to support the use of rTMS in people with acute stroke.</span> The trials included in this review were of short duration and did not report on outcome measures such as <span class=Omission_of_Key_Facts>motor function, disability, death or adverse effects</span>. <span class=Length><span class=Overgeneralization>There is a need for further well-designed, adequately powered, randomised controlled trials with long-term follow-up.</span></span>",
            "Target Summary": "Current evidence does not support the routine use of rTMS for the treatment of stroke. Further trials with larger sample sizes are needed to determine a suitable rTMS protocol and the long-term functional outcome.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004929",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Incorrect_Implication>There is insufficient evidence to support or refute <span class=Length>routine use of nasogastric tubes</span> after abdominal surgery for patients with gastric cancer.</span></span>",
            "Target Summary": "Routine nasogastric decompression does not accomplish any of its intended goals and so should be abandoned in favour of selective use of the nasogastric tube.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001878",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support or refute the use of <span class=Omission_of_Key_Facts>spinal manipulation</span> in the treatment of <span class=Population_Mismatch Omission_of_Key_Facts>tension headaches</span>.</span></span>",
            "Target Summary": "A few non-invasive physical treatments may be effective as prophylactic treatments for chronic/recurrent headaches. Based on trial results, these treatments appear to be associated with little risk of serious adverse effects. The clinical effectiveness and cost-effectiveness of non-invasive physical treatments require further research using scientifically rigorous methods. The heterogeneity of the studies included in this review means that the results of a few additional high-quality trials in the future could easily change the conclusions of our review.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005944",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support or refute the routine use of vitamin A supplementation in HIV-infected mothers and their infants to reduce infant mortality or improve immunogenicity of vaccines.</span></span></span>",
            "Target Summary": "The lack of effect on maternal and infant mortality and morbidity, with exception of some improved infant morbidity in one small study, and the improvement in maternal vitamin A status, suggest that maternal postpartum vitamin A supplementation offers limited benefits.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008607",
            "ESE Summary": "<span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>insufficient evidence</span></span> to support the use of corticosteroids for acute vestibular vertigo.</span>",
            "Target Summary": "Overall, there is currently insufficient evidence from these trials to support the administration of corticosteroids to patients with idiopathic acute vestibular dysfunction. We found no trials with a low risk of methodological bias that used the highest level of diagnostic criteria and outcome measures. We recommend that future studies should include health-related quality of life and symptom-based outcome measures, in addition to objective measures of vestibular improvement, such as caloric testing and electronystagmography.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006484",
            "ESE Summary": "<span class=Incorrect_Implication>There is insufficient evidence to determine whether <span class=Omission_of_Key_Facts>children with cancer benefit from influenza vaccination in terms of <span class=Lack_of_Focus Length>immunogenicity.</span></span></span>",
            "Target Summary": "Paediatric oncology patients receiving chemotherapy are able to generate an immune response to the influenza vaccine, but it remains unclear whether this immune response protects them from influenza infection or its complications. We are awaiting results from well-designed RCTs addressing the clinical benefit of influenza vaccination in these patients.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006309",
            "ESE Summary": "<span class=Extrinsic_Information>Interpersonal psychotherapy <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>may be an effective treatment for women with depression during pregnancy.</span></span></span> However, <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>there is insufficient evidence to recommend its use as a first-line treatment.</span></span></span>",
            "Target Summary": "The evidence is inconclusive to allow us to make any recommendations for interpersonal psychotherapy for the treatment of antenatal depression. The one trial included was too small, with a non-generalisable sample, to make any recommendations.\n[Note: The 12 citations in the awaiting classification section of the review may alter the conclusions of the review once assessed.]",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000305",
            "ESE Summary": "<span class=Extrinsic_Information>There is <span class=Lack_of_Focus Length>insufficient evidence</span> to recommend the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>LMWH</span></span> over other antithrombotic drugs</span> for the prevention of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>VTE</span></span> in patients with hip fractures.",
            "Target Summary": "U and LMW heparins protect against lower limb DVT. There is insufficient evidence to confirm either protection against pulmonary embolism or an overall benefit, or to distinguish between various applications of heparin.\nFoot and calf pumping devices appear to prevent DVT, may protect against pulmonary embolism, and reduce mortality, but compliance remains a problem.\nGood quality trials of mechanical methods as well as direct comparisons with heparin and low dose aspirin should be considered.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 3,
                    "Lack_of_Focus": 3,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007394",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus>There is <span class=Extrinsic_Information>insufficient evidence to support or refute the use of ELISA for the diagnosis of invasive aspergillosis.</span></span></span>",
            "Target Summary": "At a cut-off value 0.5 ODI in a population of 100 patients with a disease prevalence of 8% (overall median prevalence), 2 patients who have IA, will be missed (sensitivity 78%, 22% false negatives), and 17 patients will be treated or further referred unnecessarily (specificity of 81%, 19% false negatives). If we use the test at cut-off value 1.5 in the same population, that will mean that 3 IA patients will be missed (sensitivity 64%, 36% false negatives) and 5 patients will be treated or referred unnecessarily (specificity of 95%, 5% false negatives). These numbers should however be interpreted with caution, because the results were very heterogeneous.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002896",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to determine whether Vagus nerve stimulation is beneficial or harmful for people with epilepsy.</span></span></span>",
            "Target Summary": "VNS for partial seizures appears to be an effective and well tolerated treatment. Adverse effects of hoarseness, cough, pain, paresthesias, and dyspnea are associated with the treatment but appear to be reasonably well tolerated as dropouts were rare. Typical central nervous system adverse effects of antiepileptic drugs such as ataxia, dizziness, fatigue, nausea, and somnolence were not statistically significantly associated with VNS treatment.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006726",
            "ESE Summary": "There is <span class=Lack_of_Focus><span class=Inaccurate_Emphasis>some evidence</span> to support the use of <span class=Omission_of_Key_Facts>psychosocial interventions</span> for children with PTSD.</span> However, <span class=Length>the evidence is <span class=Overgeneralization>not strong enough to recommend routine use of these interventions</span>.</span> <span class=Omission_of_Key_Facts><span class=Conciseness Length><span class=Incorrect_Implication>Further research is needed.</span></span></span>",
            "Target Summary": "There is evidence for the effectiveness of psychological therapies, particularly CBT, for treating PTSD in children and adolescents for up to a month following treatment. At this stage, there is no clear evidence for the effectiveness of one psychological therapy compared to others. There is also not enough evidence to conclude that children and adolescents with particular types of trauma are more or less likely to respond to psychological therapies than others.\nThe findings of this review are limited by the potential for methodological biases, and the small number and generally small size of identified studies. In addition, there was evidence of substantial heterogeneity in some analyses which could not be explained by subgroup or sensitivity analyses.\nMore evidence is required for the effectiveness of all psychological therapies more than one month after treatment. Much more evidence is needed to demonstrate the relative effectiveness of different psychological therapies or the effectiveness of psychological therapies compared to other treatments. More details are required in future trials in regards to the types of trauma that preceded the diagnosis of PTSD and whether the traumas are single event or ongoing. Future studies should also aim to identify the most valid and reliable measures of PTSD symptoms and ensure that all scores, total and sub-scores, are consistently reported.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD004787",
            "ESE Summary": "<span class=Omission_of_Key_Facts>There is no <span class=Lack_of_Focus><span class=Extrinsic_Information>evidence to support the use of TACE</span> in patients with unresectable hepatocellular carcinoma.</span></span>",
            "Target Summary": "There is no firm evidence to support or refute TACE or TAE for patients with unresectable HCC. More adequately powered and bias-protected trials are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003096",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Length><span class=Extrinsic_Information>There is insufficient evidence from randomised controlled trials to determine whether the use of prophylactic intravenous hydration in the management of preterm labour in women with persistent contractions results in better pregnancy outcome.</span></span></span>",
            "Target Summary": "The data are too few to support the use of hydration as a specific treatment for women presenting with preterm labour. The two small studies available do not show any advantage of hydration compared to bed rest alone. Intravenous hydration does not seem to be beneficial, even during the period of evaluation soon after admission, in women with preterm labour. Women with evidence of dehydration may, however, benefit from the intervention.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003421",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus>There is some evidence to support the use of <span class=Extrinsic_Information>calcium channel blockers in patients with chronic kidney disease</span>.</span></span> <span class=Length>However, <span class=Incorrect_Implication>the evidence is not strong enough to recommend their use</span>.</span>",
            "Target Summary": "These results suggest that calcium channel blockers given in the peri-operative period may reduce the incidence of ATN post-transplantation. The result should be treated with caution due to the heterogeneity of the trials which made comparison of studies and pooling of data difficult.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003772",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>no evidence to support the routine use of oral antibiotics</span> in the treatment of acute UTIs in children.</span></span>",
            "Target Summary": "These results suggest that children with acute pyelonephritis can be treated effectively with oral antibiotics (cefixime, ceftibuten and amoxicillin/clavulanic acid) or with short courses (2 to 4 days) of IV therapy followed by oral therapy. If IV therapy is chosen, single daily dosing with aminoglycosides is safe and effective. Studies are required to determine the optimal total duration of therapy.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003467",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>insufficient evidence</span></span> to support the use of amantadine for levodopa-induced dyskinesia or motor fluctuations</span> in Parkinson's disease.",
            "Target Summary": "Due to lack of evidence it is impossible to determine whether amantadine is a safe and effective form of treatment for levodopa-induced dyskinesias in patients with Parkinson's disease.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001331",
            "ESE Summary": "High-dose <span class=Omission_of_Key_Facts>corticosteroids appear to have a <span class=Lack_of_Focus>beneficial effect on the symptoms of MS</span></span>, but <span class=Inaccurate_Emphasis><span class=Omission_of_Key_Facts><span class=Excessive_Detail>their clinical effects are unclear</span></span>.</span>",
            "Target Summary": "We found evidence favouring the corticosteroid MP for acute exacerbation in MS patients. Data are insufficient to reliably estimate effect of corticosteroids on prevention of new exacerbations and reduction of long-term disability.Studies assessing long term risk/benefit and adverse effects of corticosteroids in MS patients are urgently needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD002095",
            "ESE Summary": "Omeprazole and ranitidine are effective in relieving heartburn in patients with symptomatic GORD. <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information Ambiguity>Ranitidine and oesophagitis may be effective in reducing the frequency of heartburn, but the clinical significance is unclear.</span></span></span>",
            "Target Summary": "PPIs are more effective than H2RAs in relieving heartburn in patients with GORD who are treated empirically and in those with ENRD, although the magnitude of benefit is greater for those treated empirically.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 1,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005251",
            "ESE Summary": "The use of <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>prophylactic antibiotics in umbilical catheterisation of newborn infants cannot be recommended</span></span>. <span class=Redundancy Length>This review <span class=Inaccurate_Emphasis>highlights the <span class=Omission_of_Key_Facts>paucity of data on this intervention</span></span> and <span class=Extrinsic_Information>highlights the need for further research</span>.</span>",
            "Target Summary": "There is insufficient evidence from randomised trials to support or refute the use of prophylactic antibiotics when UVCs are inserted in newborn infants. There is no evidence to support or refute continuing antibiotics once initial cultures rule out infection in newborn infants with UVCs.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD004943",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>no evidence from randomised controlled trials</span> to support the use of <span class=Omission_of_Key_Facts>antacid prophylaxis</span> to reduce the risk of aspiration of gastric contents during caesarean section.</span></span>",
            "Target Summary": "The quality of the evidence was poor, but the findings suggest that the combination of antacids plus H2 antagonists was more effective than no intervention, and superior to antacids alone in preventing low gastric pH.However, none of the studies assessed potential adverse effects or substantive clinical outcomes. These findings are relevant for all women undergoing caesarean section under general anaesthesia.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009275",
            "ESE Summary": "<span class=Extrinsic_Information>There is insufficient evidence to determine whether a <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>low glycaemic index diet</span></span> is more effective than a <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>high glycaemia diet</span></span> in preventing pregnancy complications.</span>",
            "Target Summary": "Data for most comparisons were only available from single studies and they are too small for reliable conclusions about which types of dietary advice are the most suitable for women with GDM. Based on the current available evidence, we did not find any significant benefits of the diets investigated.\nFurther larger trials with sufficient power to assess the effects of different diets for women with GDM on maternal and infant health outcomes are needed. Outcomes such as longer-term health outcomes for women and their babies, women's quality of life and health service cost should be included.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007668",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Inaccurate_Emphasis>There is insufficient evidence to support or refute the use of psychosocial interventions for people with ASPD.</span></span></span> <span class=Omission_of_Key_Facts><span class=Length><span class=Overgeneralization>Further research is needed.</span></span></span>",
            "Target Summary": "Results suggest that there is insufficient trial evidence to justify using any psychological intervention for adults withAsPD. Disappointingly few of the included studies addressed the primary outcomes defined in this review (aggression, reconviction, global functioning, social functioning, adverse effects). Three interventions (contingency management with standard maintenance; CBT with standard maintenance; 'Driving Whilst Intoxicated program' with incarceration) appeared effective, compared to the control condition, in terms of improvement in at least one outcome in at least one study. Each of these interventions had been originally developed for people with substance misuse problems. Significant improvements were mainly confined to outcomes related to substance misuse. No study reported significant change in any specific antisocial behaviour. Further research is urgently needed for this prevalent and costly condition.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD007474",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support or refute the use of antipsychotic drugs in the treatment of schizophrenia.</span></span></span> <span class=Lack_of_Focus><span class=Omission_of_Key_Facts>Risperidone may have a therapeutic advantage over clozapine in terms of dopamine D2 blockade,</span> but this finding needs to be confirmed in larger randomised controlled trials.</span>",
            "Target Summary": "There is still lack of strong evidence for an optimal dose for clinical practice. The quality of trials suggests that an over estimate of effect is likely and we think this is most probably for the mid-range doses. One such dose (standard-lower dose range, 4-<6 mg/day) does seem optimal for clinical response and adverse effects. Weak evidence suggests that low doses (2-<4 mg/day) may be of value for people in their first episode of illness. High doses (10 mg/day) did not confer any advantage over any other dose ranges and caused more adverse effects, especially for movement disorders. Ultra low dose (<2 mg/day) seemed useless. We advise the use of dosages from low dose to standard-lower dose for different kinds of individual patients. Future trials should focus on specific populations, e.g. those in their first episode, with acute exacerbation, in relapse or refractory to treatment, and should also test the optimal dose of risperidone over a longer period of time and in the community.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002869",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Inaccurate_Emphasis>insufficient evidence to support or refute the use of antenatal education and support programs for women during pregnancy.</span></span></span>",
            "Target Summary": "The effects of general antenatal education for childbirth or parenthood, or both, remain largely unknown. Individualized prenatal education directed toward avoidance of a repeat caesarean birth does not increase the rate of vaginal birth after caesarean section.\n[Note: the 58 citations in the awaiting classification section may alter the conclusions of the review once assessed.]",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD001046",
            "ESE Summary": "<span class=Lack_of_Focus>Methylprednisolone administered within eight hours of injury <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>reduces the risk of paralysis and disabling symptoms</span></span> in patients with acute spinal cord injury.</span> However, <span class=Omission_of_Key_Facts><span class=Length>there is <span class=Inaccurate_Emphasis>insufficient evidence to determine whether this is an effect on major morbidity</span>.</span></span>",
            "Target Summary": "High-dose methylprednisolone steroid therapy is the only pharmacologic therapy shown to have efficacy in a phase three randomized trial when administered within eight hours of injury. One trial indicates additional benefit by extending the maintenance dose from 24 to 48 hours, if start of treatment must be delayed to between three and eight hours after injury. There is an urgent need for more randomized trials of pharmacologic therapy for acute spinal cord injury.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD006746",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Omission_of_Key_Facts><span class=Incorrect_Implication>There is insufficient evidence to determine whether peripheral iridotomy is superior to iridectomy</span></span> <span class=Population_Mismatch>in the treatment of primary angle-closure glaucoma.</span></span>",
            "Target Summary": "There is currently no strong evidence for laser peripheral iridoplastys use in treating angle-closure.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004888",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Extrinsic_Information><span class=Lack_of_Focus Length>insufficient evidence</span> to determine whether the addition of ribavirin to antiretroviral therapy improves virological outcomes</span></span> in HIV-infected patients.",
            "Target Summary": "Peginterferon plus ribavirin may be considered a treatment for patients with chronic hepatitis C and stable HIV who have not received treatment for hepatitis C as the intervention may clear the blood of HCV RNA. Supporting evidence comes mainly from the analysis of this non-validated surrogate outcome assessed in comparisons against other antiviral treatments. There is no evidence on treatment of patients who have relapsed or did not respond to previous therapy. Careful monitoring of adverse events is warranted.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005582",
            "ESE Summary": "Acyclovir, <span class=Extrinsic_Information>acyclovir and prednisolone are effective in the treatment of herpes zoster-related chronic pain</span>, but <span class=Lack_of_Focus Excessive_Detail>the effect of these drugs on the development of other types of neuropathic pain is unknown.</span>",
            "Target Summary": "There is moderate quality evidence that corticosteroids given acutely during zoster infection are ineffective in preventing postherpetic neuralgia. In people with acute herpes zoster the risks of administration of corticosteroids do not appear to be greater than with placebo, based on moderate quality evidence. Corticosteroids have been recommended to relieve the zoster-associated pain in the acute phase of disease. If further research is designed to evaluate the efficacy of corticosteroids for herpes zoster, long-term follow-up should be included to observe their effect on the transition from acute pain to postherpetic neuralgia. Future trials should include measurements of function and quality of life.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003458",
            "ESE Summary": "<span class=Overgeneralization>There is insufficient evidence to support or refute the use of any intervention for McArdle disease.</span> <span class=Omission_of_Key_Facts><span class=Length><span class=Incorrect_Implication>High-dose creatine, at least 75 mg/kg, appears to be more effective than placebo in improving exercise tolerance.</span></span></span>",
            "Target Summary": "Although there was low quality evidence of improvement in some parameters with creatine, oral sucrose, ramipril and a carbohydrate rich diet, none was sufficiently strong to indicate significant clinical benefit.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008591",
            "ESE Summary": "There is some evidence that <span class=Lack_of_Focus><span class=Omission_of_Key_Facts><span class=Extrinsic_Information>light therapy may be effective for the treatment of seasonal affective disorder</span></span>.</span> However, <span class=Length><span class=Omission_of_Key_Facts><span class=Inaccurate_Emphasis>the evidence is not strong enough to support the use of light therapy for this condition</span></span>.</span>",
            "Target Summary": "Evidence for the effectiveness of SGAs is limited to one small trial of fluoxetine compared with placebo, which shows a non-significant effect in favour of fluoxetine, and two small trials comparing fluoxetine against light therapy, which suggest equivalence between the two interventions. The lack of available evidence precludes the ability to draw any overall conclusions on the use of SGAs for SAD. Further larger RCTs are required to expand and strengthen the evidence base on this topic, and should also include comparisons with psychotherapy and other SGAs.\nData on adverse events were sparse, and a comparative analysis was not possible. Therefore the data we obtained on adverse effects is not robust and our confidence in the data is limited. Overall, up to 27% of participants treated with SGAs for SAD withdrew from the studies early due to adverse effects. The overall quality of evidence in this review is very low.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD007414",
            "ESE Summary": "<span class=Incorrect_Implication>Consolidation therapy with <span class=Omission_of_Key_Facts>radiotherapy or chemotherapy</span> for epithelial ovarian cancer <span class=Lack_of_Focus><span class=Omission_of_Key_Facts>prolongs PFS but not overall survival</span>.</span></span>\r\n[Note: The four citations in the awaiting classification section of the review may alter the conclusions of the study once assessed.]",
            "Target Summary": "There is no evidence to suggest that the use of platinum agents, doxorubicin or paclitaxel used as maintenance chemotherapy is more effective than observation alone. Further investigations regarding the effect of paclitaxel used as maintenance chemotherapy are required.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001998",
            "ESE Summary": "<span class=Extrinsic_Information>There is <span class=Lack_of_Focus>insufficient evidence from randomised controlled trials</span></span> to determine whether <span class=Omission_of_Key_Facts>inpatient management of symptomatic placenta previa reduces maternal and neonatal morbidity</span>.",
            "Target Summary": "There are insufficient data from trials to recommend any change in clinical practice. Available data should, however, encourage further work to address the safety of more conservative policies of hospitalisation for women with suspected placenta praevia, and the possible value of insertion of a cervical suture.\n[Note: The six citations in the awaiting classification section of the review may alter the conclusions of the review once assessed.]",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004918",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence from randomised controlled trials to determine whether <span class=Omission_of_Key_Facts>intraocular pressure control in patients with refractory glaucoma improves visual acuity</span>.</span></span>",
            "Target Summary": "Relatively few randomized trials have been published on aqueous shunts and methodology and data quality among them is poor. To date there is no evidence of superiority of one shunt over another.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005006",
            "ESE Summary": "In women with metastatic breast cancer, <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Incorrect_Implication Overgeneralization>myocet was superior to doxorubicin in terms of clinical response, time to progression and toxicity.</span></span></span> However, <span class=Omission_of_Key_Facts><span class=Excessive_Detail><span class=Extrinsic_Information>the data are limited by the small number of RCTs that were performed and the high risk of bias in the included studies.</span></span></span>",
            "Target Summary": "We are not able to favour either epirubicin or doxorubicin when given with the same dose. Based on the currently available evidence on heart failure, we conclude that in adults with a solid tumour liposomal-encapsulated doxorubicin should be favoured over doxorubicin. For both epirubicin versus doxorubicin and liposomal-encapsulated doxorubicin versus conventional doxorubicin no conclusions can be made about the effects of treatment in children treated with anthracyclines and also not in patients diagnosed with leukaemia. More research is needed. For other combinations of anthracycline derivates not enough evidence was available to make definitive conclusions about the occurrence of cardiotoxicity in patients treated with anthracyclines.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005397",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is <span class=Omission_of_Key_Facts>insufficient evidence</span> to support the effectiveness of exercise therapy for people with <span class=Population_Mismatch Omission_of_Key_Facts>BPPV</span>.</span></span> <span class=Length>There is a need for large well-designed randomised controlled trials with long-term follow-up.</span>",
            "Target Summary": "There is moderate to strong evidence that VR is a safe, effective management for unilateral peripheral vestibular dysfunction, based on a number of high quality randomised controlled trials. There is moderate evidence that VR provides a resolution of symptoms and improvement in functioning in the medium term. However, there is evidence that for the specific diagnostic group of BPPV, physical (repositioning) manoeuvres are more effective in the short term than exercise-based vestibular rehabilitation; although a combination of the two is effective for longer-term functional recovery. There is insufficient evidence to discriminate between differing forms of VR.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008643",
            "ESE Summary": "There is <span class=Extrinsic_Information>insufficient evidence from randomised trials</span> to support or refute the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Intrinsic_Information><span class=Overgeneralization>LBP</span> x-rays</span> in primary care for patients with acute or chronic LBP.</span></span>",
            "Target Summary": "The available evidence does not support the use of many red flags to specifically screen for vertebral fracture in patients presenting for LBP. Based on evidence from single studies, few individual red flags appear informative as most have poor diagnostic accuracy as indicated by imprecise estimates of likelihood ratios. When combinations of red flags were used the performance appeared to improve. From the limited evidence, the findings give rise to a weak recommendation that a combination of a small subset of red flags may be useful to screen for vertebral fracture. It should also be noted that many red flags have high false positive rates; and if acted upon uncritically there would be consequences for the cost of management and outcomes of patients with LBP. Further research should focus on appropriate sets of red flags and adequate reporting of both index and reference tests.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002992",
            "ESE Summary": "<span class=Length><span class=Intrinsic_Information Overgeneralization>Celiprolol had a small but statistically significant effect on FEV1, but was associated with a significant increase in CO2 production.</span></span> <span class=Lack_of_Focus>The effect of <span class=Intrinsic_Information Incorrect_Implication><span class=Omission_of_Key_Facts>celiproloil</span> on <span class=Omission_of_Key_Facts>FEv1</span> was not significantly different from that of placebo, but may be due to a combination of different beta-2 receptor agonists.</span></span>",
            "Target Summary": "Cardioselective beta-blockers given in mild to moderate reversible airway disease or COPD do not produce adverse respiratory effects. Given their demonstrated benefit in conditions such as heart failure, cardiac arrhythmias and hypertension, these agents should not be withheld from such patients. Long-term safety still needs to be established.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 2,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000024",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>There is no evidence to support the use of anticoagulant drugs in acute stroke patients.</span></span></span> <span class=Lack_of_Focus Length>This review was unable to address the question of <span class=Intrinsic_Information Ambiguity><span class=Omission_of_Key_Facts>dose, duration, or the effect of different types of antiepileptics</span> on mortality.</span></span>",
            "Target Summary": "Since the last version of the review, neither of the two new relevant studies have provided additional information to change the conclusions. In patients with acute ischaemic stroke, immediate anticoagulant therapy is not associated with net short or long-term benefit. Treatment with anticoagulants reduced recurrent stroke, deep vein thrombosis and pulmonary embolism, but increased bleeding risk. The data do not support the routine use of any the currently available anticoagulants in acute ischaemic stroke.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 1,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002892",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus>There is <span class=Incorrect_Implication>insufficient evidence to support or refute</span> the effectiveness of psychological interventions for reducing stress in healthcare workers.</span></span> <span class=Omission_of_Key_Facts><span class=Length><span class=Overgeneralization>Further research is needed.</span></span></span>",
            "Target Summary": "Limited evidence is available for the effectiveness of interventions to reduce stress levels in healthcare workers. Larger and better quality trials are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004194",
            "ESE Summary": "There is insufficient evidence to <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>recommend the use of any specific pacing intervention</span> for the prevention of <span class=Lack_of_Focus>vasovagal syncope</span>.</span>",
            "Target Summary": "There is insufficient evidence to support the use of any of the pharmacological or pacemaker treatments for vasovagal syncope and carotid sinus syncope. Larger studies using patient relevant outcomes are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006455",
            "ESE Summary": "There is <span class=Extrinsic_Information>insufficient evidence to recommend the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>antioxidant supplements</span></span></span> in HD.",
            "Target Summary": "Only pharmacological interventions were included and none proved to be effective as a disease-modifying therapy for HD. Further trials with greater methodological quality should be conducted using more sensitive biological markers. Pre-symptomatic mutation carriers should be included in future studies.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009154",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence</span> to determine whether progestogen supplementation during the luteal phase of IVF cycles improves live birth rates.</span></span>",
            "Target Summary": "This review showed a significant effect in favour of progesterone for luteal phase support, favouring synthetic progesterone over micronized progesterone. Overall, the addition of other substances such as estrogen or hCG did not seem to improve outcomes. We also found no evidence favouring a specific route or duration of administration of progesterone. We found that hCG, or hCG plus progesterone, was associated with a higher risk of OHSS. The use of hCG should therefore be avoided. There were significant results showing a benefit from addition of GnRH agonist to progesterone for the outcomes of live birth, clinical pregnancy and ongoing pregnancy. For now, progesterone seems to be the best option as luteal phase support, with better pregnancy results when synthetic progesterone is used.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001062",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>insufficient evidence to recommend the use of antenatal decompression for preventing pre-eclampsia.</span></span></span>",
            "Target Summary": "There is no evidence to support the use of abdominal decompression in normal pregnancies. Future research should be directed towards the use of abdominal decompression during labour, and during complicated pregnancies.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002962",
            "ESE Summary": "Acupuncture may be beneficial for induction of labour at term and to reduce the need for postpartum medication, epidural analgesia and <span class=Omission_of_Key_Facts>postpart<span class=Redundancy Length><span class=Extrinsic_Information>UM</span> pain management</span></span>. However, the evidence is not strong enough to recommend any specific type of acupuncture for this purpose.",
            "Target Summary": "There is a need for well-designed randomised controlled trials to evaluate the role of acupuncture to induce labour and for trials to assess clinically meaningful outcomes.\n[Note: the 15 citations in the awaiting classification section of the review may alter the conclusions of the review once assessed.]",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003852",
            "ESE Summary": "There is <span class=Lack_of_Focus Length><span class=Inaccurate_Emphasis>insufficient evidence</span> to determine whether <span class=Omission_of_Key_Facts>Ginkgo biloba has any effect on tinnitus</span>.</span> There is <span class=Redundancy>a need for <span class=Extrinsic_Information>large randomised controlled trials with adequate allocation concealment and blinding</span>.</span>",
            "Target Summary": "The limited evidence does not demonstrate that Ginkgo biloba is effective for tinnitus when this is the primary complaint.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD007404",
            "ESE Summary": "<span class=Incorrect_Implication>There is insufficient evidence to support or refute the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>calcitonin</span></span> for patients with <span class=Population_Mismatch><span class=Lack_of_Focus>central giant cell granuloma</span></span>.</span>",
            "Target Summary": "We did not find RCTs evaluating the effects of primary surgical versus primary non-surgical interventions for central giant cell granuloma of the jaws. Although a number of non-surgical therapies have been proposed for treating central giant cell granuloma of the jaws, our review did not identify evidence from RCTs to support their use. More research is needed on this topic.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004425",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Intrinsic_Information Overgeneralization>There is <span class=Omission_of_Key_Facts>insufficient evidence to determine whether the use of EE/LNG is associated with a reduction in acne lesions, a better progestogen-free cycle or a better quality of life.</span></span></span> <span class=Length><span class=Incorrect_Implication>There is a need for more RCTs to evaluate the efficacy of other OCPs.</span></span>",
            "Target Summary": "This update yielded six new trials but no change in conclusions. The six COCs evaluated in placebo-controlled trials are effective in reducing inflammatory and non-inflammatory facial acne lesions. Few important and consistent differences were found between COC types in their effectiveness for treating acne. How COCs compare to alternative acne treatments is unknown since only one trial addressed this issue. The use of standardized methods for assessing acne severity would help in synthesizing results across trials as well as aid in interpretation.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007066",
            "ESE Summary": "Direct renin inhibitors <span class=Overgeneralization>reduce blood pressure more than either <span class=Omission_of_Key_Facts>placebo or active comparators</span>.</span> However, the <span class=Ambiguity>magnitude of the effect on <span class=Omission_of_Key_Facts><span class=Length><span class=Length>DBP</span></span> and DBP lowering</span> with direct renin inhibitor treatment is not known.</span>",
            "Target Summary": "Aliskiren has a dose-related blood pressure lowering effect better than placebo. This effect is similar to that determined for ACE inhibitors and ARBs.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 1,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007224",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to determine whether <span class=Omission_of_Key_Facts>off-pump coronary artery bypass grafting reduces mortality or morbidity</span> in patients with coronary artery disease.</span></span>",
            "Target Summary": "Our systematic review did not demonstrate any significant benefit of off-pump compared with on-pump CABG regarding mortality, stroke, or myocardial infarction. In contrast, we observed better long-term survival in the group of patients undergoing on-pump CABG with the use of cardiopulmonary bypass and cardioplegic arrest. Based on the current evidence, on-pump CABG should continue to be the standard surgical treatment. However, off-pump CABG may be acceptable when there are contraindications for cannulation of the aorta and cardiopulmonary bypass. Further randomised clinical trials should address the optimal treatment in such patients.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002200",
            "ESE Summary": "<span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>no evidence from randomised trials</span> to support the use of <span class=Lack_of_Focus>intensive follow-up for patients with colorectal cancer</span>.</span></span>",
            "Target Summary": "The results of our review suggest that there is an overall survival benefit for intensifying the follow up of patients after curative surgery for colorectal cancer. Because of the wide variation in the follow-up programmes used in the included studies it is not possible to infer from the data the best combination and frequency of clinic (or family practice) visits, blood tests, endoscopic procedures and radiological investigations to maximise the outcomes for these patients. Nor is it possible to estimate the potential harms or costs of intensifying follow up for these patients in order to adopt a cost-effective approach in this clinical area. Large clinical trials underway or about to commence are likely to contribute valuable further information to clarify these areas of clinical uncertainty.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003260",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of cognitive rehabilitation for people with dementia.</span></span></span> <span class=Omission_of_Key_Facts><span class=Length><span class=Overgeneralization>There is a need for large, well-designed randomised controlled trials.</span></span></span>",
            "Target Summary": "Available evidence regarding cognitive training remains limited, and the quality of the evidence needs to improve. However, there is still no indication of any significant benefit derived from cognitive training. Trial reports indicate that some gains resulting from intervention may not be captured adequately by available standardised outcome measures. The results of the single RCT of cognitive rehabilitation show promise but are preliminary in nature. Further, well-designed studies of cognitive training and cognitive rehabilitation are required to obtain more definitive evidence. Researchers should describe and classify their interventions appropriately using available terminology.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007672",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence to support the use of any specific type of specialist nursing intervention for patients with cancer.</span></span></span> <span class=Length><span class=Incorrect_Implication>Further research is needed.</span></span>",
            "Target Summary": "Results from this Cochrane review do not allow us to conclude on the effectiveness of included interventions to improve continuity of care on patient, healthcare provider or process of care outcomes. Future research should evaluate interventions that target an improvement in continuity as their primary objective and describe these interventions with the categories proposed in this review. Also of importance, continuity measures should be validated with persons with cancer who have been followed in various settings.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002783",
            "ESE Summary": "There is no evidence to support the use of <span class=Lack_of_Focus><span class=Extrinsic_Information Incorrect_Implication><span class=Omission_of_Key_Facts>heparin or rt-PA</span> in the treatment of <span class=Population_Mismatch>acute deep vein thrombosis</span>.</span></span>",
            "Target Summary": "Thrombolysis appears to offer advantages in terms of reducing post-thrombotic syndrome and maintaining venous patency after DVT. Use of strict eligibility criteria has improved the safety and acceptability of this treatment. The optimum drug, dose and route of administration have yet to be determined.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009202",
            "ESE Summary": "<span class=Extrinsic_Information>There is <span class=Lack_of_Focus>insufficient evidence from <span class=Population_Mismatch>randomised controlled trials</span></span></span> to determine the <span class=Redundancy Length>relative effects of <span class=Intervention_Mismatch><span class=Intrinsic_Information>propofol and barbiturates</span></span></span> for patients with <span class=Omission_of_Key_Facts>refractory status epilepticus</span>.",
            "Target Summary": "There is lack of robust and randomised controlled evidence that can clarify the efficacy of propofol and thiopental sodium over each other in the treatment of RSE. There is a need for large, randomised controlled trials for this serious condition.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 1,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000246",
            "ESE Summary": "Antibiotic treatment in women with preterm labour <span class=Omission_of_Key_Facts><span class=Length><span class=Extrinsic_Information Overgeneralization>reduces the risk of preterm birth, perinatal mortality and the need for neonatal intensive care.</span></span></span>",
            "Target Summary": "This review fails to demonstrate a clear overall benefit from prophylactic antibiotic treatment for preterm labour with intact membranes on neonatal outcomes and raises concerns about increased neonatal mortality for those who received antibiotics. This treatment cannot therefore be currently recommended for routine practice. Further research may be justified (when sensitive markers for subclinical infection become available) in order to determine if there is a subgroup of women who could experience benefit from antibiotic treatment for preterm labour prior to membrane rupture, and to identify which antibiotic or combination of antibiotics is most effective.\n[Note: The 17 citations in the awaiting classification section of the review may alter the conclusions of the review once assessed.]",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003594",
            "ESE Summary": "Tacrolimus appears to be <span class=Incorrect_Implication>more effective than <span class=Intervention_Mismatch><span class=Lack_of_Focus>placebo</span></span></span> in inducing remission in SRNS. However, there is <span class=Omission_of_Key_Facts><span class=Length><span class=Inaccurate_Emphasis>insufficient evidence to recommend the use of this drug in the treatment of patients with refractory nephrotic syndrome</span>.</span></span>",
            "Target Summary": "Further adequately powered, well designed RCTs are needed to confirm the efficacy of cyclosporin and to evaluate other regimens for idiopathic SRNS including high dose steroids with cyclosporin.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 1,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD002255",
            "ESE Summary": "There is <span class=Lack_of_Focus Length><span class=Omission_of_Key_Facts><span class=Extrinsic_Information>no evidence to support the use of calcium channel blockers</span></span> for women with preterm labour.</span>",
            "Target Summary": "When tocolysis is indicated for women in preterm labour, calcium channel blockers are preferable to other tocolytic agents compared, mainly betamimetics. Further research should address the effects of different dosage regimens and formulations of calcium channel blockers on maternal and neonatal outcomes.\n[Note: The 39 citations in the awaiting classification section of the review may alter the conclusions of the review once assessed.]",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000460",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Length><span class=Incorrect_Implication>The results of this review suggest that the use of tartrazine in chronic asthma cannot be ruled out.</span></span></span> However, this conclusion is based on a small number of patients, most of whom have not responded to an ASA challenge before, and the results of a large scale randomised controlled trial.",
            "Target Summary": "Due to the paucity of available evidence, it is not possible to provide firm conclusions as to the effects of tartrazine on asthma control. However, the six RCTs that could be included in this review all arrived at the same conclusion. Routine tartrazine exclusion may not benefit most patients, except those very few individuals with proven sensitivity.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006385",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>There is insufficient evidence from randomised controlled trials to determine whether arthrocentesis or lavage is more effective than open surgery in the management of closed lock.</span></span></span>",
            "Target Summary": "Both arthroscopy and nonsurgical treatments reduced pain after 6 months. When compared with arthroscopy, open surgery was more effective at reducing pain after 12 months. Nevertheless, there were no differences in mandibular functionality or in other outcomes in clinical evaluations. Arthroscopy led to greater improvement in maximum interincisal opening after 12 months than arthrocentesis; however, there was no difference in pain.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003673",
            "ESE Summary": "<span class=Omission_of_Key_Facts>There is <span class=Lack_of_Focus>insufficient evidence to support or refute the use of indomethacin to prevent cognitive impairment in people with Alzheimer's disease.</span></span>",
            "Target Summary": "On the basis of this one trial and subsequent analysis of data as reported by the authors, indomethacin cannot be recommended for the treatment of mild to moderate severity Alzheimer's disease. At doses of 100-150 mg daily, serious side effects will limit its use.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD005486",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support or refute the use of <span class=Omission_of_Key_Facts>silver-releasing dressings in the management of critically colonised leg ulcers.</span></span></span> Further well-designed, conducted and reported randomised trials are needed.",
            "Target Summary": "Only three trials with a short follow-up duration were found. There is insufficient evidence to recommend the use of silver-containing dressings or topical agents for treatment of infected or contaminated chronic wounds.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007771",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>insufficient evidence</span></span></span> to recommend the use of <span class=Intervention_Mismatch><span class=Lack_of_Focus><span class=Extrinsic_Information>anti-inflammatory drugs</span></span></span> in the treatment of <span class=Population_Mismatch><span class=Lack_of_Focus><span class=Overgeneralization>rheumatoid arthritis</span></span></span>.",
            "Target Summary": "The evidence base for the use of vitamin D for chronic pain in adults is poor at present. This is due to low quality and insufficient randomised controlled trials in this area of research.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 1,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 3,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006193",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence from randomised controlled trials to determine the relative effects of <span class=Omission_of_Key_Facts>cement versus uncemented fixation</span> in total knee arthroplasty.</span></span>",
            "Target Summary": "There was a smaller displacement of the cemented tibial component in relation to the cementless fixation in studies with osteoarthritis and rheumatoid arthritis participants who underwent primary total knee prosthesis with a follow-up of two years; however, the cemented fixation presented a greater risk of future aseptic loosening than cementless fixation.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005087",
            "ESE Summary": "There is insufficient evidence to support the use of <span class=Omission_of_Key_Facts><span class=Extrinsic_Information><span class=Length>nebulised amiloride</span> for the treatment of <span class=Excessive_Detail>pulmonary exacerbations in people with cystic fibrosis</span>.</span></span> The included trials were <span class=Overgeneralization><span class=Length>small, of poor methodological quality and had a high risk of bias</span>.</span> <span class=Omission_of_Key_Facts>Further trials are needed to assess the efficacy of <span class=Intrinsic_Information><span class=Redundancy>amilORide</span> for <span class=Redundancy>pulmonary exacerbation in people who have cystic Fibrosis</span>.</span></span>",
            "Target Summary": "We found no evidence that the topical administration of a short-acting sodium channel blocker improves respiratory condition in people with cystic fibrosis and some limited evidence of deterioration in lung function.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 2,
                    "Length": 2,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006904",
            "ESE Summary": "There is evidence that <span class=Omission_of_Key_Facts><span class=Length><span class=Extrinsic_Information>VMPs reduce the duration of mechanical ventilation and the length of hospital stay</span></span> in mechanically ventilated medical patients.</span> There is <span class=Lack_of_Focus><span class=Incorrect_Implication>no evidence of a difference in mortality or reintubation rates between VMP and usual care</span>.</span>",
            "Target Summary": "There is some evidence of a reduction in the duration of mechanical ventilation, weaning duration and ICU LOS with use of standardized protocols, but there is significant heterogeneity among studies and an insufficient number of studies to investigate the source of this heterogeneity. Although some study authors suggest that organizational context may influence outcomes, these factors were not considered in all included studies and therefore could not be evaluated.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003147",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support the use of <span class=Omission_of_Key_Facts>PEP as a treatment for pulmonary exacerbations</span> in cystic fibrosis.</span></span>",
            "Target Summary": "There was no clear evidence that PEP was a more or less effective intervention overall than other forms of physiotherapy. There was limited evidence that PEP was preferred by participants compared to other techniques, but this finding is from studies of low quality.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001059",
            "ESE Summary": "There is some evidence that calcium supplementation during pregnancy reduces the risk of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>preterm birth</span>, <span class=Extrinsic_Information>preterm delivery</span>, and maternal and neonatal morbidity</span></span>. However, the evidence is not strong enough to recommend routine use of this intervention.\r\n[Note: The four citations in the awaiting classification section of the review may alter the conclusions of the reviews once assessed.]",
            "Target Summary": "Calcium supplementation appears to approximately halve the risk of pre-eclampsia, to reduce the risk of preterm birth and to reduce the occurrence of the composite outcome 'death or serious morbidity'. We considered the latter benefit to outweigh the increase in HELLP syndrome, which was small in absolute numbers. There were no other clear benefits, or harms.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 2,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006505",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Incorrect_Implication>Current evidence does not support the routine use of influenza vaccine in patients with cancer.</span></span></span> However, <span class=Omission_of_Key_Facts><span class=Redundancy Length>the small number of studies and the small sample sizes limit the conclusions that can be drawn from this review.</span></span>",
            "Target Summary": "Inactivated VZV vaccine might reduce zoster severity in adult SCT recipients. Inactivated influenza vaccine might reduce respiratory infections and hospitalization in adults with multiple myeloma or children with leukemia or lymphoma. However, the quality of evidence is low. Local adverse effects occur frequently. Further high-quality RCTs are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 2,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006533",
            "ESE Summary": "Duloxetine <span class=Inaccurate_Emphasis>is efficacious for the acute treatment of major depressive disorder.</span> However, <span class=Ambiguity>it is not clear whether efficacy is <span class=Omission_of_Key_Facts><span class=Length>maintained or maintained</span></span>.</span>\r\n\r\n\r\n2008: The available evidence is insufficient to recommend the use of this drug for the treatment of depressive disorders.\r\n2010: The most recent version of this review was published in 2009. \r\n2008 : The results of this updated review have not changed.",
            "Target Summary": "Duloxetine did not seem to provide a significant advantage in efficacy over other antidepressive agents for the acute-phase treatment of major depression. No differences in terms of efficacy were found, even though duloxetine was worse than some SSRIs (most of all, escitalopram) and newer antidepressants (like venlafaxine) in terms of acceptability and tolerability. Unfortunately, we only found evidence comparing duloxetine with a handful of other active antidepressive agents and only a few trials per comparison were found (in some cases we retrieved just one trial). This limited the power of the review to detect moderate, but clinically meaningful differences between the drugs. As many statistical tests have been used in the review, the findings from this review are better thought of as hypothesis forming rather than hypothesis testing and it would be very comforting to see the conclusions replicated in future trials. Most of included studies were sponsored by the drug industry manufacturing duloxetine. As for all other new investigational compounds, the potential for overestimation of treatment effect due to sponsorship bias should be borne in mind. In the present review no trials reported economic outcomes. Given that several SSRIs and the great majority of antidepressants are now available as generic formulation (only escitalopram, desvenlafaxine and duloxetine are still on patent), more comprehensive economic estimates of antidepressant treatment effect should be considered to better inform healthcare policy.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 1,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD001715",
            "ESE Summary": "Sertindole <span class=Incorrect_Implication>may be effective in the treatment of schizophrenia</span>, but it is associated with <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>extrapyramidal symptoms</span></span></span> and <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>a long-term dependency on other drugs</span></span></span>.",
            "Target Summary": "Sertindole at a dose of 20mg/day was found to be more antipsychotic than placebo. When used at 8, 12 or 20mg/day it appears to be as acceptable as placebo (in terms of various adverse events including movement disorders and somnolence), but seems to be associated with more cardiac problems (8, 12 or 20mg/day) and an increase in weight gain (20mg/day) than placebo.\nSertindole at a dose of 24mg/day was better tolerated than haloperidol (in terms of participants leaving the study early). It was also found to be was associated with fewer movement disorders (at 8, 16, 20 or 24mg/day) and sedation (8 or 24mg/day) than haloperidol. However, it was shown to cause more cardiac anomalies (16, 20 or 24mg/day), weight gain (all doses combined), rhinitis (16 or 24mg/day), and problems with sexual functioning (24mg/day) than haloperidol. One short term study reported that sertindole 16mg/day was the most optimal dose.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 2,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000345",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>insufficient evidence</span></span> to recommend the use of corticosteroids for chronic hepatitis B.</span>",
            "Target Summary": "Pretreatment with glucocorticosteroids before treatment with alfa interferon in patients with hepatitis B 'e' antigen positive chronic hepatitis B may be more effective than treatment with alfa interferon alone with regard to loss of hepatitis B 'e' antigen and hepatitis B virus DNA, but evidence for effect on clinical outcomes is lacking.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004495",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Incorrect_Implication>There is insufficient evidence to recommend the use of ceftazidime as a first-line antibiotic in infants less than 48 hours old with suspected sepsis.</span></span></span>",
            "Target Summary": "There is no evidence from randomised trials to suggest that any antibiotic regimen may be better than any other in the treatment of presumed early neonatal sepsis. More studies are needed to resolve this issue.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004219",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is no evidence to support or refute the use of peripheral intravenous catheters in preterm infants to reduce the risk of systemic infection.</span></span></span>",
            "Target Summary": "Data from one small study suggest that using a percutaneous central venous catheter to deliver parenteral nutrition improves nutrient input. The significance of this in relation to long-term growth and developmental outcomes is unclear. Three studies suggested that the use of a percutaneous central venous catheter decreases the number of catheters/cannulae needed to deliver the nutrition. No evidence was found to suggest that percutaneous central venous catheter use increased the risk of adverse events, particularly systemic infection.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002246",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence to support the use of safety education to reduce injury rates in children with burns.</span></span></span> <span class=Length><span class=Incorrect_Implication>There is a need for <span class=Omission_of_Key_Facts>high quality randomised controlled trials to evaluate the effectiveness of interventions to reduce injuries in children.</span></span></span>",
            "Target Summary": "This review found that programmes to promote smoke alarms have at most modest beneficial effects on smoke alarm ownership and function, and no demonstrated beneficial effect on fires or fire-related injuries. Counselling as part of child health surveillance has a somewhat greater effect on smoke alarm ownership and function, but its effects on injuries are unevaluated. Community smoke alarm give-away programmes have not been demonstrated to increase smoke alarm prevalence or to reduce fires or fire-related injuries. Community-based education programmes have not been shown to reduce burns or fire-related injuries. Community smoke alarm installation programmes may increase the prevalence of working alarms and reduce fire-related injuries, but these results require confirmation, and the cost-effectiveness of such programmes has not been evaluated. Efforts to promote smoke alarms through installation programmes should be evaluated by adequately designed randomised controlled trials measuring injury outcomes and cost-effectiveness.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD010611",
            "ESE Summary": "There is no evidence to support the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>valproex sodium</span></span></span> in the treatment of <span class=Population_Mismatch><span class=Lack_of_Focus Length><span class=Incorrect_Implication>acute migraine</span></span></span>.",
            "Target Summary": "Valproate is effective in reducing headache frequency and is reasonably well tolerated in adult patients with episodic migraine.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008302",
            "ESE Summary": "The available evidence suggests that the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>131I in patients with hypothyroid cancer</span></span></span> is associated with a <span class=Lack_of_Focus><span class=Incorrect_Implication>lower risk of radiation exposure</span></span> and a <span class=Lack_of_Focus><span class=Incorrect_Implication>higher rate of radioiodine uptake</span></span>. However, this conclusion is based on a <span class=Excessive_Detail><span class=Overgeneralization>small number of studies with a high risk of bias</span></span> and is <span class=Incorrect_Implication>not supported by the results of the included studies</span>.",
            "Target Summary": "Results from four randomised controlled clinical trials suggest that rhTSH is as effective as THW on iodine-131 thyroid remnant ablation, with limited data on significant benefits in decreased whole body radiation exposure and health-related quality of life. It is still uncertain whether lower iodine-131 doses (1110 MBq or 1850 MBq versus 3700 MBq) are equally effective for remnant ablation under rhTSH stimulation. Randomised controlled clinical trials are needed to guide treatment selection for metastatic differentiated thyroid cancer.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 3,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 3,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005129",
            "ESE Summary": "Prophylactic <span class=Omission_of_Key_Facts><span class=Length><span class=Extrinsic_Information>immunoglobulins reduce the incidence of primary CMV disease</span></span> in kidney transplant recipients.</span> The effect of prophylaxis on <span class=Omission_of_Key_Facts><span class=Ambiguity>secondary CMV infection is unknown</span>.</span>",
            "Target Summary": "Currently there are no indications for IgG in the prophylaxis of CMV disease in recipients of solid organ transplants.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 1,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007693",
            "ESE Summary": "<span class=Lack_of_Focus>There is <span class=Extrinsic_Information><span class=Omission_of_Key_Facts>insufficient evidence</span> to determine whether fluoride exposure to children in fluoridated countries affects the incidence of fluorosis.</span></span>",
            "Target Summary": "There should be a balanced consideration between the benefits of topical fluorides in caries prevention and the risk of the development of fluorosis. Most of the available evidence focuses on mild fluorosis. There is weak unreliable evidence that starting the use of fluoride toothpaste in children under 12 months of age may be associated with an increased risk of fluorosis. The evidence for its use between the age of 12 and 24 months is equivocal. If the risk of fluorosis is of concern, the fluoride level of toothpaste for young children (under 6 years of age) is recommended to be lower than 1000 parts per million (ppm).\nMore evidence with low risk of bias is needed. Future trials assessing the effectiveness of different types of topical fluorides (including toothpastes, gels, varnishes and mouthrinses) or different concentrations or both should ensure that they include an adequate follow-up period in order to collect data on potential fluorosis. As it is unethical to propose RCTs to assess fluorosis itself, it is acknowledged that further observational studies will be undertaken in this area. However, attention needs to be given to the choice of study design, bearing in mind that prospective, controlled studies will be less susceptible to bias than retrospective and/or uncontrolled studies.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004487",
            "ESE Summary": "Single dose <span class=Omission_of_Key_Facts><span class=Length><span class=Extrinsic_Information>paracetamol 1000 mg</span></span></span> is an effective analgesic for moderate to severe postoperative pain, with a <span class=Excessive_Detail><span class=Overgeneralization>statistically significant effect on pain intensity greater than 50%</span></span> with a single dose. The dose is also associated with a <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>higher incidence of adverse events</span></span></span>.",
            "Target Summary": "Paracetamol is a safe, effective drug for the treatment of postoperative pain following the surgical removal of lower wisdom teeth.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008388",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Inaccurate_Emphasis>There is insufficient evidence to <span class=Omission_of_Key_Facts>support or refute the use of visual field training</span> in people with visual field defects.</span></span> <span class=Length>Further research is needed.</span>",
            "Target Summary": "There is limited evidence which supports the use of compensatory scanning training for patients with visual field defects (and possibly co-existing visual neglect) to improve scanning and reading outcomes. There is insufficient evidence to reach a conclusion about the impact of compensatory scanning training on functional activities of daily living. There is insufficient evidence to reach generalised conclusions about the benefits of visual restitution training (VRT) (restitutive intervention) or prisms (substitutive intervention) for patients with visual field defects after stroke.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD001073",
            "ESE Summary": "<span class=Length><span class=Overgeneralization>There is insufficient evidence to determine whether the use of <span class=Population_Mismatch Omission_of_Key_Facts>D-penicillamine to prevent retinopathy of prematurity in preterm infants with low birthweights</span> is worthwhile.</span></span>",
            "Target Summary": "D-penicillamine is unlikely to affect survival, and may reduce the incidence of acute ROP among survivors. Studies to date justify further investigation of this drug in a broader population; careful attention to possible side effects is needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000168",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is no evidence to support or refute the use of pre-operative traction for hip fractures.</span></span></span>",
            "Target Summary": "From the evidence available, the routine use of traction (either skin or skeletal) prior to surgery for a hip fracture does not appear to have any benefit. However, the evidence is also insufficient to rule out the potential advantages for traction, in particular for specific fracture types, or to confirm additional complications due to traction use.\nGiven the increasing lack of evidence for the use of pre-operative traction, the onus should now be on clinicians who persist in using pre-operative traction to either stop using it or to use it only in the context of a well-designed randomised controlled trial.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002855",
            "ESE Summary": "The available evidence suggests that the combination of mifepristone and misoprostol is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>more effective than the combination alone</span></span></span>. However, there is <span class=Ambiguity>insufficient evidence to determine whether the combination is superior to the same regimen of medication</span>.\r\n[Note: The four citations in the awaiting classification section of the review may alter the conclusions of the reviews once assessed.]",
            "Target Summary": "Safe and effective medical abortion methods are available. Combined regimens are more effective than single agents. In the combined regimen, the dose of mifepristone can be lowered to 200 mg without significantly decreasing the method effectiveness. Vaginal misoprostol is more effective than oral administration, and has less side effects than sublingual or buccal. Some results are limited by the small numbers of participants on which they are based. Almost all trials were conducted in settings with good access to emergency services, which may limit the generalizability of these results.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 1,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004740",
            "ESE Summary": "<span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>insufficient evidence to recommend the use of any of the topical preparations in the treatment of acute otitis externa.</span></span></span> <span class=Inaccurate_Emphasis>The use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>topical preparations with antibiotics appears to be safe.</span></span></span>",
            "Target Summary": "There is a paucity of high quality trials evaluating interventions for acute otitis externa. The results of this systematic review are largely based on odds ratios calculated from single trials, most of which have very broad 95% confidence intervals because of small to modest sample sizes. The findings may not be wholly generalisable to primary care for a variety of reasons; only two of the 19 trials included in the review were conducted in a primary care population setting, and in 11 of the 19 trials ear cleaning formed part of the treatment (an intervention unlikely to be available in primary care). Despite these reservations, some meaningful conclusions can be drawn from the evidence available:\nTopical treatments alone, as distinct from systemic ones, are effective for uncomplicated acute otitis externa. In most cases the choice of topical intervention does not appear to influence the therapeutic outcome significantly. Any observed differences in efficacy were usually minor and not consistently present at each follow-up visit. Acetic acid was effective and comparable to antibiotic/steroid at week 1. However, when treatment needed to be extended beyond this point it was less effective. In addition, patient symptoms lasted two days longer in the acetic acid group compared to antibiotic/steroid.\nThe evidence for steroid-only drops is very limited and as yet not robust enough to allow us to reach a conclusion or provide recommendations. Further investigation is needed.\nGiven that most topical treatments are equally effective, it would appear that in most cases the preferred choice of topical treatment may be determined by other factors, such as risk of ototoxicity, risk of contact sensitivity, risk of developing resistance, availability, cost and dosing schedule. Factors such as speed of healing and pain relief are yet to be determined for many topical treatments and may also influence this decision.\nPatients prescribed antibiotic/steroid drops can expect their symptoms to last for approximately six days after treatment has begun. Although patients are usually treated with topical medication for seven to 10 days it is apparent that this will undertreat some patients and overtreat others. It may be more useful when prescribing ear drops to instruct patients to use them for at least a week. If they have symptoms beyond the first week they should continue the drops until their symptoms resolve (and possibly for a few days after), for a maximum of a further seven days. Patients with persisting symptoms beyond two weeks should be considered treatment failures and alternative management initiated.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD004884",
            "ESE Summary": "There is insufficient evidence to support or refute the use of antibiotics in the treatment of acute traumatic pneumocephalus. <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information Incorrect_Implication>Antibiotics should not be used in the presence of an open or basilar fracture.</span></span></span>",
            "Target Summary": "Currently available evidence from RCTs does not support prophylactic antibiotic use in patients with BSF, whether there is evidence of CSF leakage or not. Until more research is completed, the effectiveness of antibiotics in patients with BSF cannot be determined because studies published to date are flawed by biases. Large, appropriately designed RCTs are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001694",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus>There is no evidence from randomised controlled trials to support or refute the use of <span class=Extrinsic_Information>nebulised furosemide</span> in preterm infants with <span class=Intrinsic_Information>chronic lung disease</span>.</span></span>",
            "Target Summary": "In preterm infants > 3 weeks with CLD administration of a single dose of aerosolized furosemide improves pulmonary mechanics. In view of the lack of data from randomized trials concerning effects on important clinical outcomes, routine or sustained use of aerosolized loop diuretics in infants with (or developing) CLD cannot be recommended based on current evidence.\nRandomized controlled trials are needed to evaluate clinically important effects of aerosolized diuretics.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006660",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is currently <span class=Omission_of_Key_Facts>no evidence to support or refute the use of any intervention for preventing or treating bacterial infection following liver transplantation.</span></span></span>",
            "Target Summary": "Currently, there is no clear evidence for any intervention offering significant benefits in the reduction of bacterial infections and wound complications in liver transplantation. Selective bowel decontamination increases the risk of infection and hospital stay compared to prebiotics and probiotics. The use of prebiotics and probiotics offers promise. Further randomised clinical trials are necessary.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005952",
            "ESE Summary": "There is <span class=Extrinsic_Information>insufficient evidence</span> to support the effectiveness of <span class=Lack_of_Focus><span class=Omission_of_Key_Facts><span class=Overgeneralization>occupational therapy interventions</span> in improving mobility</span> in post-stroke patients.</span>",
            "Target Summary": "This review highlights the dearth of evidence investigating long-term therapy-based rehabilitation interventions for patients with stroke.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007926",
            "ESE Summary": "Progestins <span class=Extrinsic_Information>are <span class=Omission_of_Key_Facts>effective in the treatment of advanced or recurrent endometrial cancer.</span></span> However, <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Incorrect_Implication>there is insufficient evidence to conclude that they are effective.</span></span></span>",
            "Target Summary": "We found insufficient evidence that hormonal treatment in any form, dose or as part of combination therapy improves the survival of patients with advanced or recurrent endometrial cancer. However, a large number of patients would be needed to demonstrate an effect on survival and none of the included RCTs had a sufficient number of patients to demonstrate a significant difference. In the absence of a proven survival advantage and the heterogeneity of patient populations, the decision to use any type of hormonal therapy should be individualised and with the intent to palliate the disease. It is debatable whether outcomes such as quality of life, treatment response or palliative measures such as relieving symptoms should take preference over overall and PFS as the major objectives of future trials.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006665",
            "ESE Summary": "There is <span class=Extrinsic_Information Overgeneralization>insufficient evidence from <span class=Omission_of_Key_Facts>randomised controlled trials</span></span> to support or refute the use of <span class=Lack_of_Focus Length><span class=Intervention_Mismatch>AA</span> for the treatment of <span class=Population_Mismatch>tetanus</span>.</span>",
            "Target Summary": "A single, non-randomised, poorly reported trial of vitamin C as a treatment for tetanus suggests a considerable reduction in mortality. However, concerns about trial quality mean that this result must be interpreted with caution and that vitamin C cannot be recommended as a treatment for tetanus on the basis of this evidence. New trials should be carried out to examine the effect of vitamin C on tetanus treatment.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 1,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005421",
            "ESE Summary": "There is <span class=Inaccurate_Emphasis>insufficient evidence</span> to support or refute the effectiveness of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Overgeneralization>parent-child interventions</span></span> for preventing <span class=Lack_of_Focus>sexually transmitted infections</span> among young people.</span>",
            "Target Summary": "Evidence does not indicate that abstinence-only interventions effectively decrease or exacerbate HIV risk among participants in high-income countries; trials suggest that the programs are ineffective, but generalizability may be limited to US youth. Should funding continue, additional resources could support rigorous evaluations with behavioral or biological outcomes. More trials comparing abstinence-only and abstinence-plus interventions are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD003212",
            "ESE Summary": "There is no evidence to support the use of <span class=Intervention_Mismatch Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>NPCPAP</span></span></span> in preterm infants with RDS who are unable to be extubated. There is insufficient evidence to determine whether <span class=Intervention_Mismatch Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Intrinsic_Information>NPCPap</span></span></span> is more effective than <span class=Intervention_Mismatch Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Inaccurate_Emphasis>NCPAP</span></span></span> in preventing extubation failure in very low birth weight infants.",
            "Target Summary": "Implications for practice: NIPPV is a useful method of augmenting the beneficial effects of NCPAP in preterm infants. Its use reduces the incidence of symptoms of extubation failure more effectively than NCPAP. Within the limits of the small numbers of infants randomised to NIPPV there is a reassuring absence of the gastrointestinal side effects that were reported in previous case series.\nImplications for research: Future trials should enroll a sufficient number of infants to detect differences in important outcomes such as chronic lung disease and gastrointestinal perforation. The impact of synchronisation of NIPPV on the technique's safety and efficacy should be established in future trials.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 3,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 3
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 3,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD006715",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence to support or refute the use of TEA in patients undergoing CABG surgery.</span></span></span>",
            "Target Summary": "This meta-analysis of studies, identified to 2010, showed that the use of TEA in patients undergoing coronary artery bypass graft surgery may reduce the risk of postoperative supraventricular arrhythmias and respiratory complications. There were no effects of TEA with GA on the risk of mortality, myocardial infarction or neurological complications compared with GA alone.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009755",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support or refute the use of <span class=Omission_of_Key_Facts>selenium supplements for preventing or treating neonatal morbidity and mortality in pregnant women with HIV.</span></span></span>",
            "Target Summary": "In keeping with previous World Health Organization (WHO) recommendations everything possible should be done to promote and support adequate dietary intake of micronutrients, while recognising that this may not be sufficient to correct specific micronutrient deficiencies in all HIV-infected individuals.\nSpecific recommendations for pregnant and lactating women infected with HIV would be to include the provision of multivitamin supplements in single RDA formulations during the antenatal period and at least for 6 weeks post-partum, especially for women who are breast-feeding.\nThere is no conclusive evidence to provide stand-alone zinc or selenium supplementation to HIV-infected pregnant and lactating women.\nMicronutrient supplementation should not be used as a substitute for provision of recommended antiretroviral medication for preventing mother-to-child transmission of HIV and treating maternal HIV infection when this is recommended.\nFurther trials of single supplements are required to build the evidence base. The long-term clinical benefits, adverse effects, and optimal formulation of multiple micronutrient supplements require further investigation in pregnant women at different stages of HIV infection.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005496",
            "ESE Summary": "Prophylactic probiotics have been shown to <span class=Lack_of_Focus><span class=Omission_of_Key_Facts><span class=Inaccurate_Emphasis>reduce the incidence of NEC</span></span> in preterm infants.</span> However, <span class=Redundancy Length>the evidence is <span class=Overgeneralization>not strong enough to <span class=Omission_of_Key_Facts>recommend routine clinical use</span></span>.</span>",
            "Target Summary": "Enteral supplementation of probiotics prevents severe NEC and all cause mortality in preterm infants. Our updated review of available evidence supports a change in practice. More studies are needed to assess efficacy in ELBW infants and assess the most effective formulation and dose to be utilized.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD000483",
            "ESE Summary": "There is <span class=Incorrect_Implication>insufficient evidence to support or refute the use of prophylactic HV therapy</span> in patients with <span class=Population_Mismatch>subarachnoid haemorrhage</span>. <span class=Length>Further <span class=Overgeneralization>randomised controlled trials are needed</span>.</span>",
            "Target Summary": "The effects of volume expansion therapy have been studied properly in only two trials of patients with aneurysmal SAH, with very small numbers. At present, there is no sound evidence for the use of volume expansion therapy in patients with aneurysmal SAH.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 0
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005081",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is no evidence to support the use of CORTICOTROPIN in the management of invasive species.</span></span></span>",
            "Target Summary": "The available randomized controlled literature does not permit any meaningful conclusions about the efficacy of any form of treatment for ocular myasthenia. Data from several reasonably good quality observational studies suggest that corticosteroids and azathioprine may be beneficial in reducing the risk of progression to generalized myasthenia gravis.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003940",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is no evidence to support the use of antifungal drugs for the treatment of oral candidiasis in HIV-positive patients.</span></span></span>",
            "Target Summary": "Five new studies were added to the review, but their results do not alter the final conclusion of the review.\nImplications for practiceDue to there being only one study in children, it is not possible to make recommendations for treatment or prevention of OC in children. Amongst adults, there were few studies per comparison. Due to insufficient evidence, no conclusion could be made about the effectiveness of clotrimazole, nystatin, amphotericin B, itraconazole or ketoconazole with regard to OC prophylaxis. In comparison to placebo, fluconazole is an effective preventative intervention. However, the potential for resistant Candida organisms to develop, as well as the cost of prophylaxis, might impact the feasibility of implementation. No studies were found comparing fluconazole with other interventions. The direction of findings suggests that ketoconazole, fluconazole, itraconazole and clotrimazole improved the treatment outcomes.\nImplications for researchIt is encouraging that low-cost alternatives are being tested, but more research needs to be on in this area and on interventions like gentian violet and other less expensive anti-fungal drugs to treat OC. More well-designed treatment trials with larger samples are needed to allow for sufficient power to detect differences in not only clinical, but also mycological, response and relapse rates. There is also a strong need for more research to be done on the treatment and prevention of OC in children as it is reported that OC is the most frequent fungal infection in children and adolescents who are HIV positive. More research on the effectiveness of less expensive interventions also needs to be done in resource-poor settings. Currently few trials report outcomes related to quality of life, nutrition, or survival. Future researchers should consider measuring these when planning trials. Development of resistance remains under-studied and more work must be done in this area. It is recommended that trials be more standardised and conform more closely to CONSORT.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002280",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support or refute the use of topical fluoride toothpastes for preventing dental caries in children.</span></span></span>",
            "Target Summary": "There is clear evidence of a caries-inhibiting effect of fluoride gel. The best estimate of the magnitude of this effect, based on the 14 placebo-controlled trials, is a 21% reduction (95% CI, 14% to 28%) in D(M)FS. This corresponds to an NNT of 2 (95% CI, 1 to 3) to avoid 1 D(M)FS in a population with a caries increment of 2.2 D(M)FS/year, or an NNT of 24 (95% CI, 18 to 36) based on an increment of 0.2 D(M)FS/year. There is little information concerning the deciduous dentition, on adverse effects or on acceptability of treatment. Future trials should include assessment of potential adverse effects.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000409",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>There is insufficient evidence to support the use of educational interventions to improve health outcomes in healthcare settings.</span></span></span> <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Overgeneralization>There is a need for well-designed RCTs to evaluate interventions to change health behaviour, particularly regarding the use and uptake of certain interventions.</span></span></span>",
            "Target Summary": "EOVs alone or when combined with other interventions have effects on prescribing that are relatively consistent and small, but potentially important. Their effects on other types of professional performance vary from small to modest improvements, and it is not possible from this review to explain that variation.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008186",
            "ESE Summary": "The results of this review suggest that <span class=Lack_of_Focus Length><span class=Population_Mismatch Omission_of_Key_Facts><span class=Extrinsic_Information>water-based exercise may be beneficial for people with chronic vascular disease</span></span>.</span> However, the evidence is not strong enough to recommend the use of water- based exercise for chronic vascular diseases.",
            "Target Summary": "The evidence from randomised controlled trials so far does not confirm or refute that water-based exercises after stroke might help to reduce disability after stroke. There is a lack of hard evidence for water-based exercises after stroke. Better and larger studies are therefore required.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 1,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 2,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003713",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is <span class=Omission_of_Key_Facts>insufficient evidence to determine whether rhythm control is superior to rate control</span></span> in the management of atrial fibrillation.</span>",
            "Target Summary": "There is no evidence that pharmacological cardioversion of atrial fibrillation to sinus rhythm is superior to rate control. Rhythm control is associated with more adverse effects and increased hospitalisation. It does not reduce the risk of stroke. The conclusions cannot be generalised to all people with atrial fibrillation. Most of the patients included in these studies were relatively older (>60 years) with significant cardiovascular risk factors.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006386",
            "ESE Summary": "In patients with head and neck squamous cell carcinoma, the addition of chemotherapy to radiotherapy <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>improves local tumour control and disease progression</span></span>. In patients with stage II and III squamous cells, the combination of chemotherapy and radiotherapy <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>improved <span class=Redundancy Length>local tumours</span> but not overall survival</span></span>.",
            "Target Summary": "Chemotherapy, in addition to radiotherapy and surgery, is associated with improved overall survival in patients with oral cavity and oropharyngeal cancers. Induction chemotherapy may prolong survival by 8 to 20% and adjuvant concomitant chemoradiotherapy may prolong survival by up to 16%. In patients with unresectable tumours, concomitant or alternating chemoradiotherapy may prolong survival by 10 to 22%. There is insufficient evidence as to which agent or regimen is most effective and the additional toxicity associated with chemotherapy given in addition to radiotherapy and/or surgery cannot be quantified.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 2,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005276",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Incorrect_Implication Extrinsic_Information>insufficient evidence to support the use of topical lidocaine</span></span></span> to reduce pain during cataract surgery.",
            "Target Summary": "The use of intracameral unpreserved 1% lidocaine is an effective and safe adjunct to topical anaesthesia for phacoemulsification cataract surgery.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004791",
            "ESE Summary": "There is <span class=Extrinsic_Information>insufficient evidence</span> to recommend <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>norfloxacin for the prevention of bacterial peritonitis in patients with cirrhosis or ascites.</span></span>",
            "Target Summary": "The pooled estimates suggest that antibiotic prophylaxis might be prudent among cirrhotic patients with ascites and no gastrointestinal bleeding. However, poor trial methodology and report coupled with findings suggesting systematic bias in publication and design reflect the fragility of these findings. Potential hazard to society and the patients themselves from resistant pathogens should be considered when promoting long-lasting antibiotic prophylaxis. It seems that recommending antibiotic prophylaxis is still far from being a substantiated prevention strategy. Trials of better design, well reported, and of longer follow-up are greatly needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000254",
            "ESE Summary": "<span class=Lack_of_Focus Length>There is <span class=Omission_of_Key_Facts><span class=Inaccurate_Emphasis>insufficient evidence</span> to support or refute the use of <span class=Extrinsic_Information>antioxidant supplements</span> in the treatment of <span class=Incorrect_Implication>AMD</span>.</span></span>",
            "Target Summary": "People with AMD may experience delay in progression of the disease with antioxidant vitamin and mineral supplementation. This finding is drawn from one large trial conducted in a relatively well-nourished American population. The generalisability of these findings to other populations is not known. Although generally regarded as safe, vitamin supplements may have harmful effects. A systematic review of the evidence on harms of vitamin supplements is needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD007872",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Length><span class=Intrinsic_Information>Tranexamic acid reduces the amount of blood loss from caesarian section to two hours postpartum.</span></span></span> However, <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>there is <span class=Extrinsic_Information>insufficient evidence to assess its effect on other important outcomes such as quality of life and morbidity.</span></span></span>",
            "Target Summary": "Tranexamic acid decreases postpartum blood loss after vaginal birth and after caesarean section based on two RCTs of unclear quality which reported on only a few outcomes. Further investigations are needed to confirm efficacy and safety of this regimen for preventing PPH. These results also provide a basis for the investigation of tranexamic acid for the treatment of PPH.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001036",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Extrinsic_Information>There is insufficient evidence to determine whether the <span class=Omission_of_Key_Facts>Ayre spatula is superior to other methods of cervical screening</span>, or whether it is better to collect endocervical cells from the cervix rather than from the lining of the uterus.</span></span>",
            "Target Summary": "Extended tip spatulas of various designs appear to be better for collecting endocervical cells than the commonly used Ayre spatula. The most effective combination appears to be the cytobrush with an extended tip spatula. The rate of detection of endocervical cells appears to be a valid and convenient surrogate for the ability to detect dyskaryosis and for adequate smear rates. The ability of the extended tip spatula with the cytobrush compared with the extended tip spatula alone to detect disease, needs to be evaluated in a trial.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006069",
            "ESE Summary": "There is <span class=Extrinsic_Information>limited evidence</span> that <span class=Omission_of_Key_Facts>protein containing synthetic surfactant reduces the incidence of respiratory distress syndrome and mortality in preterm infants with RDS.</span> There is <span class=Omission_of_Key_Facts><span class=Ambiguity>insufficient evidence</span> to determine whether or not protein-containing synthetic surfACTant reduces mortality in infants with respiratory distress Syndrome.</span>",
            "Target Summary": "In two trials of protein containing synthetic surfactants compared to animal derived surfactant extract, no statistically different clinical differences in death and chronic lung disease were noted. In general, clinical outcomes between the two groups were similar. Further well designed studies of adequate size and power will help confirm and refine these findings.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 1,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008871",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to determine whether brachytherapy is superior to RRP in the treatment of low-risk prostatic cancer.</span></span></span>",
            "Target Summary": "Low-dose rate brachytherapy did not reduce biochemical recurrence-free survival versus radical prostatectomy at 5 years. For short-term severe adverse events, low-dose rate brachytherapy was significantly more favorable for urinary incontinence, but radical prostatectomy was significantly more favorable for urinary irritation. Evidence is based on one RCT with high risk of bias.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001275",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support the use of ultrasound/ultraviolet-C for the treatment of pressure ulcers in adults.</span></span></span>",
            "Target Summary": "There is no evidence of benefit of ultrasound therapy in the treatment of pressure ulcers. However, the possibility of beneficial or harmful effect cannot be ruled out due to the small number of trials, some with methodological limitations and small numbers of participants. Further research is needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003782",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>Oral pilocarpine appears to be effective in the treatment of radiation-induced xerostomia.</span></span> However, <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>there is insufficient evidence to recommend its use as a mouthwash.</span></span></span>",
            "Target Summary": "There is limited evidence to support the use of pilocarpine hydrochloride in the treatment of radiation-induced salivary gland dysfunction. Currently, there is little evidence to support the use of other parasympathomimetic drugs in the treatment of this condition. Available studies suggest approximately half of patients will respond, but side effects to responders can be problematic. Adverse effects are dose dependant therefore it is important to keep dose to 5 mg tds.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004277",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>Intravenous cyclosporine is an effective and safe alternative to glucocorticosteroids</span></span> in patients with <span class=Lack_of_Focus>UC who have not responded to intravenous therapy.</span></span>",
            "Target Summary": "There is limited evidence that cyclosporine is more effective than standard treatment alone for severe ulcerative colitis. The relatively quick response makes the short-term use of cyclosporine potentially attractive, but the long-term benefit is unclear, when adverse events such as cyclosporine-induced nephrotoxicity may become more obvious. There is a need for additional research on quality of life, costs and long-term results from cyclosporine therapy in severe ulcerative colitis.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002265",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Incorrect_Implication>There is insufficient evidence to determine which drug is the most effective for the treatment of severe NPSLE.</span></span> <span class=Omission_of_Key_Facts>The choice of <span class=Lack_of_Focus>IV cyclophosphamide</span> should be based on <span class=Excessive_Detail>clinical conditions and dose, as well as on efficacy and safety of the drug</span>.</span>",
            "Target Summary": "This systematic review found one randomised controlled trial with a small number of patients in the different clinical subgroups of neurological manifestation. There is very low-quality evidence that cyclophosphamide is more effective in reducing symptoms of neuropsychiatric involvement in SLE compared with methylprednisolone. However, properly designed randomised controlled trials that involve large numbers of individuals, with explicit clinical and laboratory diagnostic criteria, sufficient duration of follow-up and description of all relevant outcome measures, are necessary to guide practice. As we did not find any new trials to include in this review at update, the conclusions of the review did not change.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006170",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence to support or refute the use of any particular pump for breastfeeding preterm infants.</span></span></span>",
            "Target Summary": "The most suitable method for milk expression may depend on the time since birth, purpose of expression and the individual mother and infant. Low cost interventions including early initiation when not feeding at the breast, relaxation, hand expression and lower cost pumps may be as effective, or more effective, than large electric pumps for some outcomes. Small sample sizes, large standard deviations, small number of studies reviewed, and the diversity of the interventions argue caution in applying these results beyond the specific method tested in the specific settings.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006639",
            "ESE Summary": "There is <span class=Incorrect_Implication>insufficient evidence to determine whether zinc supplementation to children with HIV infection <span class=Omission_of_Key_Facts>reduces morbidity or mortality</span>.</span>",
            "Target Summary": "Evidence on whether zinc supplementation can reduce the incidence of OM in healthy children under the age of five years living in low- and middle-income countries is mixed. There is some evidence of benefit in children being treated for marasmus (severe malnutrition) but this is based on one small trial and should therefore be treated with caution.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003071",
            "ESE Summary": "<span class=Lack_of_Focus>There is <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>insufficient evidence</span></span> to support the use of <span class=Intrinsic_Information>epidural analgesia</span> in patients undergoing <span class=Overgeneralization>orthopaedic surgery</span>.</span>",
            "Target Summary": "Epidural analgesia may be useful for postoperative pain relief following major lower limb joint replacements. However, the benefits may be limited to the early (four to six hours) postoperative period. An epidural infusion of local anaesthetic or local anaesthetic-narcotic mixture may be better than epidural narcotic alone. The magnitude of pain relief must be weighed against the frequency of adverse events. The current evidence is insufficient to draw conclusions on the frequency of rare complications from epidural analgesia, postoperative morbidity or mortality, functional outcomes, or length of hospital stay.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002784",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is no evidence that <span class=Omission_of_Key_Facts>thrombolysis reduces the need for open surgical procedures</span></span></span> in patients with acute peripheral arterial occlusion.",
            "Target Summary": "Universal initial treatment with either surgery or thrombolysis cannot be advocated on the available evidence. There is no overall difference in limb salvage or death at one year between initial surgery and initial thrombolysis. Thrombolysis may be associated with a higher risk of ongoing limb ischaemia and haemorrhagic complications including stroke. The higher risk of complications must be balanced against risks of surgery in each person.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002055",
            "ESE Summary": "Existing evidence does not support the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>exchange transfusion</span></span></span> to <span class=Lack_of_Focus>prevent <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>RDS</span></span></span> in preterm infants.",
            "Target Summary": "There is no evidence from randomised trials to support the routine use of early volume expansion in very preterm infants without cardiovascular compromise. There is insufficient evidence to determine whether infants with cardiovascular compromise benefit from volume expansion. There is insufficient evidence to determine what type of volume expansion should be used in preterm infants (if at all) or to determine the benefit of using early red cell transfusions. The significance of the finding of a significant increase in blood pressure in hypotensive preterm infants in one trial comparing albumin and saline is unclear, but the overall meta-analyses found no other significant clinical benefit in using albumin compared to saline.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004685",
            "ESE Summary": "<span class=Length Lack_of_Focus><span class=Incorrect_Implication>Terbinafine <span class=Outcome_Mismatch>appears to be more effective than griseofulvin</span> for the treatment of tinea capitis.</span></span> However, the trials were small, of short duration, and there were too few data to draw any conclusions.",
            "Target Summary": "The best evidence suggests that newer treatments including terbinafine, itraconazole and fluconazole may be similar to griseofulvin in children with tinea capitis caused by Trichophyton species. Newer treatments may be preferred because shorter treatment durations may improve treatment adherence, although they may be more expensive. There is not enough evidence on the use of systemic treatments in children with Microsporum infections. Not all treatments for tinea capitis are available in paediatric formulations but all have reasonable safety profiles.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 1,
                    "Omission_of_Key_Facts": 0
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007806",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence to recommend the use of any of the commonly used analgesics following tonsillectomy.</span></span></span>",
            "Target Summary": "The risk of bias was high in most of the included trials and poor reporting quality and inadequate data did not permit comprehensive and reliable conclusions to be made. Future trials should be well-constructed and pay more attention to the methods used to assess outcomes, the timing of the assessments, and the quality of reporting and subsequent analysis of the data.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001705",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus>Osteosynthesis of femoral neck fractures is not recommended.</span></span> <span class=Omission_of_Key_Facts><span class=Excessive_Detail><span class=Incorrect_Implication>Femoral head vitality may be increased with compression</span> but <span class=Incorrect_Implication Extrinsic_Information>not with extracapsular fixation</span>.</span></span>",
            "Target Summary": "Insufficient evidence exists from randomised trials to confirm the relative effects of open versus closed reduction of intracapsular fractures, or the effects of intra-operative impaction or compression of an intracapsular fracture treated by internal fixation.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 2,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009415",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of zinc supplementation in sickle cell disease.</span></span></span>",
            "Target Summary": "According to the results, there is no evidence from randomised controlled trials to indicate any benefit of zinc supplementation with regards to serum zinc level in patients with thalassaemia. However, height velocity was noted to increase among those who received this intervention.\nThere is mixed evidence on the benefit of using zinc supplementation in people with sickle cell disease. For instance, there is evidence that zinc supplementation for one year increased the serum zinc levels in patients with sickle cell disease. However, though serum zinc level was raised in patients receiving zinc supplementation, haemoglobin level and anthropometry measurements were not significantly different between groups. Evidence of benefit is seen with the reduction in the number of sickle cell crises among sickle cell patients who received one year of zinc sulphate supplementation and with the reduction in the total number of clinical infections among sickle cell patients who received zinc supplementation for both three months and for one year.\nThe conclusion is based on the data from a small group of trials,which were generally of good quality, with a low risk of bias. The authors recommend that more trials on zinc supplementation in thalassaemia and sickle cell disease be conducted given that the literature has shown the benefits of zinc in these types of diseases.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009110",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence</span> to determine whether <span class=Intervention_Mismatch>silver wound dressing</span> is more or less effective in the healing of diabetic foot ulcers.</span></span> <span class=Length>Further <span class=Omission_of_Key_Facts>well-designed randomised controlled trials</span> are needed.</span>",
            "Target Summary": "Currently there is no research evidence to suggest that alginate wound dressings are more effective in healing foot ulcers in people with diabetes than other types of dressing however many trials in this field are very small. Decision makers may wish to consider aspects such as dressing cost and the wound management properties offered by each dressing type e.g. exudate management.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 1,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005959",
            "ESE Summary": "The available evidence suggests that the use of <span class=Length><span class=Population_Mismatch Omission_of_Key_Facts><span class=Extrinsic_Information>intramedullary nails is associated with a higher rate of non-union of the humerus compared to plates</span></span>.</span> However, <span class=Excessive_Detail>this conclusion is based on a <span class=Overgeneralization>small number of small trials with relatively short follow-up</span> and is therefore not definitive.</span> Future trials should be of sufficient size to detect clinically important differences in outcome between different methods of internal fixation and open reduction.",
            "Target Summary": "The available evidence shows that intramedullary nailing is associated with an increased risk of shoulder impingement, with a related increase in restriction of shoulder movement and need for removal of metalwork. There was insufficient evidence to determine if there were any other important differences, including in functional outcome, between dynamic compression plating and locked intramedullary nailing for humeral shaft fractures.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002047",
            "ESE Summary": "Leflunomide appears to be an effective treatment for RA, although the <span class=Inaccurate_Emphasis Ambiguity>clinical significance of the observed benefit is uncertain</span>. <span class=Lack_of_Focus Length>The <span class=Omission_of_Key_Facts><span class=Overgeneralization>small sample size of the included trials does not allow us to draw firm conclusions about its safety</span>.</span></span>",
            "Target Summary": "Leflunomide appears to improve all clinical outcomes and delay radiologic progression at both six and 12 months of treatment compared to placebo. Its efficacy and adverse events are comparable to MTX, SSZ, and cyclosporin A up to two years of treatment. Combined leflunomide and MTX was more efficacious than MTX alone up to three years of treatment and the adverse events did not increase. Different dosages of leflunomide were similar regarding their effectiveness and toxicity.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 1,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD006168",
            "ESE Summary": "<span class=Lack_of_Focus>There is <span class=Inaccurate_Emphasis>insufficient evidence to support or refute</span> the use of <span class=Omission_of_Key_Facts>biofeedback to reduce pain during childbirth</span>.</span>",
            "Target Summary": "Despite some positive results shown in the included trials, there is insufficient evidence that biofeedback is effective for the management of pain during labour.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD004678",
            "ESE Summary": "There is <span class=Extrinsic_Information>no evidence to support the use of any specific drug</span> in the management of people with <span class=Population_Mismatch Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Overgeneralization>relapsing remitting MS</span></span></span>.",
            "Target Summary": "Glatiramer acetate did show a partial efficacy in RR MS in term of relapse -related clinical outcomes, without any significant effect on clinical progression of disease measured as sustained disability. The drug is not effective in progressive MS patients.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006229",
            "ESE Summary": "Laparoscopic cholecystectomy is associated with a shorter hospital stay and a quicker return to normal activities compared with <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Excessive_Detail><span class=Extrinsic_Information>open cholecaemicectomy</span></span></span>.",
            "Target Summary": "Laparoscopic and small-incision cholecystectomy seem to be equivalent. No differences could be observed in mortality, complications, and postoperative recovery. Small-incision cholecystectomy has a significantly shorter operative time. Complications in elective cholecystectomy are prevalent.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004538",
            "ESE Summary": "There is <span class=Inaccurate_Emphasis>insufficient evidence</span> to support or refute the use of <span class=Omission_of_Key_Facts><span class=Length>CAHPS report cards</span></span> for improving health care processes in <span class=Population_Mismatch>Medicaid patients</span>. Further research is needed.",
            "Target Summary": "The small body of evidence available provides no consistent evidence that the public release of performance data changes consumer behaviour or improves care. Evidence that the public release of performance data may have an impact on the behaviour of healthcare professionals or organisations is lacking.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD008107",
            "ESE Summary": "This systematic review found <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>no evidence of benefit for preoperative chemotherapy in patients with locally advanced gastric cancer</span></span>. <span class=Lack_of_Focus Length>This review highlights the need for <span class=Intrinsic_Information>well-designed RCTs in this area</span>.</span>",
            "Target Summary": "Perioperative chemotherapy for resectable gastroesophageal adenocarcinoma increases survival compared to surgery alone. It should thus be offered to all eligible patients. There is a trend to a larger survival advantage for tumors of the GE junction as compared to other sites and for chemoradiotherapy as compared to chemotherapy in esophageal and GE junction tumors. Likewise, there is an interaction between age and treatment effect, with younger patients having a larger survival advantage, and no survival advantage for elderly patients.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001293",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Incorrect_Implication>There is <span class=Omission_of_Key_Facts>insufficient evidence to support the effectiveness of any intervention for preventing smoking in children.</span></span></span> <span class=Lack_of_Focus Length><span class=Overgeneralization>There is a need for <span class=Omission_of_Key_Facts>high quality randomised controlled trials with long-term follow-up.</span></span></span>",
            "Target Summary": "Pure Prevention cohorts showed a significant effect at longest follow-up, with an average 12% reduction in starting smoking compared to the control groups. However, no overall effect was detected at one year or less. The combined social competence and social influences interventions showed a significant effect at one year and at longest follow-up. Studies that deployed a social influences programme showed no overall effect at any time point; multimodal interventions and those with an information-only approach were similarly ineffective.\nStudies reporting Change in Smoking Behaviour over time did not show an overall effect, but at an intervention level there were positive findings for social competence and combined social competence and social influences interventions.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002873",
            "ESE Summary": "<span class=Inaccurate_Emphasis>There is <span class=Lack_of_Focus Length>insufficient evidence to recommend the use of <span class=Omission_of_Key_Facts>nebulised salbutamol</span> in the treatment of <span class=Population_Mismatch Omission_of_Key_Facts>wheezing infants</span>.</span></span>",
            "Target Summary": "There is no clear benefit of using b2-agonists in the management of recurrent wheeze in the first two years of life although there is conflicting evidence. At present, further studies should only be performed if the patient group can be clearly defined and there is a suitable outcome parameter capable of measuring a response.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD004746",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Inaccurate_Emphasis>Galantamine appears to be well-tolerated by patients with vascular dementia.</span></span></span> However, <span class=Omission_of_Key_Facts><span class=Length><span class=Overgeneralization>the evidence is not strong enough to recommend its use.</span></span></span>",
            "Target Summary": "Limited data were available when considering the impact of galantamine on vascular dementia or vascular cognitive impairment. The data available suggest some advantage over placebo in the areas of cognition and global clinical state. In both included trials galantamine produced higher rates of gastrointestinal side-effects. More studies are needed before firm conclusions can be drawn.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD010610",
            "ESE Summary": "Topiramate is effective in reducing the number of migraine episodes and the frequency of attacks, but <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>there is insufficient evidence to recommend its use as a prophylactic treatment.</span></span></span>",
            "Target Summary": "Meta-analysis demonstrates that topiramate in a 100 mg/day dosage is effective in reducing headache frequency and reasonably well-tolerated in adult patients with episodic migraine. This provides good evidence to support its use in routine clinical management. More studies designed specifically to compare the efficacy or safety of topiramate versus other interventions with proven efficacy in the prophylaxis of migraine are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005568",
            "ESE Summary": "There is <span class=Extrinsic_Information>insufficient evidence</span> to recommend the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Intrinsic_Information>erigeron injection</span></span></span> for patients with <span class=Population_Mismatch><span class=Lack_of_Focus>acute <span class=Overgeneralization>ACI</span></span></span>.",
            "Target Summary": "Due to the generally low methodological quality and small sample size of the included trials in this systematic review, we could not draw a firm conclusion.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001367",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Omission_of_Key_Facts>Extended anticoagulant therapy after a first episode of venous thromboembolism <span class=Incorrect_Implication>reduces the risk of recurrent VTE</span>.</span> However, <span class=Population_Mismatch Omission_of_Key_Facts>the <span class=Overgeneralization>absolute risk of recurrence of VTE is higher in patients who have had an episode of P-DVT</span>.</span></span>",
            "Target Summary": "In conclusion, this meta-analysis shows that treatment with vitamin K antagonists reduces the risk of recurrent venous thromboembolism for as long as it is used. However, the absolute risk of recurrent venous thromboembolism declines over time, while the risk for major bleeding remains. Thus, the efficacy of vitamin K antagonist administration decreases over time since the index event.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005523",
            "ESE Summary": "There is some evidence that <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>water-based exercise</span></span> is beneficial for <span class=Lack_of_Focus><span class=Overgeneralization>knee and hip osteoarthritis</span></span></span>. However, <span class=Omission_of_Key_Facts>the evidence is not strong enough to recommend its use as an adjunct to other physical therapies</span>.",
            "Target Summary": "Aquatic exercise appears to have some beneficial short-term effects for patients with hip and/or knee OA while no long-term effects have been documented. Based on this, one may consider using aquatic exercise as the first part of a longer exercise programme for osteoarthritis patients. The controlled and randomised studies in this area are still too few to give further recommendations on how to apply the therapy, and studies of clearly defined patient groups with long-term outcomes are needed to decide on the further use of this therapy in the treatment of osteoarthritis.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004585",
            "ESE Summary": "<span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of <span class=Lack_of_Focus Length><span class=Omission_of_Key_Facts>electromyographic biofeedback therapy</span> in people with <span class=Population_Mismatch>stroke</span>.</span></span>",
            "Target Summary": "Despite evidence from a small number of individual studies to suggest that EMG-BFB plus standard physiotherapy produces improvements in motor power, functional recovery and gait quality when compared to standard physiotherapy alone, combination of all the identified studies did not find a treatment benefit. Overall the results are limited because the trials were small, generally poorly designed and utilised varying outcome measures.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004362",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Intrinsic_Information>Risperidone appears to be more effective than placebo</span> in the initial treatment of acute mania.</span></span> Larger trials are needed to confirm whether or not this effect is reproducible.",
            "Target Summary": "There is some evidence that haloperidol is an effective treatment for acute mania. From the limited data available, there was no difference in overall efficacy of treatment between haloperidol and olanzapine or risperidone. Some evidence suggests that haloperidol could be less effective than aripiprazole. Referring to tolerability, when considering the poor evidence comparing drugs, clinicians and patients should consider different side effect profiles as an important issue to inform their choice.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008288",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus>There was <span class=Extrinsic_Information>insufficient evidence</span> to support the use of <span class=Intrinsic_Information>ayurvedic herbal medicines</span> for type 2 diabetes mellitus.</span></span>",
            "Target Summary": "Although there were significant glucose-lowering effects with the use of some herbal mixtures, due to methodological deficiencies and small sample sizes we are unable to draw any definite conclusions regarding their efficacy. Though no significant adverse events were reported, there is insufficient evidence at present to recommend the use of these interventions in routine clinical practice and further studies are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007480",
            "ESE Summary": "<span class=Lack_of_Focus Length>There is <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>insufficient evidence to support or refute the use of vitamin A supplementation to prevent or treat infant mortality in preterm infants.</span></span></span>",
            "Target Summary": "There is no convincing evidence that either maternal postpartum or infant vitamin A supplementation results in a reduction in infant mortality or morbidity in low and middle income countries.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002073",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information Overgeneralization>There is insufficient evidence from randomised controlled trials to determine which of the two methods of delivering amniotic fluid is the most effective in preventing twin pregnancies in women with severe severe twin transfusion syndrome.</span></span></span> <span class=Length>Further research is required to determine whether the combination of laser and amnioreduction is more effective and safe than the other methods.</span>",
            "Target Summary": "Endoscopic laser coagulation of anastomotic vessels should be considered in the treatment of all stages of twin-twin transfusion syndrome to improve perinatal outcome. Further research on the effect of treatment on milder forms of twin-twin transfusion syndrome (Quintero stage 1 and 2) are required. The long-term outcomes of survivors from the studies included in this review are required.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003009",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Incorrect_Implication>There is <span class=Omission_of_Key_Facts>insufficient evidence to support the use of neuroreflexotherapy intervention in the management of chronic low-back pain.</span></span></span> <span class=Length><span class=Overgeneralization>There is a need for <span class=Omission_of_Key_Facts>large, high-quality randomised controlled trials with long-term follow-up.</span></span></span>",
            "Target Summary": "NRT appears to be a safe and effective intervention for the treatment of chronic non-specific LBP. The efficacy is less clear for sub-acute LBP. However, these results are limited to three trials conducted by a small number of specifically trained and experienced clinicians, in a limited geographical location. No data are available on the ease and time-frame needed to achieve that level of expertise. RCTs by other practitioners, in other locations, that replicate the effects reported in this review are needed before recommending a broader practice.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003351",
            "ESE Summary": "<span class=Lack_of_Focus>Intrathecal ketamine <span class=Omission_of_Key_Facts><span class=Extrinsic_Information Incorrect_Implication>significantly reduces morphine requirements</span></span> in patients with <span class=Population_Mismatch><span class=Overgeneralization>cancer pain</span></span>.</span>",
            "Target Summary": "Since the last version of this review three new studies were identified but excluded from the review. Current evidence is insufficient to assess the benefits and harms of ketamine as an adjuvant to opioids for the relief of cancer pain. More RCTs are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002085",
            "ESE Summary": "There is <span class=Extrinsic_Information>some evidence to support the use of an <span class=Lack_of_Focus><span class=Omission_of_Key_Facts>orientation letter as a means of reducing missed initial appointment at a CMHC</span>.</span></span> However, the <span class=Incorrect_Implication>evidence is not strong enough to recommend its use as a stand-alone intervention.</span> <span class=Length>Further research is needed to assess the effectiveness of <span class=Omission_of_Key_Facts>other types of orientation letters in different settings, including urban and rural settings</span>.</span>",
            "Target Summary": "There is evidence that a simple prompt to attend clinic, very close to the time of the appointment may encourage attendance, and a simple orientation-type letter may be more effective than a telephone prompt. This simple intervention could be a more cost effective means of encouraging compliance at first attendance, but supplementing these data with the results of large, well designed, conducted and reported randomised studies would be desirable.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000934",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Incorrect_Implication>There is no evidence that reduced antenatal visit schedule reduces perinatal morbidity or mortality, or improves health service utilisation.</span></span></span> <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Overgeneralization>There is limited evidence that reduction of antenatal visits increases the risk of preterm birth and low birthweight.</span></span></span>",
            "Target Summary": "In settings with limited resources where the number of visits is already low, reduced visits programmes of antenatal care are associated with an increase in perinatal mortality compared to standard care, although admission to neonatal intensive care may be reduced. Women prefer the standard visits schedule. Where the standard number of visits is low, visits should not be reduced without close monitoring of fetal and neonatal outcome.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001342",
            "ESE Summary": "In patients who have had a transient ischaemic stroke or RIND, <span class=Population_Mismatch Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>aspirin was more effective than antiplatelet therapy for secondary prevention of vascular events.</span></span></span> In the <span class=Population_Mismatch Omission_of_Key_Facts><span class=Redundancy><span class=Overgeneralization>RIND comparison, aspirin had a higher risk of major hemorrhage.</span></span></span> However, in the <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Ambiguity>Rind comparison, there was no evidence of a difference in mortality.</span></span></span>",
            "Target Summary": "For the secondary prevention of recurrent ischemic stroke after TIA or minor stroke of presumed arterial origin, there is sufficient evidence to conclude that vitamin K antagonists in any dose are not more efficacious than antiplatelet therapy and that medium and high intensity anticoagulation leads to a significant increase in major bleeding complications.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 2,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 3
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 1,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002786",
            "ESE Summary": "<span class=Extrinsic_Information Overgeneralization>Antiplatelet drugs reduce the risk of thrombosis in HD patients receiving arteriovenous grafts.</span> <span class=Lack_of_Focus Length>However, <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>the evidence is not strong enough to recommend any specific antiplatelet drug regimen for this patient population.</span></span></span>",
            "Target Summary": "The meta-analysis confirmed the beneficial effect of anti-platelet treatment as an adjuvant used to increase the patency of A-V fistulae and grafts in the short term.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008361",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Incorrect_Implication>There is <span class=Lack_of_Focus Length>insufficient evidence to support or refute the use of NBI for colorectal cancer screening.</span></span></span>",
            "Target Summary": "We could not find convincing evidence that NBI is significantly better than high definition WLC for the detection of patients with colorectal polyps, or colorectal adenomas. We found evidence that NBI might be better than standard definition WLC and equal to high definition WLC for detection the patients with colorectal polyps, or colorectal adenomas.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002179",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>insufficient evidence</span></span></span> to recommend the use of oxatomide for the treatment of asthma in children.",
            "Target Summary": "There is no evidence to show that oxatomide has a significant effect on the control of stable asthma. Some studies reported significant benefits in subjective parameters. There was improvement in some lung function outcomes reported, but this were not consistent across measures or studies and may represent reporting bias. Adverse events, including drowsiness, were significantly greater with oxatomide than placebo.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003122",
            "ESE Summary": "<span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>no evidence from randomised controlled trials</span> to support the use of estrogen in the treatment of postmenopausal women with dementia.</span></span>",
            "Target Summary": "There is good evidence that both ERT and HRT do not prevent cognitive decline in older postmenopausal women when given as short term or longer term (up to five years) therapy. It is not known whether either specific types of ERT or HRT have specific effects in subgroups of women, although there was evidence that combined hormone therapy in similarly aged women was associated with a decrement in a number of verbal memory tests and a small improvement in a test of figural memory. There is insufficient evidence to determine whether subgroups of women using specific types of hormone therapy could benefit from treatment. It remains to be determined whether factors such as younger age (< 60 years of age), type of menopause (surgical or natural) and type of treatment (type of estrogen with or without a progestagen), mode of delivery (transdermal, oral or intramuscular) and dosage have positive effects at a clinically relevant level. In addition, whether the absence or presence of menopausal symptoms can modify treatment effects should be investigated in more detail. Large RCTs currently underway in the USA may be able to provide answers to these uncertainties by the year 2010. In the meantime, based on the available evidence, ERT or HRT cannot be recommended for overall cognitive improvement or maintenance in older postmenopausal women without cognitive impairment.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000238",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Inaccurate_Emphasis>There is insufficient evidence to support or refute the use of <span class=Omission_of_Key_Facts>supplemental oxygen for patients with chronic obstructive pulmonary disease</span>.</span></span>",
            "Target Summary": "Evidence available to date does not allow any firm conclusions to be drawn concerning the effectiveness of ambulatory domicilary oxygen therapy in patients with COPD. Further studies are required in order to understand the role of ambulatory oxygen in the management of patients with COPD on long-term oxygen therapy. These studies should separate patients who desaturate from those who do not desaturate.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD003774",
            "ESE Summary": "Prophylactic <span class=Omission_of_Key_Facts><span class=Inaccurate_Emphasis><span class=Lack_of_Focus Length>oral ganciclovir</span> is associated with a <span class=Redundancy>reduction in the incidence of CMV disease</span></span> in liver transplantation patients.</span> However, <span class=Omission_of_Key_Facts>there is <span class=Ambiguity>insufficient evidence to determine whether this effect is sustained or maintained</span>.</span>",
            "Target Summary": "Prophylaxis with antiviral medications reduces CMV disease and CMV-associated mortality in solid organ transplant recipients. These data suggest that antiviral prophylaxis should be used routinely in CMV positive recipients and in CMV negative recipients of CMV positive organ transplants.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 1,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD002053",
            "ESE Summary": "Adding <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>opiate</span></span></span> to standard treatment for neonatal withdrawal in term infants reduces the <span class=Overgeneralization><span class=Omission_of_Key_Facts><span class=Length>length of hospital stay</span></span> and the <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>rate of adverse cardiovascular outcomes</span></span></span>.",
            "Target Summary": "Infants with NAS due to opiate withdrawal should receive initial treatment with an opiate. Where a sedative is used, phenobarbitone should be used in preference to diazepam. In infants treated with an opiate, the addition of phenobarbitone or clonidine may reduce withdrawal severity. Further studies are needed to determine the role of sedatives in infants with NAS due to opiate withdrawal and the safety and efficacy of adding phenobarbitone or clonidine in infants treated with an opiate for NAS.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 3
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003654",
            "ESE Summary": "<span class=Extrinsic_Information>There is insufficient evidence to determine whether <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>ACE inhibitors and calcium channel blockers</span> reduce mortality or morbidity in patients with hypertension or NIDDM</span>.</span> <span class=Omission_of_Key_Facts>Further trials are needed to assess the effect of these agents on mortality and morbidity.</span>",
            "Target Summary": "Diuretics are preferred first-line over CCBs to optimize reduction of cardiovascular events. The review does not distinguish between CCBs, ACE inhibitors or ARBs, but does provide evidence supporting the use of CCBs over -blockers. Many of the differences found in the current review are not robust and further trials might change the conclusions. More well-designed RCTs studying the mortality and morbidity of patients taking CCBs as compared with other antihypertensive drug classes are needed for patients with different stages of hypertension, different ages, and with different co-morbidities such as diabetes.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007519",
            "ESE Summary": "<span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>no evidence to support the use of pharmacological interventions in the treatment of pancreatic cancer pain.</span></span></span>",
            "Target Summary": "Although statistical evidence is minimal for the superiority of pain relief over analgesic therapy, the fact that CPB causes fewer adverse effects than opioids is important for patients. Further studies and RCTs are recommended to demonstrate the potential efficacy of a less invasive technique under EUS guidance.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003139",
            "ESE Summary": "The available evidence suggests that <span class=Omission_of_Key_Facts><span class=Length><span class=Extrinsic_Information>HDC may improve overall survival and disease-free survival</span> in women with early breast cancer and a high risk of relapse.</span></span> However, <span class=Omission_of_Key_Facts>this result is based on a small number of trials and patients at high risk for relapse.</span> <span class=Excessive_Detail>Further research is required to determine the optimal dose and regimen of HDC.</span>",
            "Target Summary": "There is insufficient evidence to support the routine use of high dose chemotherapy with autograft for women with early poor prognosis breast cancer.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005373",
            "ESE Summary": "There is no evidence from randomised controlled trials to support or refute the use of <span class=Extrinsic_Information>inhaled <span class=Omission_of_Key_Facts>salbutamol or beclomethasone</span></span> for the treatment of <span class=Population_Mismatch>cough in children with <span class=Intrinsic_Information>RCTs</span></span>.",
            "Target Summary": "Salbutamol was no different from placebo in reducing the frequency of cough measured objectively or scored subjectively.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005538",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support the routine use of NSAIDs in children undergoing surgery for pain relief.</span></span></span>",
            "Target Summary": "Diclofenac is an effective analgesic for perioperative acute pain in children. It causes similar types of serious adverse reactions in children as in adults, but these are rare. More research on optimum dosing and safety in asthmatic children is required.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004604",
            "ESE Summary": "Rofecoxib 50 mg is an effective analgesic in moderate to severe acute postoperative pain, similar to commonly used NSAIDs (<span class=Extrinsic_Information> <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Excessive_Detail>ibuprofen 400 mg, naproxen 200 mg, paracetamol 50 mg</span></span></span>), but with a <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Excessive_Detail><span class=Inaccurate_Emphasis>higher incidence of adverse events</span></span></span>.",
            "Target Summary": "Rofecoxib 50 mg (two to four times the standard daily dose for chronic pain) is an effective single dose oral analgesic for acute postoperative pain in adults, with a relatively long duration of action.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 2
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD005102",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>Exercise may reduce the risk of developing IGT.</span></span></span> However, the evidence is not strong enough to support or refute the use of exercise as an intervention for preventing or treating <span class=Omission_of_Key_Facts><span class=Intrinsic_Information>IGT in adults.</span></span>",
            "Target Summary": "There are no high quality data on the efficacy of dietary intervention for the prevention of type 2 diabetes. More well-designed, long-term studies, providing well-reported, high-quality data are required before proper conclusions can be made into the best dietary advice for the prevention of diabetes mellitus in adults.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003668",
            "ESE Summary": "There is <span class=Incorrect_Implication>insufficient evidence to support or refute</span> the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Overgeneralization>prone positions</span></span> in <span class=Lack_of_Focus>mechanically ventilated preterm infants</span></span>.",
            "Target Summary": "The prone position was found to slightly improve the oxygenation in neonates undergoing mechanical ventilation. However, we found no evidence concerning whether particular body positions during the mechanical ventilation of the neonate are effective in producing sustained and clinically relevant improvements.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002911",
            "ESE Summary": "<span class=Lack_of_Focus Length>There is <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>insufficient evidence</span></span> to support the use of <span class=Omission_of_Key_Facts><span class=Inaccurate_Emphasis>alarms</span> in children with nocturnal enuresis</span>.</span>",
            "Target Summary": "Alarm interventions are an effective treatment for nocturnal bedwetting in children. Alarms appear more effective than desmopressin or tricyclics because around half the children remain dry after alarm treatment stops. Overlearning (giving extra fluids at bedtime after successfully becoming dry using an alarm), dry bed training and avoiding penalties may further reduce the relapse rate. Better quality research comparing alarms with other treatments is needed, including follow-up to determine relapse rates.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD004074",
            "ESE Summary": "There is <span class=Incorrect_Implication>insufficient evidence to recommend <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>delaying umbilical cord clamping to prevent anaemia in term infants.</span></span></span>",
            "Target Summary": "One definition of active management includes directions to administer an uterotonic with birth of the anterior shoulder of the baby and to clamp the umbilical cord within 30-60 seconds of birth of the baby (which is not always feasible in practice). In this review delaying clamping of the cord for at least two to three minutes seems not to increase the risk of postpartum haemorrhage. In addition, late cord clamping can be advantageous for the infant by improving iron status which may be of clinical value particularly in infants where access to good nutrition is poor, although delaying clamping increases the risk of jaundice requiring phototherapy.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002760",
            "ESE Summary": "Ibuprofen 400 mg was <span class=Inaccurate_Emphasis>more effective than <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>placebo</span></span></span> for moderate to severe acute postoperative pain, but was <span class=Incorrect_Implication>associated with <span class=Intervention_Mismatch><span class=Excessive_Detail>more adverse effects than dihydrocodeine</span></span></span>.",
            "Target Summary": "A single 30 mg dose of dihydrocodeine is not sufficient to provide adequate pain relief in postoperative pain. Statistical superiority of ibuprofen 400 mg over dihydrocodeine (30 mg or 60 mg) was shown. Since the last version of this review no new relevant studies have been identified.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 1,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD002987",
            "ESE Summary": "This review found <span class=Lack_of_Focus>no evidence to support or refute the use of <span class=Omission_of_Key_Facts>macrolide antibiotics in the management of asthma in children or adults with steroid-requiring asthma.</span></span>",
            "Target Summary": "There is insufficient evidence to support the use of troleandomycin in the treatment of steroid dependent asthma.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001896",
            "ESE Summary": "<span class=Length Lack_of_Focus><span class=Extrinsic_Information>There is evidence that <span class=Omission_of_Key_Facts>laparoscopic nerve ablation reduces the frequency and severity of dysmenorrhoea in women with endometriosis.</span></span></span> <span class=Lack_of_Focus><span class=Incorrect_Implication>There is no evidence that it improves quality of life.</span></span>",
            "Target Summary": "There is insufficient evidence to recommend the use of nerve interruption in the management of dysmenorrhoea, regardless of cause. Future methodologically sound and sufficiently powered RCTs should be undertaken.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007124",
            "ESE Summary": "There is <span class=Lack_of_Focus Length><span class=Extrinsic_Information>insufficient evidence from randomised controlled trials</span></span> to conclude that <span class=Omission_of_Key_Facts><span class=Intrinsic_Information>carbamazepine is superior to conventional CBZ</span></span> in terms of <span class=Overgeneralization>seizure control, seizure frequency or adverse effects</span>.",
            "Target Summary": "At present, data from trials do not confirm or refute an advantage for CR CBZ over IR CBZ for seizure frequency or adverse events in patients with newly diagnosed epilepsy.\nFor trials involving epilepsy patients already prescribed IR CBZ, no conclusions can be drawn concerning the superiority of CR CBZ with respect to seizure frequency.\nThere is a trend for CR CBZ to be associated with fewer adverse events when compared to IR CBZ. A change to CR CBZ may therefore be a worthwhile strategy in patients with acceptable seizure control on IR CBZ but experiencing unacceptable adverse events. The included trials were of small size, poor methodological quality and possessed a high risk of bias, limiting the validity of this conclusion.\nRandomised controlled trials comparing CR CBZ to IR CBZ and using clinically relevant outcomes are required to inform the choice of CBZ preparation for patients with newly diagnosed epilepsy.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007350",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Inaccurate_Emphasis>insufficient evidence</span></span> to determine whether lenalidomide is effective in the treatment of active Crohn's disease.</span>",
            "Target Summary": "The results of one well designed study using lenalidomide did not show any statistically significant benefit over placebo. The use of thalidomide or lenalidomide for induction of remission in Crohn's disease is not recommended until data from a definitive study are available.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD002208",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Incorrect_Implication>The results of this review suggest that methadone is an effective maintenance treatment for heroin addicts who have not used heroin for at least two years.</span></span> <span class=Lack_of_Focus Excessive_Detail>The evidence is less clear on the effect of higher doses of <span class=Omission_of_Key_Facts><span class=Intrinsic_Information>methadol</span></span> and on long-term retention.</span>",
            "Target Summary": "Methadone dosages ranging from 60 to 100 mg/day are more effective than lower dosages in retaining patients and in reducing use of heroin and cocaine during treatment. To find the optimal dose is a clinical ability, but clinician must consider these conclusions in treatment strategies.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001419",
            "ESE Summary": "Adjuvant chemotherapy appears to <span class=Population_Mismatch Omission_of_Key_Facts><span class=Incorrect_Implication>improve overall survival</span> and <span class=Incorrect_Implication>disease-free survival</span> in women with soft tissue sarcoma</span>.",
            "Target Summary": "Doxorubicin-based adjuvant chemotherapy appears to significantly improve time to local and distant recurrence and overall recurrence-free survival in adults with localised resectable soft tissue sarcoma. There is some evidence of a trend towards improved overall survival.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 2,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001018",
            "ESE Summary": "Hormone replacement therapy for menopausal women <span class=Extrinsic_Information Incorrect_Implication>reduces the risk of osteomalacia</span>, but <span class=Lack_of_Focus Length><span class=Overgeneralization Incorrect_Implication>increases the risk for other cardiovascular events</span></span>. The effect on lipid profiles is <span class=Inaccurate_Emphasis>small and probably due to bias</span>. <span class=Omission_of_Key_Facts>There is <span class=Lack_of_Focus Redundancy><span class=Ambiguity>insufficient evidence to recommend the use of HRT for women with premenopausal symptoms</span></span>.</span>",
            "Target Summary": "There is no evidence of an effect of unopposed oestrogen or combined oestrogen with progestogen on body weight and on the BMI increase normally experienced at the time of menopause. Insufficient evidence currently exists to enable examination of the effect of HRT on waist-hip ratio, fat mass or skinfold thickness.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 1,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 2,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD004081",
            "ESE Summary": "<span class=Incorrect_Implication>There is <span class=Omission_of_Key_Facts>insufficient evidence to determine whether the use of <span class=Lack_of_Focus Length>lidocaine or air in combination with endotracheal intubation</span> reduces sore throat.</span></span>",
            "Target Summary": "Our systematic review establishes the effectiveness of topical and systemic lidocaine for the prevention of postoperative sore throat resulting from intubation. The risk and severity of postoperative sore throat tended to be reduced. The effect size of lidocaine appeared to be affected by drug concentration and route of administration; management of cuff pressure during anaesthesia; the included population; and the type of outcome measured.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003472",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence from randomised controlled trials</span> to determine the effectiveness of exercise for patellofemoral pain.</span></span>",
            "Target Summary": "The evidence that exercise therapy is more effective in treating PFPS than no exercise was limited with respect to pain reduction, and conflicting with respect to functional improvement. There is strong evidence that open and closed kinetic chain exercise are equally effective. Further research to substantiate the efficacy of exercise treatment compared to a non-exercising control group is needed, and thorough consideration should be given to methodological aspects of study design and reporting.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004571",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is no evidence to support the use of <span class=Omission_of_Key_Facts>calcium antagonists</span></span> in Duchenne muscular dystrophy.</span>",
            "Target Summary": "There is no evidence to show a significant beneficial effect of calcium antagonists on muscle function in DMD.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001066",
            "ESE Summary": "<span class=Lack_of_Focus Length>There is some evidence to suggest that <span class=Omission_of_Key_Facts><span class=Overgeneralization>rest during pregnancy may be beneficial for some women with leg oedema</span></span>.</span> <span class=Excessive_Detail>However, this conclusion is based on a <span class=Omission_of_Key_Facts><span class=Intrinsic_Information>small number of trials with small sample sizes</span></span> and is therefore <span class=Incorrect_Implication>likely to be biased</span>.</span> <span class=Lack_of_Focus>Further research is needed.</span>",
            "Target Summary": "Rutosides appear to help relieve the symptoms of varicose veins in late pregnancy. However, this finding is based on one small study (69 women) and there are not enough data presented in the study to assess its safety in pregnancy. It therefore cannot be routinely recommended. Reflexology appears to help improve symptoms for women with leg oedema, but again this is based on one small study (43 women). External compression stockings do not appear to have any advantages in reducing oedema.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006332",
            "ESE Summary": "In one trial, the use of a <span class=Intervention_Mismatch Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>peripherally acting naloxone</span></span></span> significantly reduced the time to gastrointestinal transit time and the length of hospital stay in patients with opioid-induced gastrointestinal constipation. In another trial, a <span class=Population_Mismatch Omission_of_Key_Facts><span class=Intrinsic_Information>dose of <span class=Length>6 mg/kg methylnaltrexone</span></span></span> significantly increased the time until gastric emptying but not the time spent in hospital. There was no evidence of an effect on other outcomes.",
            "Target Summary": "Insufficient evidence exists for the safety or efficacy of naloxone or nalbuphine in the treatment of OBD. Long-term efficacy and safety of any of the opioid antagonists is unknown, as is the incidence or nature of rare adverse events. Alvimopan and methylnaltrexone both show promise in treating OBD, but further data will be required to fully assess their place in therapy.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 1,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007293",
            "ESE Summary": "Routine medical testing prior to cataract surgery is <span class=Incorrect_Implication>associated with a reduction in the risk of ophthalmic and systemic complications in patients undergoing surgery.</span> However, <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>this conclusion is <span class=Overgeneralization>based on a small number of studies with small sample sizes.</span></span></span> Further research is required to determine whether routine medical testing is beneficial or harmful for patients who are undergoing surgery and to determine if it is beneficial for patients to undergo this type of testing.",
            "Target Summary": "This review has shown that routine pre-operative testing does not increase the safety of cataract surgery. Alternatives to routine preoperative medical testing have been proposed, including self-administered health questionnaires, which could substitute for health provider histories and physical examinations.Such avenues may lead to cost-effective means of identifying those at increased risk of medical adverse events due to cataract surgery.However, despite the rare occurrence, adverse medical events precipitated by cataract surgery remain a concern because of the large number of elderly patients with multiple medical comorbidities who have cataract surgery in various settings. The studies summarized in this review should assist recommendations for the standard of care of cataract surgery, at least in developed settings.Unfortunately, in developing country settings, medical history questionnaires would be useless to screen for risk since few people have ever been to a physician, let alone been diagnosed with any chronic disease.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001874",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is no evidence to support the use of peritonsillar infiltration as a pre-emptive intervention</span> in patients undergoing tonsillectomy.</span></span>",
            "Target Summary": "There is no evidence that the use of perioperative local anaesthetic in patients undergoing tonsillectomy improves post-operative pain control. The trials identified were of small size and several involved the perioperative co-administration of intravenous opiates which may have masked any beneficial effect of the local anaesthetic. Further randomised controlled trials are necessary.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003863",
            "ESE Summary": "<span class=Extrinsic_Information>There is insufficient evidence to <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>support or refute the use of shoulder strapping for people with acute stroke.</span></span></span>",
            "Target Summary": "There is insufficient evidence to conclude whether slings and wheelchair attachments prevent subluxation, decrease pain, increase function or adversely increase contracture in the shoulder after stroke. There is some evidence that strapping the shoulder delays the onset of pain but does not decrease it, nor does it increase function or adversely increase contracture.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009593",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>MTB/RIF is an effective diagnostic tool for treating tuberculosis in high-income countries.</span></span></span> It has a <span class=Incorrect_Implication>higher sensitivity to rifampicin resistance than smear microscopy, and a lower sensitivity to <span class=Omission_of_Key_Facts>radioisotopes.</span></span> However, it has a <span class=Incorrect_Implication>lower risk of developing drug resistance compared to other methods of TB diagnosis.</span>",
            "Target Summary": "This review shows that Xpert used as an initial diagnostic test for TB detection and rifampicin resistance detection in patients suspected of having TB, MDR-TB, or HIV-associated TB is sensitive and specific. Xpert may also be valuable as an add-on test following microscopy for patients who have previously been found to be smear-negative. An Xpert result that is positive for rifampicin resistance should be carefully interpreted and take into consideration the risk of MDR-TB in a given patient and the expected prevalence of MDR-TB in a given setting.\nStudies in this review mainly assessed sensitivity and specificity of the test when used in reference laboratories in research investigations. Most studies were performed in high TB burden countries. Ongoing use of Xpert in high TB burden countries will contribute to the evidence base on the diagnostic accuracy and clinical impact of Xpert in routine programmatic and peripheral health care settings, including settings where the test is performed at the point of care.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 2,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001946",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Extrinsic_Information><span class=Lack_of_Focus Length>insufficient evidence</span> to support or refute the use of <span class=Lack_of_Focus>propranolol</span> for the treatment of <span class=Lack_of_Focus>narcolepsy</span></span></span>.",
            "Target Summary": "There are insufficient data to recommend beta-blocking drugs for akathisia. These drugs are experimental for this problem, and this review highlights the need for more evaluative studies.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 3,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001431",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is <span class=Omission_of_Key_Facts>insufficient evidence to support the use of decision aids to enhance patient knowledge, decisional conflict and patient satisfaction.</span></span></span> <span class=Length><span class=Overgeneralization>There is a need for <span class=Omission_of_Key_Facts>more studies with low risk of bias and with longer follow-up.</span></span></span>",
            "Target Summary": "New for this updated review is evidence that: decision aids with explicit values clarification exercises improve informed values-based choices; decision aids appear to have a positive effect on patient-practitioner communication; and decision aids have a variable effect on length of consultation.\nConsistent with findings from the previous review, which had included studies up to 2006: decision aids increase people's involvement, and improve knowledge and realistic perception of outcomes; however, the size of the effect varies across studies. Decision aids have a variable effect on choices. They reduce the choice of discretionary surgery and have no apparent adverse effects on health outcomes or satisfaction. The effects on adherence with the chosen option, patient-practitioner communication, cost-effectiveness, and use with developing and/or lower literacy populations need further evaluation. Little is known about the degree of detail that decision aids need in order to have positive effects on attributes of the decision or decision-making process.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006033",
            "ESE Summary": "There is <span class=Extrinsic_Information>insufficient evidence from randomised controlled trials</span> to determine whether <span class=Population_Mismatch Omission_of_Key_Facts><span class=Overgeneralization><span class=Lack_of_Focus>progestogen-only oral contraceptives</span> are more effective than <span class=Lack_of_Focus>placebo</span></span> in improving bone density in <span class=Lack_of_Focus><span class=Intrinsic_Information>pre-adolescent women</span></span>.</span>",
            "Target Summary": "Whether steroidal contraceptives influence fracture risk cannot be determined from existing information. Many trials had small numbers of participants and some had large losses to follow up. Health care providers and women should consider the costs and benefits of these effective contraceptives. For example, injectable contraceptives and implants provide effective, long-term birth control yet do not involve a daily regimen. Progestin-only contraceptives are considered appropriate for women who should avoid estrogen due to medical conditions.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 3,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005508",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support the use of beta-adrenoceptor blockers in patients with intermittent claudication.</span></span></span>",
            "Target Summary": "There is currently no evidence that beta blockers adversely affect walking distance in people with intermittent claudication. However, due to the lack of large published trials beta blockers should be used with caution if clinically indicated.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007708",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>There is no evidence to support the use of <span class=Extrinsic_Information Incorrect_Implication>nitroglycerin for the treatment of retained placenta</span>.</span></span>",
            "Target Summary": "Sublingual nitroglycerin, given when oxytocin fails, seems to reduce both the need for manual removal of placenta and blood loss during the third stage of labour when compared to placebo. Further trials are needed to confirm its clinical role and safety. Its routine use cannot be recommended based on a single small study. There is no evidence available for other types of tocolytics.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006447",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence to support the use of parental presence during anaesthesia for children and their parents.</span></span></span> <span class=Lack_of_Focus Redundancy><span class=Overgeneralization>There is a need for further research.</span></span>",
            "Target Summary": "This review shows that the presence of parents during induction of general anaesthesia does not reduce their child's anxiety. Promising non-pharmacological interventions such as parental acupuncture; clown doctors; hypnotherapy; low sensory stimulation; and hand-held video games needs to be investigated further.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006972",
            "ESE Summary": "There is insufficient evidence to determine whether <span class=Population_Mismatch Omission_of_Key_Facts>initial L-thyroxine dose is more beneficial than initial T4 dose for children with congenital hypothyroidism.</span>",
            "Target Summary": "There is currently only one randomised controlled trial evaluating the effects of high versus low dose of initial thyroid hormone replacement for CHT. There is inadequate evidence to suggest that a high dose is more beneficial compared to a low dose initial thyroid hormone replacement in the treatment of CHT.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003032",
            "ESE Summary": "There is <span class=Extrinsic_Information><span class=Omission_of_Key_Facts>insufficient evidence to recommend the use of melatonin for seizure control</span>.</span> There is a need for <span class=Excessive_Detail><span class=Overgeneralization><span class=Omission_of_Key_Facts>large, well-designed randomised controlled trials with long-term follow-up</span>.</span></span>",
            "Target Summary": "Although ethosuximide, lamotrigine and valproate are commonly used to treat people with absence seizures we have insufficient evidence to inform clinical practice, and the few trials included in this review were of poor methodological quality and did not have sufficient number of participants. More trials of better quality are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002113",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Inaccurate_Emphasis>There is <span class=Omission_of_Key_Facts>insufficient evidence to support or refute the effectiveness of prompted voiding for treating urinary incontinence in nursing home residents.</span></span></span>",
            "Target Summary": "There was insufficient evidence to reach firm conclusions for practice. There was suggestive evidence of short-term benefit from prompted voiding, but longer-term effects are not known, and prompted voiding has significant resource implications.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD000123",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support the use of glycosaminoglycan therapy for people with intermittent claudication.</span></span></span>",
            "Target Summary": "Lipid-lowering therapy is effective in reducing cardiovascular mortality and morbidity in people with PAD. It may also improve local symptoms. Until further evidence on the relative effectiveness of different lipid-lowering agents is available, use of a statin in people with PAD and a blood cholesterol level  3.5 mmol/litre is most indicated.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006963",
            "ESE Summary": "There is insufficient evidence from <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>randomised controlled trials</span></span></span> to determine the <span class=Lack_of_Focus><span class=Intrinsic_Information>role of <span class=Omission_of_Key_Facts>osteotomy for mandibular prognathism</span></span></span>.",
            "Target Summary": "There is insufficient evidence from the two included trials, to conclude that one procedure is better or worse than another.The included trials compared different interventions and were at high risk of bias and therefore no implications for practice can be given.Further high quality randomized controlled trials with long term follow-up are required.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004181",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>insufficient evidence to support or refute the use of immunoglobulin prophylaxis in the prevention of hepatitis A.</span></span></span>",
            "Target Summary": "Immunoglobulins seem to be effective for pre-exposure and post-exposure prophylaxis of hepatitis A. However, caution is warranted for the positive findings due to the limited number of trials, year of conductance, and risk of bias. Conductance of rigorous trials will be justifiable.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003005",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support or refute the use of dorsal nerve block for analgesia following circumcision.</span></span></span>",
            "Target Summary": "Differences in the need for rescue or other analgesia could not be detected between caudal, parenteral and penile block methods. In day-case surgery, penile block may be preferable to caudal block in children old enough to walk due to the possibility of temporary leg weakness after caudal block. Evidence from trials is limited by small numbers and poor methodology. There is a need for properly designed trials comparing caudal epidural block with other methods such as morphine, simple analgesics and topical local anaesthetic creams, emulsions or gels.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003794",
            "ESE Summary": "<span class=Lack_of_Focus Length>In people with COPD, inhaled corticosteroids appear to <span class=Extrinsic_Information>improve lung function</span> and <span class=Overgeneralization>reduce the number of exacerbations per year</span>.</span> <span class=Lack_of_Focus Redundancy>In comparison with <span class=Omission_of_Key_Facts>placebo, the use of inhaled steroids appears to be <span class=Incorrect_Implication>safe</span>.</span></span>",
            "Target Summary": "Compared with placebo, combination therapy led to a significant reduction of a quarter in exacerbation rates. There was a significant reduction in all-cause mortality with the addition of data from the TORCH trial. The increased risk of pneumonia is a concern, and better reporting of this outcome in future studies would be helpful. In order to draw firmer conclusions about the effects of combination therapy in a single inhaler more data are necessary, particularly in relation to the profile of adverse events and benefits in relation to different doses of inhaled corticosteroids.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008890",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to recommend the use of intracystic radiotherapy</span> for patients with cystic craniopharyngiomas.</span>",
            "Target Summary": "Since no RCTs, quasi-randomised trials or CCTs in which only the use of intracystic bleomycin differed between the treatment groups in the treatment of cystic craniopharyngiomas in children, no definitive conclusions could be made about the effects of intracystic bleomycin in these patients. Only one low-power RCT comparing intracystic bleomycin with intracystic 32P treatment was available, but no definitive conclusions can be made about the effectiveness of these agents in children with cystic craniopharyngiomas. Based on the currently available evidence, we are not able to give recommendations for the use of intracystic bleomycin in the treatment of cystic craniopharyngiomas in children. High quality RCTs are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001297",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to recommend the use of any of the GnRH agonists for the treatment of endometriosis.</span></span></span>",
            "Target Summary": "Both danazol and progesterone + oestrogen add-back have been shown to be protective of BMD, while on treatment and up to six and 12 months later, respectively. However, by 24 months of follow-up there was no difference in BMD in those women who had HRT add-back. Studies of danazol versus GnRHa did not report long-term follow-up. The significant side effects associated with danazol limit its use.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001539",
            "ESE Summary": "There is <span class=Lack_of_Focus Length><span class=Omission_of_Key_Facts><span class=Incorrect_Implication>insufficient evidence to support the use of audio-visual interventions</span></span> to enhance patient recall of medical consultations.</span>",
            "Target Summary": "The provision of recordings or summaries of key consultations may benefit most adults with cancer. Although more research is needed to improve our understanding of these interventions, most patients find them very useful. Practitioners should consider offering people recordings or written summaries of their consultations",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003219",
            "ESE Summary": "<span class=Incorrect_Implication>There is <span class=Lack_of_Focus Length><span class=Omission_of_Key_Facts>insufficient evidence to support or refute the use of any intervention for CTS</span>.</span></span> <span class=Overgeneralization>There is a <span class=Redundancy Length>need for <span class=Omission_of_Key_Facts>large, well-designed randomised controlled trials with long-term follow-up</span>.</span></span>",
            "Target Summary": "Current evidence shows significant short-term benefit from oral steroids, splinting, ultrasound, yoga and carpal bone mobilisation. Other non-surgical treatments do not produce significant benefit. More trials are needed to compare treatments and ascertain the duration of benefit.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 2,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003385",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Extrinsic_Information>There is insufficient evidence from randomised controlled trials</span> to support the use of <span class=Lack_of_Focus>psychosocial interventions</span> for bulimia nervosa.</span>",
            "Target Summary": "Using a more conservative statistical approach, combination treatments were superior to single psychotherapy. This was the only statistically significant difference between treatments. The number of trials might be insufficient to show the statistical significance of a 19% absolute risk reduction in efficacy favouring psychotherapy or combination treatments over single antidepressants. Psychotherapy appeared to be more acceptable to subjects. When antidepressants were combined with psychological treatments, acceptability of the latter was significantly reduced.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001439",
            "ESE Summary": "<span class=Incorrect_Implication>There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>insufficient evidence to support the use of prophylactic antibiotics in patients with appendicitis who have undergone appendicectomy.</span></span></span>",
            "Target Summary": "Antibiotic prophylaxis is effective in the prevention of postoperative complications in appendectomised patients, whether the administration is given pre-, peri- or post-operatively, and could be considered for routine in emergency appendectomies.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008112",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Extrinsic_Information Overgeneralization>There is <span class=Omission_of_Key_Facts>insufficient evidence to support the use of any specific type of therapy</span> for chronic low-back pain.</span></span> <span class=Lack_of_Focus Length><span class=Incorrect_Implication>There is a <span class=Omission_of_Key_Facts>need for well-designed RCTs that compare the effectiveness of different types of therapy</span>.</span></span>",
            "Target Summary": "High quality evidence suggests that there is no clinically relevant difference between SMT and other interventions for reducing pain and improving function in patients with chronic low-back pain. Determining cost-effectiveness of care has high priority. Further research is likely to have an important impact on our confidence in the estimate of effect in relation to inert interventions and sham SMT, and data related to recovery.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006197",
            "ESE Summary": "<span class=Length><span class=Inaccurate_Emphasis>There is <span class=Omission_of_Key_Facts>insufficient evidence</span> to support the use of <span class=Omission_of_Key_Facts>dehydroepiandrosterone augmentation</span> for the treatment of <span class=Population_Mismatch>schizophrenia</span>.</span></span>",
            "Target Summary": "Results are inconclusive with most outcomes being either non-significant or producing contradictory findings. Currently, adjunctive DHEA should remain an experimental treatment for people with schizophrenia.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD002068",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>Pamidronate is effective in reducing pain and improving bone function in patients with metastatic breast cancer.</span></span> However, <span class=Omission_of_Key_Facts><span class=Length><span class=Inaccurate_Emphasis>the evidence is not strong enough to recommend its use.</span></span></span>",
            "Target Summary": "There is evidence to support the effectiveness of bisphosphonates in providing some pain relief for bone metastases. There is insufficient evidence to recommend bisphosphonates for immediate effect; as first line therapy; to define the most effective bisphosphonates or their relative effectiveness for different primary neoplasms. Bisphosphonates should be considered where analgesics and/or radiotherapy are inadequate for the management of painful bone metastases.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD004115",
            "ESE Summary": "The available evidence suggests that <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>5-ASA is an effective treatment for mild to moderately active distal ulcerative colitis.</span></span></span> However, <span class=Lack_of_Focus Redundancy><span class=Incorrect_Implication>there is <span class=Omission_of_Key_Facts>insufficient evidence to conclude that it is superior to other topical treatments.</span></span></span>",
            "Target Summary": "Rectal 5-ASA should be considered a first-line therapy for patients with mild to moderately active distal UC. The optimal total daily dose and dose frequency of 5-ASA remain to be determined. Future research should define differences in efficacy among patient subgroups defined by proximal disease margin and disease activity. There is a strong need for consensus standardization of outcome measurements for clinical trials in ulcerative colitis.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007294",
            "ESE Summary": "The results of this review support the use of <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>interstitial chemotherapy treatments</span></span> in patients with <span class=Population_Mismatch><span class=Overgeneralization>GBM</span></span>. However, there is a need for further large <span class=Omission_of_Key_Facts><span class=Intrinsic_Information>RCTs</span></span> to confirm the efficacy of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Intrinsic_Information>inter interstitial treatments</span></span></span> in <span class=Population_Mismatch><span class=Overgeneralization>GBM patients</span></span>.",
            "Target Summary": "Carmustine impregnated wafers (Gliadel) result in improved survival without an increased incidence of adverse events over placebo wafers when used for primary disease therapy. There is no evidence of benefit for any other outcome measures. In recurrent disease Gliadel does not appear to confer any additional benefit.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 2,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 3
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 2,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 2,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005190",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Incorrect_Implication><span class=Lack_of_Focus>PAN is superior to benzodiazepines</span> in the treatment of alcoholic withdrawal.</span></span>",
            "Target Summary": "Results indicate that PAN may be an effective treatment of the mild to moderate alcoholic withdrawal state. The rapidity of the therapeutic effect of PAN therapy coupled with the minimal sedative requirements, may enable patients to enter the psychological treatment phase more quickly than those on sedative regimens, accelerating the patients recovery. Our review does not provide strong evidence due to the small sample sizes of the included trials. Neither does the review indicate any causes for concern that PAN is more harmful than the benzodiazepines. Clinicians wishing to use PAN may initially wish to do so within trial settings. Further high quality trials should be done to confirm these findings and to investigate whether the PAN therapy has fewer adverse effects than other treatments for the alcohol withdrawal states. Studies to investigate the possible cost-effectiveness of PAN by reducing costly hospital admissions and decreasing post administration supervision also need to be performed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005137",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>insufficient evidence to support the use of <span class=Lack_of_Focus>spectacle correction in children with amblyopic vision.</span></span></span>",
            "Target Summary": "In some cases of unilateral refractive amblyopia it appears that there is a treatment benefit from refractive correction alone. Where amblyopia persists there is evidence that adding occlusion further improves vision. Despite advances in the understanding of the treatment of amblyopia it is currently still not possible to tailor individual treatment plans for amblyopia. The nature of any dose/response effect from occlusion still needs to be clarified. Partial occlusion appears to have the same treatment effect as glasses alone when started simultaneously for the treatment of unilateral refractive amblyopia. Treatment regimes for bilateral and unilateral refractive amblyopia need to be investigated further.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002271",
            "ESE Summary": "There is <span class=Extrinsic_Information>no evidence to support the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>CPAP or PPO2</span></span></span> in infants with <span class=Omission_of_Key_Facts>respiratory failure</span>.",
            "Target Summary": "In preterm infants with respiratory distress the application of CDP either as CPAP or CNP is associated with reduced respiratory failure and reduced mortality. CDP is associated with an increased rate of pneumothorax. Four out of six of these trials were done in the 1970's. Therefore, the applicability of these results to current practice is difficult to assess. Where resources are limited, such as in developing countries, CPAP for RDS may have a clinical role. Further research is required to determine the best mode of administration and the role of CDP in modern intensive care settings",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005365",
            "ESE Summary": "Prophylactic <span class=Lack_of_Focus Length><span class=Omission_of_Key_Facts><span class=Overgeneralization>antibiotic use during surgical procedures reduces the incidence of postoperative infections</span></span>, but <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>not the rate at which such infections occur</span></span>.</span>",
            "Target Summary": "We could demonstrate a benefit of systemic prophylactic antibiotics for the first 24 hours postoperatively to prevent shunt infection, regardless of the patient's age and the type of internal shunt used. The benefit of its use after this period remains uncertain. However this data derives from the rate of shunt infection, which is an intermediary outcome. Future trials should evaluate the effectiveness of different regimens of systemic antibiotics rather than placebo, and should include all-cause mortality, shunt revision and adverse events as additional outcomes. Evidence suggests that antibiotic-impregnated catheters reduce the incidence of shunt infection although more well-designed clinical trials testing the effect of antibiotic-impregnated shunts are required to confirm their net benefit.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003275",
            "ESE Summary": "There is insufficient evidence to support or refute the use of <span class=Omission_of_Key_Facts><span class=Length><span class=Extrinsic_Information>hydroxychloroquine</span></span></span> for the treatment of <span class=Population_Mismatch>chronic steroid dependent asthma</span>.",
            "Target Summary": "There is insufficient evidence to support the use of chloroquine as an oral steroid-sparing agent in chronic asthma. Further trials should optimise oral steroid dosage before addition of the steroid-sparing agent.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008203",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is <span class=Omission_of_Key_Facts>insufficient evidence to support or refute the use of statins for the prevention of VTE.</span></span></span> <span class=Length>A large <span class=Omission_of_Key_Facts>randomised controlled trial of statin versus placebo is needed.</span></span>",
            "Target Summary": "Available evidence showed that rosuvastatin was associated with a reduced incidence of VTE, but the evidence was limited to a single RCT. Randomised controlled trials of statins (including rosuvastatin) are needed to evaluate the efficacy of statins in the prevention of VTE.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007191",
            "ESE Summary": "Prophylaxis with azithromycin for the prevention of MAC disease in HIV-1 patients with a CD4 cell count < 100/mm3 is associated with a reduction in the risk of developing MAC disease and a shorter time to death. <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Excessive_Detail>The risk of pneumonia is increased with the use of <span class=Extrinsic_Information>rifabutin</span>.</span></span>",
            "Target Summary": "Based on limited data, azithromycin or clarithromycin appeared to be a prophylactic agent of choice for MAC infection. Further studies are needed, especially direct comparison of clarithromycin and azithromycin. In additions, studies that will compare different doses and regimens are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003893",
            "ESE Summary": "<span class=Lack_of_Focus Excessive_Detail><span class=Extrinsic_Information Overgeneralization>Antihypertensive drugs such as <span class=Omission_of_Key_Facts>methyldopa and indapamide reduce blood pressure but do not affect standing or diastolic pressure.</span></span></span> <span class=Length Excessive_Detail>Higher doses ( 500 mg) and lower doses ( < 1000 mg) <span class=Extrinsic_Information Overgeneralization>reduce cardiovascular disease and cardiovascular morbidity.</span></span> <span class=Lack_of_Focus Length>The effect of these drugs on mortality and cardiovascular disease is unknown.</span>",
            "Target Summary": "Methyldopa lowers blood pressure to varying degrees compared to placebo for patients with primary hypertension. Its effect on clinical outcomes, however, remains uncertain.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 2
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 2,
                    "Ambiguity": 0,
                    "Overgeneralization": 2,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001024",
            "ESE Summary": "There is no evidence from randomised controlled trials to support <span class=Omission_of_Key_Facts><span class=Length><span class=Extrinsic_Information>tamoxifen as an effective treatment for advanced HCC</span>.</span></span>",
            "Target Summary": "These data do not support the use of tamoxifen for patients with hepatocellular carcinoma. Further research on the effects of tamoxifen in hepatocellular carcinoma does not seem warranted.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008241",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>no evidence</span> to support the use of <span class=Intrinsic_Information>reamed or unreamed nails</span> for closed tibial shaft fractures.</span></span>",
            "Target Summary": "Overall, there is insufficient evidence to draw definitive conclusions on the best type of, or technique for, intramedullary nailing for tibial shaft fractures in adults. 'Moderate' quality evidence suggests that there is no clear difference in the rate of major re-operations and complications between reamed and unreamed intramedullary nailing. Reamed intramedullary nailing has, however, a lower incidence of implant failure than unreamed nailing. 'Low' quality evidence suggests that reamed nailing may reduce the incidence of major re-operations related to non-union in closed fractures rather than in open fractures. 'Low' quality evidence suggests that the Ender nail has poorer results in terms of re-operation and malunion than an interlocking nail.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006378",
            "ESE Summary": "There is <span class=Extrinsic_Information>no evidence</span> to support the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Overgeneralization>NSAIDs</span></span></span> in the treatment of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>Alzheimer's disease</span></span>.",
            "Target Summary": "Based on the studies carried out so far, the efficacy of aspirin, steroid and NSAIDs (traditional NSAIDs and COX-2 inhibitors) is not proven. Therefore, these drugs cannot be recommended for the treatment of AD.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002214",
            "ESE Summary": "<span class=Lack_of_Focus>There is <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>insufficient evidence to support or refute the use of a nurse-led unit for acute care.</span></span></span>",
            "Target Summary": "There is some evidence that patients discharged from a NLU are better prepared for discharge but it is unclear if this is simply a product of an increased length of inpatient stay. No statistically significant adverse effects were noted but the possibility of increased early mortality cannot be discounted. More research is needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004136",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is no evidence to support the use of ACE inhibitors in patients with type 1 diabetes.</span></span></span> <span class=Omission_of_Key_Facts><span class=Length><span class=Incorrect_Implication>There is a need for larger randomised controlled trials with long-term follow-up.</span></span></span>",
            "Target Summary": "ACEi were found to prevent new onset DKD and death in normoalbuminuric people with diabetes, and could therefore be used in this population. More data are needed to clarify the role of ARB and other drug classes in preventing DKD.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006728",
            "ESE Summary": "There is <span class=Extrinsic_Information>insufficient evidence</span> to support the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>family therapy as an adjunctive treatment to pharmacotherapy for people with <span class=Intrinsic_Information>bipolar disorder</span>.</span></span>",
            "Target Summary": "The current evidence base is too heterogeneous and sparse to draw conclusions on the overall effectiveness of family therapy in the treatment of depression. At this point, use of psychological interventions for the treatment of depression for which there is already an evidence-base would seem to be preferable to family therapy. Further high quality trials examining the effectiveness and comparative effectiveness of explicitly defined forms of family therapy are required.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001984",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus>There is <span class=Extrinsic_Information>insufficient evidence to support the effectiveness of cognitive behavioural interventions for fibromyalgia</span>.</span></span> <span class=Omission_of_Key_Facts><span class=Length>There is a need for <span class=Overgeneralization>well-designed RCTs with low risk of bias and with long-term follow-up</span>.</span></span>",
            "Target Summary": "We conclude that there appears to be little scientific evidence for the effectiveness of multidisciplinary rehabilitation for these musculoskeletal disorders. However, multidisciplinary rehabilitation is a commonly used intervention for chronic musculoskeletal disorders, which cause much personal suffering and substantial economic loss to the society. There is a need for high quality trials in this field.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000525",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Extrinsic_Information><span class=Lack_of_Focus>Zuclopenthixol acetate appears to be an effective treatment for acute psychosis,</span> <span class=Length>but there is no evidence of a difference in efficacy between the two drugs.</span></span></span>",
            "Target Summary": "Recommendations on the use of zuclopenthixol acetate for the management of psychiatric emergencies in preference to 'standard' treatment have to be viewed with caution. Most of the small trials present important methodological flaws and findings are poorly reported. This review did not find any suggestion that zuclopenthixol acetate is more or less effective in controlling aggressive acute psychosis, or in preventing adverse effects than intramuscular haloperidol, and neither seemed to have a rapid onset of action. Use of zuclopenthixol acetate may result in less numerous coercive injections and low doses of the drug may be as effective as higher doses. Well-conducted pragmatic randomised controlled trials are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000436",
            "ESE Summary": "There is <span class=Extrinsic_Information>insufficient evidence from randomised controlled trials</span> to determine whether <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>altering salt intake in people with asthma improves lung function or reduces the use of anti-asthma drugs.</span></span>",
            "Target Summary": "This review did not find any evidence that dietary sodium reduction significantly improves asthma control. Although dietary sodium reduction may result in improvements in lung function in exercise-induced asthma, the clinical significance of this effect is unclear.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004829",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support the use of PCA for oocyte retrieval.</span></span></span> <span class=Omission_of_Key_Facts><span class=Length><span class=Overgeneralization>There is a need for more studies with low risk of bias and with longer follow-up periods.</span></span></span>",
            "Target Summary": "The evidence from this review of 21 randomised controlled trials did not support one particular method or technique over another in providing effective conscious sedation and analgesia for pain relief during and after oocyte recovery. The simultaneous use of more than one method of sedation and pain relief resulted in better pain relief than one modality alone. The various approaches and techniques reviewed appeared to be acceptable and were associated with a high degree of satisfaction in women. As women vary in their experience of pain and in coping strategies, the optimal method may be individualised depending on the preferences of both the women and the clinicians and resource availability.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006866",
            "ESE Summary": "Acyclovir, 800 mg, and famciclovir, 750 mg, <span class=Omission_of_Key_Facts><span class=Redundancy Length><span class=Extrinsic_Information>reduced the incidence of chronic pain, the occurrence of neurodevelopmental complications, and the number of lesions per person.</span></span></span> No significant difference in the incidence and severity of intraocular complications was observed.",
            "Target Summary": "Oral acyclovir did not reduce the incidence of PHN significantly. There is insufficient evidence from randomised controlled trials to determine whether other antiviral treatments prevent PHN. Additional well-designed, randomised controlled trials of famciclovir or other new antiviral agents, with a greater number of participants are needed. Future trials should pay more attention to the severity of pain and quality of life of participants, and should be conducted among different subgroups of people, such as people who are immunocompromised.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006667",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Inaccurate_Emphasis>There is <span class=Lack_of_Focus>insufficient evidence to support or refute the use of recruitment manoeuvres in patients with acute lung injury and acute respiratory distress syndrome.</span></span></span> Further research is needed.",
            "Target Summary": "There is not evidence to make conclusions on whether recruitment manoeuvres reduce mortality or length of ventilation in patients with ALI or ARDS.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD006107",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Extrinsic_Information>There is some evidence that <span class=Lack_of_Focus>ultrasound during embryo transfer increases live birth rates compared with touch transfer.</span></span></span> However, <span class=Omission_of_Key_Facts><span class=Excessive_Detail><span class=Incorrect_Implication>the evidence is not strong enough to support the use of ultrasound during ET.</span></span></span>",
            "Target Summary": "The studies are limited by their quality with only two studies reporting details of both computerised randomisation techniques and adequate allocation concealment. Ultrasound guidance does appear to improve the chances of live/ongoing and clinical pregnancies compared with clinical touch methods. The quality of future studies should be improved with adequate reporting of randomisation, allocation concealment, and power calculations. The primary outcome measure of future studies should be the reporting of live births per woman randomised.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009274",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is <span class=Omission_of_Key_Facts>insufficient evidence to support or refute the use of topical corticosteroids in the treatment of chronic rhinosinusitis.</span></span></span>",
            "Target Summary": "Topical steroid is a beneficial treatment for CRS without polyps and the adverse effects are minor. It may be included in a comprehensive treatment of CRS without polyps. Direct delivery of steroid to the sinuses may bring more beneficial effect. Further studies comparing different topical drug delivery methods to the sinuses, with appropriate treatment duration (longer than 12 weeks), are required.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004842",
            "ESE Summary": "<span class=Length><span class=Inaccurate_Emphasis>Dipyrone is an effective analgesic for acute migraine pain,</span> with a statistically significant benefit compared to placebo.</span> <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Overgeneralization>There is insufficient evidence to recommend dipyrone as a first-line treatment, or as an adjunct to other analgesics.</span></span></span>",
            "Target Summary": "Evidence from a small number of trials suggests that dipyrone is effective for ETTH and migraine. No serious adverse events were observed in the included trials, but agranulocytosis is rare and would probably not be observed in such a relatively small sample. A study now ongoing in Latin America may clarify the true risk of agranulocytosis associated with dipyrone use.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD005539",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Inaccurate_Emphasis>insufficient evidence</span> to determine whether screening of patients for malnutrition improves outcomes.</span></span>",
            "Target Summary": "Current evidence is insufficient to support the effectiveness of nutritional screening, although equally there is no evidence of no effect. Therefore, more high quality studies should be conducted to assess the effectiveness of nutritional screening in different settings.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD001939",
            "ESE Summary": "<span class=Inaccurate_Emphasis>There is insufficient evidence to support the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>branched-chain amino acids</span></span> for the treatment of <span class=Population_Mismatch><span class=Lack_of_Focus>patients with hepatic encephalopathy</span></span>.</span>",
            "Target Summary": "We did not find convincing evidence that BCAA had a significant beneficial effect on patients with hepatic encephalopathy. The trials performed in this field were small with short follow-up and most had low methodological quality.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD006883",
            "ESE Summary": "There is some evidence that the administration of <span class=Omission_of_Key_Facts><span class=Redundancy Length><span class=Extrinsic_Information>amicar</span></span> reduces blood loss and transfusion requirements in patients with scoliosis undergoing surgery for posterior spinal fusion.</span> However, the evidence is not strong enough to recommend the use of <span class=Incorrect_Implication><span class=Redundancy Length>this drug</span> in clinical practice</span>. Further research is needed to determine the optimal dose and route of administration of <span class=Redundancy Length>this medication</span>.",
            "Target Summary": "The effect of antifibrinolytic drugs on mortality could not be assessed. Antifibrinolytic drugs reduced blood loss and the amount of blood transfused in children undergoing scoliosis surgery; however, their effect on the number of children requiring blood transfusion remains unclear. Aprotinin, tranexamic acid and aminocaproic acid seem to be similarly effective.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 3,
                    "Length": 3,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003913",
            "ESE Summary": "This review provides evidence that in patients with supratentorial glioma, <span class=Length><span class=Extrinsic_Information>radiotherapy plus <span class=Intervention_Mismatch>BCNU</span> may improve survival compared to <span class=Intervention_Mismatch>radiotherapy alone</span></span>.</span> However, <span class=Excessive_Detail><span class=Overgeneralization>this conclusion is based on a <span class=Omission_of_Key_Facts>small number of patients</span></span> and <span class=Incorrect_Implication>the risk of adverse events is high</span>.</span>",
            "Target Summary": "This small but clear improvement in survival from chemotherapy encourages further study of drug treatment of these tumours",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 2,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004572",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Overgeneralization>There is <span class=Omission_of_Key_Facts>insufficient evidence to support or refute</span> the use of aldose reductase inhibitors in the treatment of peripheral neuropathy.</span></span>",
            "Target Summary": "We found no statistically significant difference between aldose reductase inhibitors and placebo in the treatment of diabetic polyneuropathy. Any future clinical trials of aldose reductase inhibitors should be restricted to compounds proven to have substantial biological or preclinical advantages over previously tested agents.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007566",
            "ESE Summary": "<span class=Lack_of_Focus>There is some evidence that <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>exercise therapy may improve physical and mental health outcomes</span> in women with cancer</span>.</span> However, the evidence is not strong enough to <span class=Incorrect_Implication>recommend its use as a standard therapy for <span class=Omission_of_Key_Facts>cancer-related fatigue</span></span>. <span class=Omission_of_Key_Facts><span class=Length>More research is needed.</span></span>",
            "Target Summary": "This systematic review indicates that exercise may have beneficial effects on HRQoL and certain HRQoL domains including cancer-specific concerns (e.g. breast cancer), body image/self-esteem, emotional well-being, sexuality, sleep disturbance, social functioning, anxiety, fatigue, and pain at varying follow-up periods. The positive results must be interpreted cautiously due to the heterogeneity of exercise programs tested and measures used to assess HRQoL and HRQoL domains, and the risk of bias in many trials. Further research is required to investigate how to sustain positive effects of exercise over time and to determine essential attributes of exercise (mode, intensity, frequency, duration, timing) by cancer type and cancer treatment for optimal effects on HRQoL and its domains.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 3
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007617",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is <span class=Omission_of_Key_Facts>insufficient evidence to support the use of family-based interventions for the management of grief for cancer patients.</span></span></span> <span class=Length>Further research is needed.</span>",
            "Target Summary": "There is evidence that supportive interventions may help reduce caregivers' psychological distress. These findings suggest that practitioners should enquire about the concerns of caregivers and should consider that they may benefit from additional support. There is, however, a need for further research to explore the benefits identified, and to assess the interventions' effects on physical health, and potential harms. Trials need to report their methods fully.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008586",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to determine whether seizure control in patients with supratentorial glioma is equivalence with other antiepileptic drugs.</span></span></span>",
            "Target Summary": "There is a lack of robust, randomised, controlled evidence to support the choice of antiepileptic drug for the treatment of seizures in adults with brain tumours. While some authors support the use of non enzyme-inducing antiepileptic drugs, reliable, comparative evidence to provide clinical justification for this is limited. There is a need for further large, randomised, controlled trials in this area.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006853",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support the use of <span class=Omission_of_Key_Facts>long-term aerobic exercise for the treatment of RA</span>.</span></span> <span class=Length>Further research is needed.</span>",
            "Target Summary": "Based on the evidence, aerobic capacity training combined with muscle strength training is recommended as routine practice in patients with RA.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007024",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support disulfiram as a treatment for cocaine dependence.</span></span></span>",
            "Target Summary": "There is low evidence, at the present, supporting the clinical use of disulfiram for the treatment of cocaine dependence. Larger randomised investigations are needed investigating relevant outcomes and reporting data to allow comparisons of results between studies. Results from ongoing studies will be added as soon as their results will be available.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007579",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>no evidence</span> to support the use of <span class=Omission_of_Key_Facts>prophylactic drugs</span> during <span class=Omission_of_Key_Facts>caesarean section</span>.</span></span>",
            "Target Summary": "This review indicates that many different interventions have efficacy in preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section. There is little evidence that combinations of treatment are better than single agents.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 3
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001340",
            "ESE Summary": "<span class=Incorrect_Implication>There is insufficient evidence to support or refute the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>extracorporeal membrane oxygenation</span></span> in newborn infants with <span class=Population_Mismatch><span class=Lack_of_Focus>persistent pulmonary hypertension</span></span>.</span>",
            "Target Summary": "A policy of using ECMO in mature infants with severe but potentially reversible respiratory failure results in significantly improved survival without increased risk of severe disability. The benefit of ECMO for babies with diaphragmatic hernia is unclear.\nFurther studies are needed to consider the optimal timing for introducing ECMO; to identify which infants are most likely to benefit; and to address the implications of neonatal ECMO during later childhood and adult life.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002982",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence</span> to recommend the use of <span class=Omission_of_Key_Facts>psychosomatic therapy</span> for asthma.</span></span>",
            "Target Summary": "This review was unable to draw firm conclusions for the role of psychological interventions in asthma due to the absence of an adequate evidence base. Larger, well-conducted and reported randomised trials are required in this area, in order to determine the effects of these techniques in the treatment of asthma in adults.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003123",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>There is no evidence to support the use of nebulised epinephrine in infants with acute bronchiolitis.</span></span></span> <span class=Omission_of_Key_Facts><span class=Length><span class=Overgeneralization>There is a need for larger randomised controlled trials to evaluate the effects of this intervention on long-term outcomes.</span></span></span>",
            "Target Summary": "This review demonstrates the superiority of epinephrine compared to placebo for short-term outcomes for outpatients, particularly in the first 24 hours of care. Exploratory evidence from a single study suggests benefits of epinephrine and steroid combined for later time points. More research is required to confirm the benefits of combined epinephrine and steroids among outpatients. There is no evidence of effectiveness for repeated dose or prolonged use of epinephrine or epinephrine and dexamethasone combined among inpatients.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001490",
            "ESE Summary": "There is <span class=Inaccurate_Emphasis>insufficient evidence</span> to support the <span class=Overgeneralization>routine use</span> of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>intravenous magnesium</span></span> in patients with asthma who fail to respond to <span class=Excessive_Detail>standard treatment</span>.",
            "Target Summary": "Current evidence does not support routine use of intravenous magnesium sulfate in all patients with acute asthma presenting to the emergency department. Magnesium sulfate appears to be safe and beneficial in patients who present with severe acute asthma.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD006133",
            "ESE Summary": "<span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>insufficient evidence</span> to support or refute the use of combined oral contraceptives.</span></span>",
            "Target Summary": "Current evidence suggests no major differences in carbohydrate metabolism between different hormonal contraceptives in women without diabetes. We cannot make strong statements due to having few studies that compared the same types of contraceptives. Many trials had small numbers of participants and some had large losses. Many of the earlier studies had limited reporting of methods.\nWe still know very little about women at risk for metabolic problems due to being overweight. More than half of the trials had weight restrictions as inclusion criteria. Only one small trial stratified the groups by body mass index (obese versus normal).",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005083",
            "ESE Summary": "<span class=Lack_of_Focus>Honey dressings <span class=Omission_of_Key_Facts><span class=Inaccurate_Emphasis>appear to be more effective in promoting wound healing than standard dressings</span>.</span></span> However, <span class=Omission_of_Key_Facts>the evidence is <span class=Overgeneralization>not strong enough to recommend the use of honey dressings over other wound treatments</span>.</span>",
            "Target Summary": "Honey dressings do not increase rates of healing significantly in venous leg ulcers when used as an adjuvant to compression. Honey may delay healing in partial- and full-thickness burns in comparison to early excision and grafting, and in cutaneous Leishmaniasis when used as an adjuvant with meglumine antimoniate. Honey might be superior to some conventional dressing materials, but there is considerable uncertainty about the replicability and applicability of this evidence. There is insufficient evidence to guide clinical practice in other types of wounds, and health services may wish to consider avoiding routine use of honey dressings until sufficient evidence of effect is available.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD005262",
            "ESE Summary": "There is some evidence that <span class=Lack_of_Focus><span class=Omission_of_Key_Facts>pentoxifylline improves walking distance in people with intermittent claudication</span>.</span> However, <span class=Extrinsic_Information Overgeneralization>the evidence is not strong enough to recommend its use as a treatment for chronic arterial disease.</span>",
            "Target Summary": "Given the generally poor quality of the published studies and the large degree of heterogeneity in the interventions and the results, the overall benefit of pentoxifylline for patients with Fontaine class II intermittent claudication remains uncertain.Pentoxifylline is generally well tolerated.\nBased on the totality of the available evidence, it is possible that pentoxifylline could have a place in the treatment of IC as a means of improving walking distance and as a complimentary treatment assuming all other essential measures such as lifestyle change, exercise and treatment for secondary prevention have been taken into account.However, the response to pentoxifylline should be assessed on an individual basis.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001900",
            "ESE Summary": "This review provides evidence that <span class=Omission_of_Key_Facts><span class=Overgeneralization>add-on drugs can reduce seizure frequency and severity</span></span> in patients with epilepsy. However, <span class=Length>the evidence is based on a <span class=Omission_of_Key_Facts><span class=Intrinsic_Information>small number of trials with small sample sizes</span></span></span> <span class=Excessive_Detail>and is therefore <span class=Omission_of_Key_Facts><span class=Inaccurate_Emphasis>not suitable for general clinical practice</span></span>.</span>",
            "Target Summary": "Given the modest effect on seizure frequency and significant withdrawal rate it is unlikely that remacemide will be further developed as an antiepileptic drug.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 3
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD004668",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>insufficient evidence to determine whether <span class=Lack_of_Focus>dry-bed training</span> is superior to <span class=Lack_of_Focus>other forms of behavioural therapy</span></span></span> for children with enuresis.",
            "Target Summary": "Although DBT and FSHT were better than no treatment when used in combination with an alarm, there was insufficient evidence to support their use without an alarm. An alarm on its own was also better than DBT on its own, but there was some evidence that combining an alarm with DBT was better than an alarm on its own, suggesting that DBT may augment the effect of an alarm. There was also some evidence that direct contact with a therapist might enhance the effects of an intervention.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004376",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>limited evidence</span></span></span> that exercise therapy for knee osteoarthritis <span class=Omission_of_Key_Facts>improves pain, improves function, and reduces length of hospital stay</span> in the short term. There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>insufficient evidence to recommend or discourage the use of exercise therapy in the long term.</span></span></span>",
            "Target Summary": "There is platinum level evidence that land-based therapeutic exercise has at least short term benefit in terms of reduced knee pain and improved physical function for people with knee OA. The magnitude of the treatment effect would be considered small, but comparable to estimates reported for non-steroidal anti-inflammatory drugs.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 3
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005181",
            "ESE Summary": "<span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence to recommend the use of <span class=Lack_of_Focus Length>IFN beta</span> in the treatment of patients with <span class=Lack_of_Focus Length>secondary progressive MS</span>.</span></span>",
            "Target Summary": "Well designed RCTs, evaluating a high number of patients were included in the review. Recombinant IFN beta does not prevent the development of permanent physical disability in SPMS. We were unable to verify the effect on cognitive function for the lack of comparable data. This treatment significantly reduces the risk of relapse and of short -term relapse-related disability.\nOverall, these results show that IFNs' anti-inflammatory effect is unable to retard progression, when established. In the future, no new RCTs for IFNs versus placebo in SPMS will probably be undertaken, because research is now focusing on innovative drugs. We believe that this review gives conclusive evidence on the clinical efficacy of IFNs versus placebo in SPMS.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008391",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Overgeneralization>insufficient evidence</span></span> to support the use of <span class=Redundancy><span class=Extrinsic_Information>any specific type of cognitive rehabilitation</span></span></span> for people with <span class=Population_Mismatch>acquired brain injury</span>.",
            "Target Summary": "We identified insufficient high-quality evidence to reach any generalised conclusions about the effect of cognitive rehabilitation on executive function, or other secondary outcome measures. Further high-quality research comparing cognitive rehabilitation with no intervention, placebo or sensorimotor interventions is recommended.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006122",
            "ESE Summary": "There is <span class=Lack_of_Focus Length><span class=Inaccurate_Emphasis>insufficient evidence</span> to determine whether <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>low-fat nutrition support is beneficial or harmful</span> for people with severe burns.</span></span>",
            "Target Summary": "The available evidence suggests that use of high-carbohydrate, high-protein, low-fat enteral feeds in patients with at least 10% TBSA burns might reduce the incidence of pneumonia compared with use of a low-carbohydrate, high-protein, high-fat diet. The available evidence is inconclusive regarding the effect of either enteral feeding regimen on mortality. Note that the available evidence is limited to two small studies judged to be of moderate risk of bias. Further research is needed in this area before strong conclusions can be drawn.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD000143",
            "ESE Summary": "There is no evidence that the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>NCPAP compared to headbox oxygen</span></span></span> in <span class=Population_Mismatch>preterm or low birth weight infants</span> reduces the risk of respiratory failure or the need for reintubation.",
            "Target Summary": "Implications for practice: nasal CPAP is effective in preventing failure of extubation in preterm infants following a period of endotracheal intubation and IPPV.\nImplication for research: further definition of the gestational age and weight groups in whom these results apply is warranted. Optimal levels of NCPAP as well as methods of administration remain to be determined.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004481",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Overgeneralization>There is <span class=Lack_of_Focus>insufficient evidence</span> to support the use of colchicine for patients with primary biliary cirrhosis.</span></span>",
            "Target Summary": "We did not find evidence either to support or refute the use of colchicine for patients with primary biliary cirrhosis. As we are not able to exclude a detrimental effect of colchicine, we suggest that it is only used in randomised clinical trials.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005237",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Length><span class=Extrinsic_Information>Olanzapine may have a small but statistically significant effect on the 'positive' symptoms of schizophrenia compared to typical antipsychotic treatment.</span></span></span> However, the effect is likely to be small and probably not clinically meaningful.\r\n<span class=Lack_of_Focus>Future research should focus on comparisons between <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>risperidone and other atypical antipsychotics.</span></span></span>",
            "Target Summary": "We know very little of the effects of these drugs regarding service outcomes, general functioning and behaviours, engagement with services and treatment satisfaction from evaluative studies. There was generally a high rate of attrition in the trials and there appears to be little to differentiate between risperidone and olanzapine except on issues of adverse effects. Both drugs are associated with a reduction in psychotic symptoms but both commonly cause unpleasant adverse effects.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006945",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>Rasburicase appears to be more effective than allopurinol in the prevention and treatment of TLS in patients with advanced stage Burkitt's lymphoma.</span></span></span>",
            "Target Summary": "Although urate oxidase might be effective in reducing serum uric acid, it is still unclear whether this translates into a reduction in mortality or renal failure. Clinicians should weigh the potential benefits of reducing uric acid and uncertain benefits of preventing renal failure or mortality from TLS against the potential risk of adverse effects.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007610",
            "ESE Summary": "There is some evidence to support the use of <span class=Omission_of_Key_Facts>foot care education</span> in the management of patients with diabetes. However, <span class=Length><span class=Intrinsic_Information Overgeneralization>this evidence is based on a <span class=Omission_of_Key_Facts>small number of studies with unclear risk of bias</span></span>.</span> Further research is needed to confirm the effectiveness of this intervention in the primary prevention of diabetic foot complications.",
            "Target Summary": "There is no high-quality research evidence evaluating complex interventions for preventing diabetic foot ulceration and insufficient evidence of benefit.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007712",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is no evidence to support or refute the use of <span class=Omission_of_Key_Facts>VVBP</span> during or after liver transplantation.</span></span>",
            "Target Summary": "There is no evidence to support or refute the use of veno-venous bypass in liver transplantation. There is no evidence to prefer any particular technique of veno-venous bypass in liver transplantation.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003264",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Incorrect_Implication>There is no evidence that <span class=Lack_of_Focus>rhGH improves growth in children with chronic renal failure</span>.</span></span> However, <span class=Omission_of_Key_Facts>there is a need for further <span class=Length>randomised controlled trials</span>.</span>",
            "Target Summary": "One year of 28 IU/m/wk rhGH in children with CKD resulted in a 3.88 cm increase in height velocity above that of untreated patients. Studies were too short to determine if continuing treatment resulted in an increase in final adult height.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004214",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is <span class=Omission_of_Key_Facts>insufficient evidence to determine whether early weaning from the incubator is better than no weaning at all</span></span></span> <span class=Length><span class=Extrinsic_Information>and further research is needed.</span></span>",
            "Target Summary": "Medically stable preterm infants can be transferred to unheated open cots at a lower body weight of 1600 grams without adverse effects on temperature stability or weight gain. Earlier transfer does not necessarily result in earlier discharge.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004185",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence</span> to determine whether SSRIs are superior to placebo in the treatment of depression.</span></span>",
            "Target Summary": "There are statistically significant differences in terms of efficacy and tolerability between fluoxetine and certain ADs, but the clinical meaning of these differences is uncertain, and no definitive implications for clinical practice can be drawn. From a clinical point of view the analysis of antidepressants' safety profile (adverse effect and suicide risk) remains of crucial importance and more reliable data about these outcomes are needed. Waiting for more robust evidence, treatment decisions should be based on considerations of clinical history, drug toxicity, patient acceptability, and cost. We need for large, pragmatic trials, enrolling heterogeneous populations of patients with depression to generate clinically relevant information on the benefits and harms of competitive pharmacological options. A meta-analysis of individual patient data from the randomised trials is clearly necessary.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004381",
            "ESE Summary": "There is some evidence to suggest that the use of <span class=Omission_of_Key_Facts><span class=Redundancy Length><span class=Extrinsic_Information>music composed for children with autism</span></span></span> may be effective in reducing the frequency of target <span class=Redundancy Length>behaviour</span>. However, the evidence is limited by the <span class=Omission_of_Key_Facts><span class=Overgeneralization><span class=Redundancy Length>small number of included studies, the small sample sizes of the included studies</span> and the <span class=Redundancy Length>heterogeneity of the outcome measures</span></span></span>.",
            "Target Summary": "The included studies were of limited applicability to clinical practice. However, the findings indicate that music therapy may help children with autistic spectrum disorder to improve their communicative skills. More research is needed to examine whether the effects of music therapy are enduring, and to investigate the effects of music therapy in typical clinical practice.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 4,
                    "Length": 4,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003026",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>Olanzapine may be <span class=Intervention_Mismatch>more effective than haloperidol</span> for the <span class=Outcome_Mismatch>short term treatment</span> of amphetamine psychosis.</span></span> However, <span class=Length Excessive_Detail><span class=Inaccurate_Emphasis><span class=Omission_of_Key_Facts>long term efficacy and tolerability data are still lacking</span>.</span></span>\r\n[Note: The four citations in the awaiting classification section of the review may alter the conclusions of the reviews once assessed.]",
            "Target Summary": "Only one RCT of treatment for amphetamine psychosis has been published. Outcomes from this trial indicate that antipsychotic medications effectively reduce symptoms of amphetamine psychosis, the newer generation and more expensive antipsychotic medication, olanzapine, demonstrates significantly better tolerability than the more affordable and commonly used medication, haloperidol.\nThere are other two studies that did not meet the inclusion criteria for this review. The results of these two studies show that agitation and some psychotic symptoms may be abated within an hour after antipsychotic injection. \nWhether this limited evidence can be applied for amphetamine psychotic patients is not yet known. \nThe medications that should be further investigate are conventional antipsychotics, newer antipsychotics and benzodiazepines. However, naturalistic studies of amphetamine psychotic symptoms and the prevalence of relapse to psychosis in the presence of amphetamine, are also crucial for advising the development of study designs appropriate for further treatment studies of amphetamine psychosis.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 1,
                    "Outcome_Mismatch": 1,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD009153",
            "ESE Summary": "<span class=Lack_of_Focus Length>There is <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>insufficient evidence</span></span> to determine the effect of ART on HIV-1 transmission.</span>\r\n<span class=Length>[Note: The four citations in the awaiting classification section of the review may alter the conclusions of the reviewed review once assessed.]</span>",
            "Target Summary": "ART is a potent intervention for prevention of HIV in discordant couples in which the index partner has 550 CD4 cells/L. A recent multicentre RCT confirms the suspected benefit seen in earlier observational studies and reported in more recent ones. Questions remain about durability of protection, the balance of benefits and adverse events associated with earlier therapy, long-term adherence and transmission of ART-resistant strains to partners. Resource limitations and implementation challenges must also be addressed.\nCounselling, support, and follow up, as well as mutual disclosure, may have a role in supporting adherence, so programmes should be designed with these components. In addition to ART provision, the operational aspects of delivering such programmes must be considered.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000369",
            "ESE Summary": "<span class=Lack_of_Focus>There is insufficient evidence to recommend the use of <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>interferon</span></span> for the treatment of acute hepatitis C.</span> <span class=Lack_of_Focus Length>The effects of <span class=Omission_of_Key_Facts><span class=Intrinsic_Information>interferson</span></span> on chronic hepatitis C have not been demonstrated.</span>",
            "Target Summary": "Interferon alfa is effective in improving biochemical outcomes and achieving sustained virologic clearance in patients with transfusion-acquired acute hepatitis C. The effect on long-term clinical outcomes could not be assessed due to limitations in the current data.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005562",
            "ESE Summary": "There is some evidence to support the use of <span class=Lack_of_Focus><span class=Overgeneralization><span class=Omission_of_Key_Facts>reality orientation therapy</span> for people with dementia</span>.</span> However, the evidence is <span class=Inaccurate_Emphasis>not strong enough to recommend its use as a stand-alone therapy</span>. <span class=Length>Further research is needed to evaluate the effectiveness of this intervention in comparison to <span class=Omission_of_Key_Facts>other forms of cognitive rehabilitation</span>.</span>",
            "Target Summary": "There was consistent evidence from multiple trials that cognitive stimulation programmes benefit cognition in people with mild to moderate dementia over and above any medication effects. However, the trials were of variable quality with small sample sizes and only limited details of the randomisation method were apparent in a number of the trials. Other outcomes need more exploration but improvements in self-reported quality of life and well-being were promising. Further research should look into the potential benefits of longer term cognitive stimulation programmes and their clinical significance.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD001168",
            "ESE Summary": "<span class=Lack_of_Focus>There is <span class=Overgeneralization>insufficient evidence to support the use of topical corticosteroids in the treatment of OLP.</span></span> <span class=Length>Further RCTs are needed to confirm the effectiveness of topical steroids in the management of <span class=Omission_of_Key_Facts><span class=Intrinsic_Information>OLB</span></span> and to compare their effects on other chronic inflammatory conditions.</span>",
            "Target Summary": "Although topical steroids are considered to be first line treatment, we identified no RCTs that compared steroids with placebo in patients with symptomatic OLP.From the trials in this review there is no evidence that one steroid is any more effective than another.There is weak evidence that aloe vera may reduce the pain of OLP and improve the clinical signs of disease compared to placebo.There is weak and unreliable evidence that cyclosporin may reduce pain and clinical signs of OLP. There is no evidence that other calcineurin inhibitors reduce pain compared to either steroids or placebo. From the 28 trials included in this systematic review, the wide range of interventions compared means there is insufficient evidence to support the effectiveness of any specific treatment as being superior.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007718",
            "ESE Summary": "There is some evidence that <span class=Length><span class=Extrinsic_Information>telehealth may reduce hospital admissions</span> and <span class=Omission_of_Key_Facts><span class=Overgeneralization>improve patient self-efficacy in COPD patients</span></span>.</span> However, <span class=Excessive_Detail><span class=Omission_of_Key_Facts>the evidence is not strong enough to recommend the use of telehealth for COPD</span>.</span>",
            "Target Summary": "Telehealthcare in COPD appears to have a possible impact on the quality of life of patients and the number of times patients attend the emergency department and the hospital. However, further research is needed to clarify precisely its role since the trials included telehealthcare as part of more complex packages.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 3
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003812",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Inaccurate_Emphasis>There is insufficient evidence</span> to support or refute the use of occlusal adjustment in the treatment of chronic temporomandibular disorders.</span></span>",
            "Target Summary": "There is an absence of evidence, from RCTs, that occlusal adjustment treats or prevents TMD. Occlusal adjustment cannot be recommended for the management or prevention of TMD. Future trials should use standardised diagnostic criteria and outcome measures when evaluating TMD.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD008493",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Extrinsic_Information>There is some evidence that preoperative statins reduce the risk of postoperative AF, but <span class=Lack_of_Focus Length>the evidence is not strong enough to support routine use of statins in this population.</span></span></span>",
            "Target Summary": "Preoperative statin therapy reduces the odds of post-operative AF and shortens the stay on the ICU and in the hospital. Statin pretreatment had no influence on perioperative mortality, stroke, myocardial infarction or renal failure. Since analysed studies included mainly patients undergoing myocardial revascularizations the results cannot be extrapolated to patients undergoing other cardiac procedures such as heart valve or aortic surgery.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006734",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>Breastfeeding with antiretroviral prophylaxis is associated with a reduction in the risk of HIV transmission among women infected with HIV.</span></span></span> However, <span class=Omission_of_Key_Facts><span class=Length><span class=Incorrect_Implication>the evidence is not strong enough to recommend the use of this intervention over other feeding modalities.</span></span></span>\r\n[Note: The four citations in the awaiting classification section of the review may alter the conclusions of the reviews once assessed.]",
            "Target Summary": "Complete avoidance of breastfeeding is efficacious in preventing MTCT of HIV, but this intervention has significant associated morbidity (e.g., diarrheal morbidity if formula is prepared without clean water). If breastfeeding is initiated, two interventions 1). exclusive breastfeeding during the first few months of life; and 2) extended antiretroviral prophylaxis to the infant (nevirapine alone, or nevirapine with zidovudine) are efficacious in preventing transmission.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005950",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence from randomised controlled trials to determine whether mental therapy plus physical therapy is effective in improving affected arm function after stroke.</span></span></span>",
            "Target Summary": "There is limited evidence to suggest that MP in combination with other rehabilitation treatment appears to be beneficial in improving upper extremity function after stroke, as compared with other rehabilitation treatment without MP. Evidence regarding improvement in motor recovery and quality of movement is less clear. There is no clear pattern regarding the ideal dosage of MP required to improve outcomes. Further studies are required to evaluate the effect of MP on time post stroke, volume of MP that is required to affect the outcomes and whether improvement is maintained long-term. Numerous large ongoing studies will soon improve the evidence base.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003770",
            "ESE Summary": "The results of this review support the use of <span class=Lack_of_Focus Length><span class=Extrinsic_Information Incorrect_Implication><span class=Omission_of_Key_Facts>adjuvant HAI</span> to prevent recurrence of liver metastases</span> in patients with colorectal cancer undergoing liver resection.</span>",
            "Target Summary": "Though recurrence in the remaining liver happened less in the hepatic artery chemotherapy group, overall survival was not improved, and even favoured the control group, though not significantly. This added intervention cannot be recommended at this time.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005609",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Overgeneralization>The results of this review suggest that there is an urgent need for improvement in the <span class=Omission_of_Key_Facts>reporting of healthcare events</span>.</span></span>",
            "Target Summary": "Because of the limitations of the studies it is not possible to draw conclusions for clinical practice.Anyone introducing a system into practice should give careful consideration to conducting an evaluation using a robust design.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004127",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Incorrect_Implication>We found no evidence to support the use of non-invasive ventilation in patients with COPD who are difficult to wean or who have severe hypercapnic respiratory failure.</span></span></span> However, <span class=Redundancy Length>the studies included in this review were of poor quality and had a high risk of bias.</span> Therefore, <span class=Lack_of_Focus Redundancy>we recommend the introduction of NIV to this group of patients.</span>",
            "Target Summary": "Summary estimates from 12 small studies of moderate to good quality that included predominantly COPD patients demonstrated a consistent, positive effect on mortality and ventilator associated pneumonia. The net clinical benefits associated with noninvasive weaning remain to be fully elucidated.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 2,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004317",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of reminders to increase contraceptive adherence.</span></span> <span class=Length>Further trials are needed to assess the effectiveness of reminders in different populations, <span class=Intrinsic_Information>settings and <span class=Omission_of_Key_Facts>settings.</span></span></span>",
            "Target Summary": "Most studies to date have shown no benefit of strategies to improve adherence and continuation. These trials have important limitations, however. Three had small sample sizes, four had high losses to follow up, and the intervention and its intensity varied across the studies. High-quality research is a priority, since adherence and continuation are fundamentally important to the successful use of hormonal contraceptives.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005542",
            "ESE Summary": "<span class=Lack_of_Focus Length>There is <span class=Extrinsic_Information>insufficient evidence from randomised controlled trials to determine whether <span class=Population_Mismatch Omission_of_Key_Facts>enhanced insulin therapy is better or worse for pregnant women with type 1 or type II diabetes</span>.</span></span> Further trials are needed to assess the <span class=Intrinsic_Information><span class=Omission_of_Key_Facts>effectiveness and safety of intensified insulin therapy for both preterm and late pregnancy</span>.</span>",
            "Target Summary": "There is little evidence to support the use of one particular form of insulin administration over another for pregnant women with diabetes. The data are few, there are only a small number of trials appropriate for meta-analysis, a small number of women included and questionable generalisability of the trial population. Conclusions cannot be made from the available data. Well-designed randomised trials are needed. These trials should be adequately powered to assess the effect of CSII versus MDI on important outcomes for women with diabetes and their infants.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001418",
            "ESE Summary": "There is <span class=Incorrect_Implication><span class=Omission_of_Key_Facts>insufficient evidence</span> to determine whether the addition of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>cisplatin</span></span> to <span class=Lack_of_Focus Length>cyclophosphamide</span> improves survival or progression</span> in women with advanced ovarian cancer.",
            "Target Summary": "Available evidence, although not conclusive, suggests platinum-based chemotherapy is better than non-platinum therapy. There is some evidence that combination therapy improves survival compared with platinum alone. No difference in effect has been shown between cisplatin and carboplatin.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003038",
            "ESE Summary": "There is insufficient evidence to determine whether the combination of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>amikacin and ceftazidime</span></span> is superior to the <span class=Redundancy><span class=Intrinsic_Information>combination alone</span></span></span> in the treatment of febrile neutropenic cancer.",
            "Target Summary": "Beta-lactam monotherapy is advantageous compared with beta-lactam-aminoglycoside combination therapy with regard to survival, adverse events and fungal super-infections. Treatment failure should not be regarded as the primary outcome in open-label trials, as it reflects mainly treatment modifications.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006028",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Incorrect_Implication>There is insufficient evidence to support the use of <span class=Lack_of_Focus>atrial natriuretic peptide therapy in patients with acute renal failure.</span></span></span>",
            "Target Summary": "ANP may be associated with improved outcomes when used in low doses for preventing AKI and in managing postsurgery AKI and should be further explored in these two settings. There were no significant adverse events in the prevention studies, however in the high dose ANP treatment studies there were significant increases hypotension and arrhythmias.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004751",
            "ESE Summary": "There is <span class=Incorrect_Implication>insufficient evidence to determine whether laparoscopy is superior to open adnexal surgery</span> in the treatment of benign ovarian cysts.",
            "Target Summary": "In women undergoing surgery for benign ovarian tumours, laparoscopy was associated with a reduction in fever, urinary tract infection, postoperative complications, postoperative pain, number of days in hospital, and total cost. These findings should be interpreted with caution since only a small number of studies were identified. These included a total of only 769 women and not all of the important outcomes were reported in each study.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004611",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to recommend the use of <span class=Omission_of_Key_Facts>S boulardii in combination with other antibiotics</span> for the treatment of <span class=Omission_of_Key_Facts>recurrent Clostridium difficile disease</span>.</span></span>",
            "Target Summary": "There is insufficient evidence to recommend probiotic therapy as an adjunct to antibiotic therapy for C. difficile colitis. There is no evidence to support the use of probiotics alone in the treatment of C. difficile colitis.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006161",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is no evidence from randomised controlled trials to support or refute the use of supplementary oxygen during caesarean section.</span></span></span>",
            "Target Summary": "Current evidence suggests that supplementary oxygen given to healthy term pregnant women during elective caesarean section under regional anaesthesia is associated with higher maternal and neonatal oxygen levels (maternal SpO2, PaO2, UaPO2 and UvPO2) and higher levels of oxygen free radicals. However, the intervention was neither beneficial nor harmful to the neonate's short-term clinical outcome as assessed by Apgar scores.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001332",
            "ESE Summary": "There is <span class=Extrinsic_Information>insufficient evidence from randomised controlled trials</span> to determine the <span class=Overgeneralization>role of <span class=Omission_of_Key_Facts>cannabinoids</span> in the treatment of <span class=Population_Mismatch>spasticity in MS</span></span>.",
            "Target Summary": "The absolute and comparative efficacy and tolerability of anti-spasticity agents in multiple sclerosis is poorly documented and no recommendations can be made to guide prescribing. The rationale for treating features of the upper motor neurone syndrome must be better understood and sensitive, validated spasticity measures need to be developed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003764",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is <span class=Omission_of_Key_Facts>insufficient evidence to support the use of antibiotics in fracture surgery.</span></span></span>",
            "Target Summary": "Antibiotics reduce the incidence of early infections in open fractures of the limbs. Further placebo controlled randomised trials are unlikely to be justified in middle and high income countries, except for open fractures of the fingers. Further research is necessary to the determine the avoidable burden of morbidity in countries where antibiotics are not used routinely in the management of open fractures.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004878",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support the use of oral corticosteroids in children with acute bronchiolitis.</span></span></span>",
            "Target Summary": "Current evidence does not support a clinically relevant effect of systemic or inhaled glucocorticoids on admissions or length of hospitalisation. Combined dexamethasone and epinephrine may reduce outpatient admissions, but results are exploratory and safety data limited. Future research should further assess the efficacy, harms and applicability of combined therapy.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000255",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to determine the role of anticoagulation in the management of patients with cervical artery dissection.</span></span></span>",
            "Target Summary": "There were no randomised trials comparing either anticoagulants or antiplatelet drugs with control, thus there is no evidence to support their routine use for the treatment of extracranial internal carotid artery dissection. There were also no randomised trials that directly compared anticoagulants with antiplatelet drugs and the reported non-randomised studies did not show any evidence of a significant difference between the two.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006101",
            "ESE Summary": "In patients with COPD, the addition of a long-acting inhaled beta2-agonist to <span class=Population_Mismatch><span class=Lack_of_Focus><span class=Extrinsic_Information>formoterol</span></span></span> improves symptoms and airway conductance compared with placebo, but there is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>no evidence of an effect on quality of life</span></span></span>.",
            "Target Summary": "The available data from the trials suggest that there is little difference between regular long term use of IpB alone and salmeterol if the aim is to improve COPD symptoms and exercise tolerance. However, salmeterol was more effective in improving lung function variables. In terms of post-bronchodilator lung function, combination therapy conferred modest benefits, a significant improvement in HRQL, and reduced supplemental short-acting beta-agonist requirement, although this effect was not consistent. Additional studies are needed to assess the relative effects of combining therapies, using validated subjective measurements, and should consider concordance and the convenience of people having to use different inhaler devices.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004217",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of topical anaesthetics during circumcision.</span></span></span>",
            "Target Summary": "DPNB was the most frequently studied intervention and was the most effective for circumcision pain. Compared to placebo, EMLA was also effective, but was not as effective as DPNB. Both interventions appear to be safe for use in newborns. None of the studied interventions completely eliminated the pain response to circumcision.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001069",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support the use of <span class=Omission_of_Key_Facts>sucrose as an analgesic during surgical procedures in preterm infants.</span></span></span>",
            "Target Summary": "Sucrose is safe and effective for reducing procedural pain from single events. An optimal dose could not be identified due to inconsistency in effective sucrose dosage among studies. Further investigation on repeated administration of sucrose in neonates and the use of sucrose in combination with other non-pharmacological and pharmacological interventions is needed. Sucrose use in extremely preterm, unstable, ventilated (or a combination of these) neonates needs to be addressed. Additional research is needed to determine theminimally effective dose of sucrose duringa single painful procedure and the effect of repeated sucrose administration on immediate (pain intensity) and long-term (neurodevelopmental) outcomes.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003042",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Inaccurate_Emphasis>insufficient evidence</span> to determine whether chest tube manipulation is <span class=Incorrect_Implication>beneficial or harmful</span> for improving mediastinal drainage</span></span> in patients undergoing revascularisation.",
            "Target Summary": "There are insufficient studies which compare differing methods of chest drain clearance to support or refute the relative efficacy of the various methods in preventing cardiac tamponade. Nor can the need to manipulate chest drains be supported or refuted by results from RCTs.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD003659",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Overgeneralization>There is insufficient evidence from randomised controlled trials to determine the effectiveness of face-washing interventions in reducing the incidence of trachoma.</span></span></span>",
            "Target Summary": "There is some evidence that face washing combined with topical tetracycline can be effective in reducing severe trachoma and in increasing the prevalence of clean faces. Current evidence does not however support a beneficial effect of face washing alone or in combination with topical tetracycline in reducing active trachoma.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005009",
            "ESE Summary": "<span class=Lack_of_Focus>Intermittent versus combined LHRH agonist therapy for the treatment of locally advanced prostate cancer has not been rigorously evaluated in RCTs.</span> <span class=Omission_of_Key_Facts><span class=Excessive_Detail><span class=Incorrect_Implication>Intermittent therapy is associated with a higher risk of biochemical failure.</span></span></span>",
            "Target Summary": "Data from RCTs comparing IAS to CAS are limited by small sample size and short duration. There are no data for the relative effectiveness of IAS versus CAS for overall survival, prostate cancer-specific survival, or disease progression. Limited information suggests IAS may have slightly reduced adverse events. Overall, IAS was also as effective as CAS for potency, but was superior during the interval of cycles (96%).",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002217",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Incorrect_Implication>There is insufficient evidence to determine whether <span class=Lack_of_Focus Length>phenytoin is more or less effective than carbamazepine for the treatment of generalized tonic-clonic epilepsy.</span></span></span>",
            "Target Summary": "The results of this review show that phenobarbitone was significantly more likely to be withdrawn than phenytoin. Given that no significant differences for seizure outcomes were found, the higher withdrawal rate with phenobarbitone may be due to adverse effects. Several factors may have confounded the results of this review.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003838",
            "ESE Summary": "There is <span class=Incorrect_Implication>insufficient evidence to recommend the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>long-term diuretics</span></span></span> in patients with <span class=Population_Mismatch><span class=Lack_of_Focus Length>congestive heart failure</span></span>.",
            "Target Summary": "The available data from several small trials show that in patients with chronic heart failure, conventional diuretics appear to reduce the risk of death and worsening heart failure compared to placebo. Compared to active control, diuretics appear to improve exercise capacity.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004998",
            "ESE Summary": "There is insufficient evidence from randomised controlled trials to determine the role of meditation in the management of anxiety. <span class=Lack_of_Focus Length><span class=Omission_of_Key_Facts><span class=Extrinsic_Information Incorrect_Implication>Muscle biofeedback and transcendental meditation may be useful treatments for people with OCD</span></span>, but further research is needed.</span>",
            "Target Summary": "The small number of studies included in this review do not permit any conclusions to be drawn on the effectiveness of meditation therapy for anxiety disorders. Transcendental meditation is comparable with other kinds of relaxation therapies in reducing anxiety, and Kundalini Yoga did not show significant effectiveness in treating obsessive-compulsive disorders compared with Relaxation/Meditation. Drop out rates appear to be high, and adverse effects of meditation have not been reported. More trials are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001112",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of caffeine in the treatment of asthma.</span></span></span>",
            "Target Summary": "Caffeine appears to improve airways function modestly, for up to four hours, in people with asthma. People may need to avoid caffeine for at least four hours prior to lung function testing, as caffeine ingestion could cause misinterpretation of the results. Drinking caffeinated coffee before taking exhaled nitric oxide measurements does not appear to affect the results of the test, but more studies are needed to confirm this.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008454",
            "ESE Summary": "<span class=Extrinsic_Information>There is currently <span class=Omission_of_Key_Facts>insufficient evidence</span> to support the use of NSAIDs to prevent the development of PD.</span> <span class=Length><span class=Overgeneralization>There is a need for further high quality randomised controlled trials with larger sample sizes and longer follow-up periods.</span></span>",
            "Target Summary": "There is currently no evidence for the use of NSAIDs in the secondary prevention of PD. Non-aspirin NSAIDs, particularly ibuprofen, may reduce the risk of developing PD. However, little is known of the effects of other individual drugs and at present no recommendations can be made regarding their use in primary prevention.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008424",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Overgeneralization>There is some evidence that <span class=Lack_of_Focus Length>curcumin may be a useful maintenance therapy for patients with quiescent ulcerative colitis.</span></span></span> However, <span class=Omission_of_Key_Facts><span class=Redundancy>this conclusion is based on a <span class=Incorrect_Implication>small number of trials</span></span></span> and <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Excessive_Detail><span class=Inaccurate_Emphasis>the risk of bias is high.</span></span></span>",
            "Target Summary": "Curcumin may be a safe and effective therapy for maintenance of remission in quiescent UC when given as adjunctive therapy along with mesalamine or sulfasalazine. However, further research in the form of a large scale methodologically rigorous randomized controlled trial is needed to confirm any possible benefit of curcumin in quiescent UC.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 3
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD008216",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Overgeneralization>There is insufficient evidence to recommend the use of any of the interventions in this review.</span></span></span> <span class=Length><span class=Incorrect_Implication>Further trials are needed.</span></span>",
            "Target Summary": "Due to a lack of comparative studies, it is unclear whether participants with NRSTS have improved survival from autologous HSCT following HDCT. Owing to this current gap in knowledge, at present HDCT and autologous HSCT for NRSTS should only be used within controlled trials.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000491",
            "ESE Summary": "<span class=Outcome_Mismatch Omission_of_Key_Facts><span class=Lack_of_Focus Excessive_Detail><span class=Incorrect_Implication Overgeneralization>Single-dose therapy for asymptomatic bacteriuria in pregnancy is superior to conventional therapy, with a lower risk of infection and fewer side effects.</span></span></span>",
            "Target Summary": "Single-dose regimen of antibiotics may be less effective than the seven-day regimen. Women with asymptomatic bacteriuria in pregnancy should be treated by the standard regimen of antibiotics until more data become available testing seven-day compared with three- or five-day regimens.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 1,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004128",
            "ESE Summary": "We found no evidence to support the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>HF</span></span></span> in patients with <span class=Population_Mismatch>out-of-hospital cardiac arrest</span>.",
            "Target Summary": "Conventional cooling methods to induce mild therapeutic hypothermia seem to improve survival and neurologic outcome after cardiac arrest. Our review supports the current best medical practice as recommended by the International Resuscitation Guidelines.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000074",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Extrinsic_Information Overgeneralization>There is insufficient evidence to support or refute the use of <span class=Omission_of_Key_Facts>theophylline or doxapram for the treatment of apnea</span>.</span></span> <span class=Length>Further randomised controlled trials are needed.</span>",
            "Target Summary": "Although intravenous doxapram might reduce apnea within the first 48 hours of treatment, there are insufficient data to evaluate the precision of this result or to assess potential adverse effects. No long-term outcomes have been measured. Further studies are needed to determine the role of this treatment in clinical practice.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003543",
            "ESE Summary": "<span class=Overgeneralization><span class=Lack_of_Focus>There is some evidence that interventions to reduce antibiotic use, such as <span class=Omission_of_Key_Facts>restriction of antibiotic use in hospitalised patients with pneumonia</span>,</span> <span class=Length><span class=Omission_of_Key_Facts>reduce hospitalisation and improve patient outcomes</span>.</span></span> <span class=Lack_of_Focus>However, the evidence is not strong enough to support or refute this conclusion.</span>",
            "Target Summary": "The results show that interventions to reduce excessive antibiotic prescribing to hospital inpatients can reduce antimicrobial resistance or hospital-acquired infections, and interventions to increase effective prescribing can improve clinical outcome. This update provides more evidence about unintended clinical consequences of interventions and about the effect of interventions to reduce exposure of patients to antibiotics. The meta-analysis supports the use of restrictive interventions when the need is urgent, but suggests that persuasive and restrictive interventions are equally effective after six months.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005208",
            "ESE Summary": "<span class=Incorrect_Implication>There is some evidence to suggest that <span class=Length><span class=Omission_of_Key_Facts>abciximab may improve some outcomes in patients with acute ischaemic stroke</span>.</span></span> However, <span class=Excessive_Detail>this evidence is based on a <span class=Population_Mismatch Omission_of_Key_Facts>small number of patients</span> and the risk of bias is high.</span> Further well-designed RCTs are needed.",
            "Target Summary": "There is currently not enough evidence from randomised controlled trials regarding the efficacy or safety of GP IIb-IIIa inhibitors therapy in acute ischaemic stroke. Results from ongoing trials will help to understand the risk to benefit ratio of these agents.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007979",
            "ESE Summary": "Evidence from <span class=Overgeneralization>two small trials</span> suggests that <span class=Omission_of_Key_Facts><span class=Redundancy Length>reminders after a fracture may increase the number of patients receiving BMD measurement and osteoporosis medication compared to usual care.</span></span> However, <span class=Omission_of_Key_Facts>the evidence is <span class=Inaccurate_Emphasis>not strong enough to recommend the use of EMRs as the first line of treatment for post-fracture patients</span>.</span>",
            "Target Summary": "As only one study was identified for inclusion, the results are inadequate to inform clinical practice in regard to the use of email for clinical communication between healthcare professionals. Future research needs to use high-quality study designs that take advantage of the most recent developments in information technology, with consideration of the complexity of email as an intervention, and costs.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD007289",
            "ESE Summary": "<span class=Lack_of_Focus>Prophylactic chemotherapy <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>does not reduce the incidence of trophoblastic disease</span></span> in high-risk patients with complete hydatidiform mole.</span>",
            "Target Summary": "P-Chem may reduce the risk of progression to GTN in women with CMs who are at a high risk of malignant transformation; however, current evidence in favour of P-Chem is limited by the poor methodological quality and small size of the included studies. As P-Chem may increase drug resistance, delay treatment of GTN and expose women unnecessarily to toxic side effects, this practice cannot currently be recommended.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002828",
            "ESE Summary": "There is <span class=Extrinsic_Information>insufficient evidence</span> to support the use of <span class=Lack_of_Focus><span class=Intrinsic_Information><span class=Omission_of_Key_Facts>azathioprine</span> or <span class=Omission_of_Key_Facts>IVMP</span></span></span> as initial treatment for <span class=Lack_of_Focus>myasthenia gravis</span>.",
            "Target Summary": "Limited evidence from randomised controlled trials suggests that corticosteroid treatment offers short-term benefit in myasthenia gravis compared with placebo. This supports the conclusions of observational studies and expert opinion. Limited evidence from randomised controlled trials does not show any difference in efficacy between corticosteroids and either azathioprine or intravenous immunoglobulin.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002231",
            "ESE Summary": "There is <span class=Inaccurate_Emphasis>insufficient evidence to support or refute the use of <span class=Population_Mismatch Omission_of_Key_Facts><span class=Lack_of_Focus>Phyllanthus amarus</span> for the treatment of <span class=Lack_of_Focus>asymptomatic or symptomatic hepatitis B virus patients</span></span>.</span>",
            "Target Summary": "Based on one low quality trial, the medicinal herb 'Jianpi Wenshen recipe' may have an antiviral activity in asymptomatic carriers of hepatitis B virus. However, rigorous randomised, double-blind, placebo-controlled trials are needed before herbs should be used for this condition.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD009379",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>There is currently no evidence to support the use of amniotic membrane transplantation in people with acute ocular burns.</span></span></span>",
            "Target Summary": "Conclusive evidence supporting the treatment of acute ocular surface burns with AMT is lacking. Heterogeneity of disease presentation, variations in treatment, undefined criteria for treatment success and failure, and non-uniform outcome measures are some of the factors complicating the search for clear evidence regarding this treatment.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007428",
            "ESE Summary": "<span class=Length><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence from randomised controlled trials</span> to determine which is the best plate for midclavicular nonunion.</span></span> <span class=Lack_of_Focus>A <span class=Omission_of_Key_Facts>large randomised trial comparing different methods of internal fixation of the clavicle with open reduction is needed</span>.</span>",
            "Target Summary": "There is limited evidence, from single trials only, regarding the effectiveness of different methods of surgical fixation of fractures and non-union of the middle third of the clavicle.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000259",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of interventions to improve health care in settings with high risk of infection, or in settings where health service provision is poor.</span></span></span> <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Incorrect_Implication>There is a need for high quality RCTs with long-term follow-up to assess the effects of interventions on morbidity and mortality.</span></span></span>",
            "Target Summary": "Audit and feedback generally leads to small but potentially important improvements in professional practice. The effectiveness of audit and feedback seems to depend on baseline performance and how the feedback is provided. Future studies of audit and feedback should directly compare different ways of providing feedback.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003541",
            "ESE Summary": "There is insufficient evidence to support the use of <span class=Lack_of_Focus><span class=Incorrect_Implication><span class=Omission_of_Key_Facts>process consultation</span> as a means of reducing stress in healthcare settings</span>.</span> There is a need for <span class=Length><span class=Omission_of_Key_Facts><span class=Extrinsic_Information>well-designed, adequately powered randomised controlled trials of this intervention</span></span>.</span>",
            "Target Summary": "There is insufficient evidence for the effectiveness of stress management training interventions to reduce job stress and prevent burnout among healthcare workers beyond the intervention period. Low quality evidence suggests that longer-term interventions with refresher or booster sessions may have more sustained positive effect, but this needs to be rigorously evaluated in further trials.\nLow quality evidence exists to show that management interventions may improve some measures of job satisfaction. However, further trials are needed to assess whether this finding is replicable in other settings. There was insufficient\n\n evidence of the benefit of management interventions on staff absenteeism.\nRigorous trials are needed to assess the effects of longer-term stress management training and management interventions in primary care and developing country settings.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002277",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Overgeneralization>There is insufficient evidence to determine whether <span class=Omission_of_Key_Facts>IVIG is superior to placebo</span> in the treatment of myasthenia gravis.</span></span>",
            "Target Summary": "In exacerbation of myasthenia gravis, one RCT of IVIg versus placebo showed some evidence of the efficacy of IVIg and two did not show a significant difference between IVIg and plasma exchange. Another showed no significant difference in efficacy between 1 g/kg and 2 g/kg of IVIg. A further, but underpowered, trial showed no significant difference between IVIg and oral methylprednisolone. In chronic myasthenia gravis, there is insufficient evidence from RCTs to determine whether IVIg is efficacious.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002781",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>no evidence to support the use of <span class=Lack_of_Focus>fluoride mouthrinse or topical fluoride varnish</span> in children.</span></span>",
            "Target Summary": "Topical fluorides (mouthrinses, gels, or varnishes) used in addition to fluoride toothpaste achieve a modest reduction in caries compared to toothpaste used alone. No conclusions about any adverse effects could be reached, because data were scarcely reported in the trials.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006616",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of antioxidant drugs</span> in the treatment of patients with acute respiratory distress.</span></span>",
            "Target Summary": "Overall, this meta-analysis puts doubt on the safety and utility of intravenous N-acetylcysteine as an adjuvant therapy in SIRS and sepsis. At best, N-acetylcysteine is ineffective in reducing mortality and complications in this patient population. At worst, it can be harmful, especially when administered later than 24 hours after the onset of symptoms, by causing cardiovascular depression. Unless future RCTs provide evidence of treatment effect, clinicians should not routinely use intravenous N-acetylcysteine in SIRS or sepsis and academics should not promote its use.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001943",
            "ESE Summary": "Loxapine <span class=Incorrect_Implication>appears to be <span class=Lack_of_Focus Length><span class=Intervention_Mismatch>more effective than trifluoperidol</span> for the treatment of acute schizophrenia.</span></span> However, the clinical significance of this conclusion is <span class=Ambiguity>uncertain.</span>",
            "Target Summary": "Loxapine is an antipsychotic which is not clearly distinct from typical or atypical drugs in terms of its effects on global or mental state. Loxapines profile of adverse effects is similar to that of the older generation of antipsychotic drugs.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 1,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 0
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 1,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003243",
            "ESE Summary": "<span class=Lack_of_Focus>The results of this review suggest that <span class=Extrinsic_Information><span class=Omission_of_Key_Facts>laparoscopic antireflux surgery</span> is an effective treatment for <span class=Population_Mismatch>GORD</span></span>.</span> <span class=Length>However, there is a need for further <span class=Intrinsic_Information>well-designed <span class=Omission_of_Key_Facts>RCTs</span></span>.</span>",
            "Target Summary": "There is evidence that laparoscopic fundoplication surgery is more effective than medical management for the treatment of GORD at least in the short to medium term. Surgery does carry some risk and whether the benefits of surgery are sustained in the long term remains uncertain. Treatment decisions for GORD should be based on patient and surgeon preference.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000432",
            "ESE Summary": "There is <span class=Incorrect_Implication>insufficient evidence to support the use of caffeine in the treatment of apnoea.</span> <span class=Lack_of_Focus Length>Further trials are needed to <span class=Extrinsic_Information>confirm or refute the effectiveness of caffeine on <span class=Outcome_Mismatch>death or disability</span></span> and to determine the timing of commencement of treatment.</span>",
            "Target Summary": "The results of this review do not support the use of prophylactic caffeine for preterm infants at risk of apnoea.\nAny future studies need to examine the effects of prophylactic methylxanthines in preterm infants at higher risk of apnoea. This should include examination of important clinical outcomes such as need for IPPV, neonatal morbidity, length of hospital stay and long term development.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 1,
                    "Omission_of_Key_Facts": 0
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006655",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to determine whether laparotomy is more or less effective in the treatment of early stage endometrial cancer.</span></span></span>",
            "Target Summary": "This review has found evidence to support the role of laparoscopy for the management of early endometrial cancer.\nFor presumed early stage primary endometrioid adenocarcinoma of the endometrium, laparoscopy is associated with similar overall and disease-free survival. Laparoscopy is associated with reduced operative morbidity and hospital stay. There is no significant difference in severe post-operative morbidity between the two modalities.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002815",
            "ESE Summary": "There is some evidence to support the use of <span class=Population_Mismatch Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>non-cued interventions</span></span></span> in the rehabilitation of people with Parkinson's disease. However, this evidence is based on a <span class=Omission_of_Key_Facts><span class=Length>small number of patients</span></span> and <span class=Length><span class=Overgeneralization>studies are at a <span class=Omission_of_Key_Facts>high risk of bias</span></span></span>. Further research is needed.",
            "Target Summary": "Considering the small number of patients examined, the methodological flaws in many of the studies and the possibility of publication bias, there is insufficient evidence to support or refute the efficacy of any given form of physiotherapy over another in Parkinson's disease. Another Cochrane review, Physiotherapy for patients with Parkinson's Disease, found that there was insufficient evidence to support or refute the efficacy of physiotherapy compared to no physiotherapy in Parkinson's disease. \nA wide range of physiotherapy approaches were used in these studies and a survey of UK physiotherapists confirmed that they also use an eclectic combination of techniques in the treatment of Parkinson's disease (Plant 1999). Therefore a consensus must be found as to 'best practice' physiotherapy for Parkinson's disease.\nThe efficacy of 'standard' physiotherapy should be proved first before examining variations in physiotherapy methods. Therefore large well designed randomised controlled trials are needed to judge the effect of physiotherapy in Parkinson's disease. After this large RCTs are needed to demonstrate the most effective form of physiotherapy in Parkinson's disease. Outcome measures with particular relevance to patients, carers, physiotherapists and physicians should be chosen and the patients monitored for at least 6 months to determine the duration of any effect. The trials should be reported according to CONSORT guidelines (CONSORT 1996).",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 3
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009192",
            "ESE Summary": "There is evidence that the use of <span class=Incorrect_Implication><span class=Omission_of_Key_Facts><span class=Length>telephone notification for HIV testing in high-risk youth</span></span> is associated with a <span class=Lack_of_Focus Excessive_Detail>statistically significant increase in the likelihood of receiving test results</span>.</span> However, <span class=Omission_of_Key_Facts><span class=Inaccurate_Emphasis>the evidence is not strong enough to support or refute this conclusion.</span></span>",
            "Target Summary": "We found only one eligible study. Although this study showed the use of the telephone for HIV test results notification was more effective than face-to-face delivery, it had a high-risk of bias. The study was conducted about 13 years ago in a high-income country, on a high-risk population, with low HIV prevalence, and the applicability of its results to other settings and contexts is unclear. The study did not provide information about telephone HIV test results notification of HIV positive people since none of the intervention group participants were HIV positive. We found no information about the acceptability of the intervention to patients and providers, its economic outcomes or potential adverse effects. There is a need for robust evidence from various settings on the effectiveness of telephone use for HIV test results notification.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD006432",
            "ESE Summary": "There is insufficient <span class=Lack_of_Focus><span class=Omission_of_Key_Facts><span class=Extrinsic_Information>evidence to support or refute the use of bilateral arm training</span></span> in people with chronic stroke.</span>",
            "Target Summary": "There is insufficient good quality evidence to make recommendations about the relative effect of simultaneous bilateral training compared to placebo, no intervention or usual care. We identified evidence that suggests that bilateral training may be no more (or less) effective than usual care or other upper limb interventions for performance in ADL, functional movement of the upper limb or motor impairment outcomes.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002139",
            "ESE Summary": "In patients with <span class=Population_Mismatch><span class=Intrinsic_Information>early stage</span> NSCLC</span>, <span class=Lack_of_Focus>chemotherapy combined with radiotherapy significantly improves survival compared to radiotherapy alone</span>. However, <span class=Length>the quality of the evidence is low</span>.",
            "Target Summary": "At the outset of this meta-analysis there was considerable pessimism about the role of chemotherapy in the treatment of non-small cell lung cancer. These results offer hope of progress and suggest that chemotherapy may have a role in treating this disease.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 0
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004873",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of <span class=Omission_of_Key_Facts>chest physiotherapy</span> in infants with <span class=Population_Mismatch>acute bronchiolitis</span>.</span></span>",
            "Target Summary": "Since the last publication of this review new good-quality evidence has appeared, strengthening the conclusions of the review. Chest physiotherapy does not improve the severity of the disease, respiratory parameters, or reduce length of hospital stay or oxygen requirements in hospitalised infants with acute bronchiolitis not on mechanical ventilation. Chest physiotherapy modalities (vibration and percussion or passive expiratory techniques) have shown equally negative results.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009308",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Overgeneralization>There is some evidence that <span class=Omission_of_Key_Facts>parent education interventions for adolescents and their parents reduce alcohol and drug use</span>.</span></span> However, <span class=Length><span class=Inaccurate_Emphasis>the evidence is not strong enough to support the use of this intervention in general.</span></span> <span class=Excessive_Detail>There is a need for more studies with a focus on <span class=Omission_of_Key_Facts>interventions aimed at preventing alcohol and drugs among youth and their families</span>.</span>",
            "Target Summary": "In conclusion, in this Cochrane systematic review we found that that the effects of family-based prevention interventions are small but generally consistent and also persistent into the medium- to longer-term.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD007214",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Overgeneralization>There is insufficient evidence to support or refute the use of TENS for pain relief in labour.</span></span></span>",
            "Target Summary": "There is only limited evidence that TENS reduces pain in labour and it does not seem to have any impact (either positive or negative) on other outcomes for mothers or babies. The use of TENS at home in early labour has not been evaluated. TENS is widely available in hospital settings and women should have the choice of using it in labour.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007298",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Length><span class=Extrinsic_Information>There is currently no evidence from randomised controlled trials</span> to support or refute the use of calcium and vitamin D supplementation in people with cystic fibrosis.</span></span>",
            "Target Summary": "There is no evidence of benefit or harm in the limited number of small-sized published trials. Adherence to relevant CF guidelines on vitamin D should be considered until further evidence is available.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003954",
            "ESE Summary": "<span class=Extrinsic_Information><span class=Lack_of_Focus>There is no evidence to support or refute the use of</span><span class=Redundancy Length><span class=Omission_of_Key_Facts>iazepines</span> for the treatment of tetanus.</span></span>",
            "Target Summary": "Although this review suggests that diazepam alone compared with combination of phenobarbitone and chlorpromazine may be more effective in treating tetanus, the small size, methodological limitations and lack of data on drug safety from available trials preclude definite conclusions to support change in current clinical practice. The application of this observation should be moderated by local needs and circumstances, pending the availability of better evidence. We recommend a reinforcement of preventive measures against tetanus infection and it is hoped that in the light of clear evidence about the preventive efficacy of tetanus toxoid immunization, concerted efforts should be made towards preventive interventions and ultimate eradication such that there will not be enough case materials for a trial. In the event of a need for a trial, a large prospective, multicenter, randomized controlled trial, which compares diazepam alone with combinations of other drugs (excluding diazepam) will be ideal.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003916",
            "ESE Summary": "Postoperative <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>VBT reduces the risk of recurrent endometrial cancer in women with high-intermediate risk of developing high metastases.</span></span></span> The effect on recurrence is <span class=Intervention_Mismatch Omission_of_Key_Facts><span class=Incorrect_Implication>similar to that of <span class=Lack_of_Focus>EBRT.</span></span></span>",
            "Target Summary": "EBRT reduces the risk of locoregional recurrence but has no significant impact on cancer-related deaths or overall survival. It is associated with significant morbidity and a reduction in quality of life. There is no demonstrable survival advantage from adjuvant EBRT for high-risk stage I endometrial cancer, however, the meta-analyses of this subgroup were underpowered and also included high-intermediate risk women, therefore we cannot exclude a small benefit in the high-risk subgroup. EBRT may have an adverse effect on endometrial cancer survival when used to treat uncomplicated low-risk (IA/B grade 1/2) endometrial cancer. For the intermediate to high-intermediate risk group, VBT alone appears to be adequate in ensuring vaginal control compared to EBRT. Further research is needed to guide practice for lesions that are truly high risk. In addition, the definitions of risk should be standardised.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 1,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006943",
            "ESE Summary": "<span class=Lack_of_Focus>There is <span class=Omission_of_Key_Facts>insufficient evidence to support or refute the use of screening programmes to detect <span class=Intrinsic_Information>cobert</span> bacteriuria in children.</span></span>",
            "Target Summary": "The included studies do not provide sufficient detail about the harms and benefits of treating covert bacteriuria to enable formation of reliable conclusions. It appears that antibiotic treatment for covert bacteriuria is unlikely to benefit children in the long term.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD005046",
            "ESE Summary": "There is <span class=Incorrect_Implication>insufficient evidence to determine whether or not <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>intrasphincteric botulinum toxin injection</span> is superior to <span class=Lack_of_Focus>balloon dilation</span></span></span> for the treatment of achalasia.",
            "Target Summary": "The results of this meta-analysis would suggest that PD is the more effective endoscopic treatment in the long term (greater than six months) for patients with achalasia.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005514",
            "ESE Summary": "<span class=Lack_of_Focus>There is <span class=Omission_of_Key_Facts>insufficient evidence to support or refute the use of splints in the management of bruxism.</span></span>",
            "Target Summary": "There is not sufficient evidence to state that the occlusal splint is effective for treating sleep bruxism. Indication of its use is questionable with regard to sleep outcomes, but it may be that there is some benefit with regard to tooth wear. This systematic review suggests the need for further investigation in more controlled RCTs that pay attention to method of allocation, outcome assessment, large sample size, and sufficient duration of follow up. The study design must be parallel, in order to eliminate the bias provided by studies of cross-over type. A standardisation of the outcomes of the treatment of sleep bruxism should be established in the RCTs.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD003034",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>The <span class=Omission_of_Key_Facts>clips appear to be as effective as the tubal ring for intraoperative sterilisation.</span></span></span> However, there is a need for further well-designed RCTs to evaluate the effects of <span class=Omission_of_Key_Facts>clips on perioperative outcomes.</span>",
            "Target Summary": "Electrocoagulation was associated with less morbidity including post-operative pain when compared with the modified Pomeroy and tubal ring methods, despite the risk of burns to the small bowel. The small sample size and the relative short period of follow-up in these studies limited the power to show clinical or statistical differences for rare outcomes such as failure rates. Aspects such as training, costs and maintenance of the equipment may be important factors in deciding which method to choose.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004504",
            "ESE Summary": "There is some evidence that <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>topical <span class=Lack_of_Focus>Harpagophytum procumbens</span></span></span> may be effective in treating acute low-back pain. However, the evidence is not strong enough to recommend its use as a first-line treatment.",
            "Target Summary": "Harpagophytum Procumbens, Salix Alba and Capsicum Frutescens seem to reduce pain more than placebo. Additional trials testing these herbal medicines against standard treatments are needed. The quality of reporting in these trials was generally poor. Trialists should refer to the CONSORT statement extension for reporting trials of herbal medicine interventions.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009118",
            "ESE Summary": "<span class=Incorrect_Implication>There is <span class=Lack_of_Focus Length>insufficient evidence</span> to recommend the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>polyethylene glycol (PEG) 3350</span></span> as a first-line treatment for <span class=Population_Mismatch Omission_of_Key_Facts>chronic constipation in children</span>.</span>",
            "Target Summary": "The pooled analyses suggest that PEG preparations may be superior to placebo, lactulose and milk of magnesia for childhood constipation. GRADE analyses indicated that the overall quality of the evidence for the primary outcome (number of stools per week) was low or very low due to sparse data, inconsistency (heterogeneity), and high risk of bias in the studies in the pooled analyses. Thus, the results of the pooled analyses should be interpreted with caution because of quality and methodological concerns, as well as clinical heterogeneity, and short follow up. However, PEG appears safe and well tolerated. There is also evidence suggesting the efficacy of liquid paraffin (mineral oil), which was also well tolerated.There is no evidence to demonstrate the superiority of lactulose when compared to the other agents studied, although there is a lack of placebo controlled studies. Further research is needed to investigate the long term use of PEG for childhood constipation, as well as the role of liquid paraffin.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD005214",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of injectable contraceptives in Egypt.</span></span></span>",
            "Target Summary": "While the choice between DPMA and NET-EN as injectable progestogen contraceptives may vary between both health providers and patients, data from randomized controlled trials indicate little difference between the effects of these methods, except that women on DMPA are more likely to develop amenorrhoea. There is inadequate data to detect differences in some non-menstrual major and minor clinical effects.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003051",
            "ESE Summary": "<span class=Lack_of_Focus>There is <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>no evidence to support the use of any specific surgical sealant</span> for preventing air leaks after pulmonary lobectomy.</span></span>",
            "Target Summary": "Surgical sealants reduce postoperative air leaks and time to chest drain removal but this reduction is not always associated with a reduction in length of postoperative hospital stay. Therefore, systematic use of surgical sealants with the objective of reducing hospital stay cannot be recommended at the moment. More and larger randomized controlled clinical trials are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000996",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Overgeneralization>There is insufficient evidence to support the use of inhaled steroids for chronic bronchiectasis.</span></span></span>",
            "Target Summary": "The present review indicates that there is insufficient evidence to recommend the routine use of inhaled steroids in adults with stable state bronchiectasis. While a therapeutic trial may be justified in adults with difficult to control symptoms and in certain subgroups, this has to be balanced with adverse events especially if high doses are used. No recommendation can be made for the use of ICS in adults during an acute exacerbation or in children (for any state) as there were no studies.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004908",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Inaccurate_Emphasis>NSAIDs are effective in treating moderate to severe postpartum uterine pain</span>, but there is insufficient evidence to conclude that they are superior to placebo.</span></span>\r\n[Note: The four citations in the awaiting classification section may alter the conclusions of the review once assessed.]",
            "Target Summary": "Non-steroidal anti-inflammatory drugs (NSAID) including aspirin were better than placebo at relieving pain from uterine cramping/involution following vaginal birth. NSAIDs were better than paracetamol and paracetamol was not better than placebo, though numbers of participants for these comparisons were small. Data for opioids compared with NSAIDs and opioids compared with placebo were conflicting, with some measures showing similar effect and others indicating NSAIDs were better than opioids and opioids were not better than placebo. There were insufficient data to make conclusions regarding the effectiveness of opioids at relieving pain from uterine cramping/involution.\nThe median year of publication of included studies was 1981; therefore more research is needed to assess the effectiveness of current pharmacological and non-pharmacological analgesia at relieving pain from uterine cramping/involution following vaginal birth.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD000479",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>no evidence from randomised controlled trials</span></span> to support or refute the use of varicocele surgery for infertile men.</span>",
            "Target Summary": "There is evidence suggesting that treatment of a varicocele in men from couples with otherwise unexplained subfertility may improve a couple's chance of pregnancy. However, findings are inconclusive as the quality of the available evidence is very low and more research is needed with live birth or pregnancy rate as the primary outcome.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004735",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>no evidence to support the use of corticosteroids or other interventions</span> for women with <span class=Population_Mismatch>PROM</span>.</span></span>",
            "Target Summary": "There is insufficient evidence to guide clinical practice on the benefits and harms of immediate delivery compared with expectant management for women with PPROM. To date all of the clinical trials have had methodological weaknesses and have been underpowered to detect meaningful measures of infant and maternal morbidity.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001266",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is no evidence to support the use of <span class=Omission_of_Key_Facts>nebulised bronchodilators</span> in <span class=Population_Mismatch>infants with acute bronchiolitis</span>.</span></span>",
            "Target Summary": "Bronchodilators do not improve oxygen saturation, do not reduce hospital admission after outpatient treatment, do not shorten the duration of hospitalization and do not reduce the time to resolution of illness at home. The small improvements in clinical scores for outpatients must be weighed against the costs and adverse effects of bronchodilators.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004950",
            "ESE Summary": "<span class=Incorrect_Implication>There is <span class=Lack_of_Focus Length>insufficient evidence to support the use of any of the interventions for pain relief in term infants undergoing <span class=Omission_of_Key_Facts>venepuncture.</span></span></span>",
            "Target Summary": "If available, breastfeeding or breast milk should be used to alleviate procedural pain in neonates undergoing a single painful procedure rather than placebo, positioning or no intervention. Administration of glucose/sucrose had similar effectiveness as breastfeeding for reducing pain. The effectiveness of breast milk for painful procedure should be studied in the preterm population, as there are currently a limited number of studies in the literature that have assessed it's effectiveness in this population.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006907",
            "ESE Summary": "<span class=Lack_of_Focus Excessive_Detail><span class=Incorrect_Implication Overgeneralization>Tailored control of blood pressure in pregnancy <span class=Omission_of_Key_Facts>reduces the risk of preterm birth</span> and severe hypertension, but <span class=Omission_of_Key_Facts>increases the risk for maternal and neonatal hospitalisation</span>.</span></span>",
            "Target Summary": "For pregnant women with non-severe pre-existing or non-proteinuric gestational hypertension, there is insufficient evidence to determine how tight control of hypertension should be achieved to improve maternal and fetal-neonatal outcomes.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004020",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of a brace for OA.</span></span></span>",
            "Target Summary": "Based on two brace and three insole studies, we conclude that there is 'silver' level evidence (www.cochranemsk.org) that a brace and a lateral wedge insole have small beneficial effect. There is 'silver' level evidence that strapped insoles correct leg alignment. However, long-term adherence to brace and insole treatment is low. There is no evidence whether a brace is more effective than an insole.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008175",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>no evidence to support the routine use of vitamin D in the treatment of CKD</span>.</span></span>",
            "Target Summary": "There are not sufficient data to determine the effect of vitamin D compounds on mortality and cardiovascular outcomes in people with CKD not requiring dialysis. While vitamin D compounds reduce serum PTH (49.3 pg/mL (5.6 pmol/L)) compared with placebo, the relative clinical benefits of PTH lowering versus treatment-related increases in serum phosphorus and calcium remain to be understood.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006283",
            "ESE Summary": "<span class=Extrinsic_Information>There is currently insufficient evidence to support the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>facial neuromuscular re-education</span></span> as a treatment for <span class=Population_Mismatch><span class=Lack_of_Focus>Bell's palsy</span></span>.</span>",
            "Target Summary": "There is no high quality evidence to support significant benefit or harm from any physical therapy for idiopathic facial paralysis. There is low quality evidence that tailored facial exercises can help to improve facial function, mainly for people with moderate paralysis and chronic cases. There is low quality evidence that facial exercise reduces sequelae in acute cases. The suggested effects of tailored facial exercises need to be confirmed with good quality randomised controlled trials.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006403",
            "ESE Summary": "<span class=Extrinsic_Information Overgeneralization>There is insufficient evidence to support or refute the use of different routes of administration of anthrax vaccines for different populations.</span> <span class=Ambiguity>The studies included in this review were of relatively short duration and had a high risk of bias.</span> <span class=Length Lack_of_Focus><span class=Incorrect_Implication>Further research is required to determine the optimal route of administration for anthrax vaccine given to <span class=Population_Mismatch Omission_of_Key_Facts>people with normal anthrax disease</span>.</span></span>",
            "Target Summary": "One cluster-RCT provides limited evidence that a live-attenuated vaccine is effective in preventing cutaneous anthrax. Vaccines based on anthrax antigens are immunogenic in most vaccinees with few adverse events or reactions. Ongoing randomized controlled trials are investigating the immunogenicity and safety of anthrax vaccines.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 1,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000297",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>Cyclosporine significantly improves Crohn's disease activity</span></span></span> and <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>reduces the need for surgery</span></span></span>. However, <span class=Omission_of_Key_Facts><span class=Excessive_Detail>it does not reduce the risk of adverse events</span></span>.",
            "Target Summary": "Brynskov 1989a enrolled a small number of patients and the modified clinical grading scale used in the study has not been validated in other studies. Furthermore, statistically significant clinical improvement does not imply induction of clinical remission. Indeed, Brynskov 1989a found no statistically significant differences in the mean Crohn's Disease Activity Index score at 12 weeks indicating that cyclosporine was no more effective than placebo for induction of remission in Crohn's disease. The results of this review demonstrate that low dose (5 mg/kg/day) oral cyclosporine is not effective for the induction of remission in Crohn's disease. Patients treated with low dose oral cyclosporine are more likely than placebo treated patients to experience adverse events including renal dysfunction. The use of low dose oral cyclosporine for the treatment of chronic active Crohn's disease does not appear to be justified. Oral dosing at higher levels or parenteral administration of cyclosporine have not been adequately evaluated in controlled clinical trials. Higher doses of cyclosporine are not likely to be useful for the long-term management of Crohn's disease because of the risk of nephrotoxicity and the availability of other proven interventions.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 3
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 2,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003881",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to determine whether <span class=Omission_of_Key_Facts>bulking agents are more or less effective than placebo</span> in the treatment of stress urinary incontinence.</span></span> <span class=Length>There is a need for larger randomised controlled trials with longer follow-up.</span>",
            "Target Summary": "The available evidence base remains insufficient to guide practice. In addition, the finding that placebo saline injection was followed by a similar symptomatic improvement to bulking agent injection raises questions about the mechanism of any beneficial effects. One small trial comparing silicone particles with pelvic floor muscle training was suggestive of benefit at three months but it is not known if this was sustained, and the treatment was associated with high levels of postoperative retention and dysuria. Greater symptomatic improvement was observed with surgical treatments, though the advantages need to be set against likely higher risks. No clear-cut conclusions could be drawn from trials comparing alternative agents, although dextranomer hyaluronic acid was associated with more local side effects and is no longer commercially available for this indication. There is insufficient evidence to show superiority of mid-urethral or bladder neck injection. The single trial of autologous fat provides a reminder that periurethral injections can occasionally cause serious side effects.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006771",
            "ESE Summary": "<span class=Extrinsic_Information>There is <span class=Lack_of_Focus Length><span class=Omission_of_Key_Facts>no evidence to support the use of subcutaneous heparin as an initial treatment for VTE</span>.</span></span>",
            "Target Summary": "Subcutaneous unfractionated heparin for the treatment of venous thromboembolism cannot be considered non-inferior to other treatment modalities in terms of recurrent DVT and PE at three months, but seems as safe and effective with regards to rates of major bleeding and death.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004198",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is no evidence to support the use of <span class=Omission_of_Key_Facts>Stilboestrol</span> in people with <span class=Population_Mismatch>SS disease</span>.</span></span>",
            "Target Summary": "There is a lack of evidence for the benefits or risks of the different treatments for both stuttering and fulminant priapism in sickle cell disease. This systematic review has clearly identified the need for well-designed, adequately-powered, multicentre randomised controlled trials assessing the effectiveness of specific interventions for priapism in sickle cell disease.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006717",
            "ESE Summary": "There is <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>insufficient evidence</span></span> to support the use of <span class=Overgeneralization>taping and exercise</span> for the treatment of patellofemoral pain.</span>",
            "Target Summary": "The currently available evidence from trials reporting clinically relevant outcomes is low quality and insufficient to draw conclusions on the effects of taping, whether used on its own or as part of a treatment programme. Further research involving large, preferably multi-centre, good quality and well reported randomised controlled trials that measure clinically important outcomes and long-term results is warranted. Before this, consensus is required on the diagnosis of patellofemoral pain syndrome, the standardisation of outcome measurement and an acceptable approach for patellar taping.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004170",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence to support the routine provision of rehabilitation services for people with traumatic brain injury.</span></span></span>",
            "Target Summary": "Problems following ABI vary. Consequently, different interventions and combinations of interventions are required to suit the needs of patients with different problems. Patients presenting acutely to hospital with moderate to severe brain injury should be routinely followed up to assess their needs for rehabilitation. Intensive intervention appears to lead to earlier gains. The balance between intensity and cost-effectiveness has yet to be determined. Patients discharged from in-patient rehabilitation should have access to out-patient or community-based services appropriate to their needs. Those with milder brain injury benefit from follow up and appropriate information and advice. Not all questions in rehabilitation can be addressed by randomised controlled trials or other experimental approaches. Some questions include which treatments work best for which patients over the long term, and which models of service represent value for money in the context of life-long care. In future, such questions will need to be set alongside practice-based evidence gathered from large systematic, longitudinal cohort studies conducted in the context of routine clinical practice.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008510",
            "ESE Summary": "The results of this review suggest that <span class=Population_Mismatch Omission_of_Key_Facts><span class=Length><span class=Incorrect_Implication>Zhixue Baotai Decoction may have a fetus protection effect compared to progesterone treatment</span>.</span></span> However, the results are based on a small number of women and <span class=Ambiguity>the risk of bias is high</span>. <span class=Excessive_Detail>Further randomised controlled trials are required to determine the optimal treatment for this condition.</span>  \r\n[Note: The four citations in the awaiting classification section of the review may alter the conclusions of the reviews once assessed.]",
            "Target Summary": "There was insufficient evidence to assess the effectiveness of Chinese herbal medicines alone for treating threatened miscarriage.\nA combination of Chinese herbal and Western medicines was more effective than Western medicines alone for treating threatened miscarriage. However, the quality of the included studies was poor. More high quality studies are necessary to further evaluate the effectiveness of Chinese herbal medicines for threatened miscarriage.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 1,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002230",
            "ESE Summary": "There is no evidence that <span class=Extrinsic_Information>enoximone improves mortality</span> or <span class=Incorrect_Implication>exercise tolerance in patients with chronic heart failure</span>.",
            "Target Summary": "Our results confirm that PDIs are responsible for an increase in mortality rate compared with placebo in patients suffering from chronic heart failure. Currently available results do not support the hypothesis that the increased mortality rate is due to additional vasodilator treatment. Consequently, the chronic use of PDIs should be avoided in heart failure patients.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001351",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>Acupuncture appears to be an effective treatment for <span class=Omission_of_Key_Facts>chronic low-back pain</span></span>, although there is <span class=Omission_of_Key_Facts>insufficient evidence to support its use</span>.</span>",
            "Target Summary": "The data do not allow firm conclusions about the effectiveness of acupuncture for acute low-back pain. For chronic low-back pain, acupuncture is more effective for pain relief and functional improvement than no treatment or sham treatment immediately after treatment and in the short-term only. Acupuncture is not more effective than other conventional and \"alternative\" treatments. The data suggest that acupuncture and dry-needling may be useful adjuncts to other therapies for chronic low-back pain. Because most of the studies were of lower methodological quality, there certainly is a further need for higher quality trials in this area.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002122",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is no evidence to support the use of progestin in the treatment of endometriosis.</span></span></span>",
            "Target Summary": "There is only limited evidence to support the use of progestagens and anti-progestagens for pain associated with endometriosis.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000972",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Incorrect_Implication>There is insufficient evidence to support or refute the use of <span class=Omission_of_Key_Facts>dexamethasone for treating cerebral malaria</span>.</span></span> <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>High-dose quinine therapy should not be used.</span></span>",
            "Target Summary": "There is currently no evidence of benefit from corticosteroids, but the small number of participants means it is difficult to exclude an effect on death in either direction. Data on clinical complications are difficult to assess.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003420",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to support or refute the use of antithyroid drugs in Graves' disease.</span></span></span>",
            "Target Summary": "The evidence suggests that the optimal duration of antithyroid drug therapy for the titration regimen is 12 to 18 months. The titration (low dose) regimen had fewer adverse effects than the block-replace (high dose) regimen and was no less effective. Continued thyroxine treatment following initial antithyroid therapy does not appear to provide any benefit in terms of recurrence of hyperthyroidism. Immunosuppressive therapies need further evaluation.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD006002",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence</span> to recommend the use of interferon for the treatment of hepatitis D.</span></span> <span class=Length><span class=Overgeneralization>There is a need for <span class=Omission_of_Key_Facts>large randomised controlled trials with long-term follow-up</span>.</span></span>",
            "Target Summary": "Interferon alpha does not seem to cure hepatitis D in most patients. The agent seems effective in suppressing viral and liver disease activity in some patients, but this improvement is not sustained in the majority of patients. We cannot exclude overestimation of benefits and underestimation of harms due to high risk of bias (systematic errors) and high risk play of chance (random errors). Therefore, more randomised trials with large sample sizes and less risk of bias are needed before interferon can be recommended or refuted.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001261",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Incorrect_Implication>There is insufficient evidence from randomised controlled trials to determine whether the <span class=Omission_of_Key_Facts>Vi capsular polysaccharide vaccine is effective in preventing typhoid</span>.</span></span>",
            "Target Summary": "The licensed Ty21a and Vi polysaccharide vaccines are efficacious. The new and unlicensed Vi-rEPA vaccine is as efficacious and may confer longer immunity.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008765",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Overgeneralization>Secondary surgery appears to improve survival in selected patients with recurrent epithelial ovarian cancer.</span></span></span> However, <span class=Omission_of_Key_Facts><span class=Length><span class=Inaccurate_Emphasis>there is a need for further research.</span></span></span>",
            "Target Summary": "In women with platinum-sensitive recurrent ovarian cancer, ability to achieve surgery with complete cytoreduction (no visible residual disease) is associated with significant improvement in overall survival. However, in the absence of RCT evidence, it is not clear whether this is solely due to surgical effect or due to tumour biology. Indirect evidence would support surgery to achieve complete cytoreduction in selected women. The risks of major surgery need to be carefully balanced against potential benefits on a case-by-case basis.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD005331",
            "ESE Summary": "There is <span class=Incorrect_Implication>insufficient evidence to support or refute</span> the use of <span class=Lack_of_Focus><span class=Omission_of_Key_Facts>hypnosis in the treatment of <span class=Overgeneralization>motor conversion disorder</span></span>.</span>",
            "Target Summary": "Randomised studies are possible in this field. The use of psychosocial interventions for conversion disorder requires more research and it is not possible to draw any conclusions about their potential benefits or harms from the included studies.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002037",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>Trials have shown that induction therapy with antiretroviral drugs is better than <span class=Extrinsic_Information>no treatment at all</span>.</span></span> However, <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length>the evidence is <span class=Ambiguity>not strong enough</span> to recommend routine use of these regimens.</span></span> <span class=Omission_of_Key_Facts><span class=Length Excessive_Detail>Further research is required to determine the <span class=Overgeneralization>optimal duration of induction therapy for HIV infection</span>.</span></span>",
            "Target Summary": "Although it is desirable to reduce the number of antiretroviral drugs given in combination therapy for reasons of compliance and toxicity, maintenance regimens with fewer drugs are associated with significantly increased resistance and risk of loss of viral suppression. Successful initial therapy, as evidenced by suppresion of viral load, should not be modified in the maintenance phase unless clinically necessary.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 3
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 3,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 1,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD009072",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Extrinsic_Information>There is insufficient evidence to determine whether or not <span class=Lack_of_Focus Length>platelet transfusion inactivated viruses are more effective than no treatment or no treatment at all</span> in the treatment of thrombocytopenia.</span></span>",
            "Target Summary": "We found no evidence of a difference in mortality, 'clinically significant' or 'severe bleeding', transfusion reactions or adverse events between pathogen-reduced and standard platelets. For a range of laboratory outcomes the results indicated evidence of some benefits for standard platelets over pathogen-reduced platelets. These conclusions are based on data from 1422 patients included in 10 trials. Results from ongoing or new trials are required to determine if there are clinically important differences in bleeding risk between pathogen-reduced platelet transfusions and standard platelet transfusions. Given the variability in trial design, bleeding assessment and quality of outcome reporting, it is recommended that future trials apply standardised approaches to outcome assessment and follow-up, including safety reporting.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004207",
            "ESE Summary": "Single dose SnMP was superior to PT in reducing the number of bilirubin determinations and the length of time spent in the hospital for treatment of hyperbilirubinaemia in <span class=Population_Mismatch>term and near-term infants</span>. <span class=Lack_of_Focus Length><span class=Incorrect_Implication Overgeneralization>SnMP did not significantly reduce the <span class=Outcome_Mismatch>length and duration of medical observation</span> for this condition.</span></span>",
            "Target Summary": "Treatment of neonatal unconjugated hyperbilirubinemia with metalloporphyrins may reduce neonatal bilirubin levels and decrease the need for phototherapy and hospitalization. There is no evidence to support or refute the possibility that treatment with a metalloporphyrin decreases the risk of neonatal kernicterus or of long-term neurodevelopmental impairment due to bilirubin encephalopathy. There is no evidence to support or refute the possibility that cutaneous photosensitivity is increased with metalloporphyrin treatment. Routine treatment of neonatal unconjugated hyperbilirubinemia with a metalloporphyrin cannot be recommended at present.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 1,
                    "Omission_of_Key_Facts": 0
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003804",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>Ginseng therapy may improve mood and cognitive function in patients with type 2 DM.</span></span></span> However, <span class=Omission_of_Key_Facts><span class=Length><span class=Incorrect_Implication>there is insufficient evidence to recommend its use as a long-term treatment.</span></span></span>",
            "Target Summary": "There is no convincing evidence relating type or intensity of diabetic treatment to the prevention or management of cognitive impairment in Type II diabetes. Future research on treatments for diabetes should include standardized assessments of cognitive function as outcome measures.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001831",
            "ESE Summary": "<span class=Lack_of_Focus><span class=Extrinsic_Information>There is <span class=Omission_of_Key_Facts>insufficient evidence to support the use of antihistamines for the treatment of cough in adults with the common cold.</span></span></span>",
            "Target Summary": "There is no good evidence for or against the effectiveness of OTC medicines in acute cough. The results of this review have to be interpreted with caution due to differences in study characteristics and quality. Studies often showed conflicting results with uncertainty regarding clinical relevance. Higher quality evidence is needed to determine the effectiveness of self care treatments for acute cough.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD010257",
            "ESE Summary": "Antibiotic <span class=Length>treatment</span> in the treatment of acute exacerbations of COPD is associated with a <span class=Omission_of_Key_Facts><span class=Inaccurate_Emphasis>reduction in the need for further hospitalisations</span></span> and the <span class=Omission_of_Key_Facts><span class=Excessive_Detail><span class=Incorrect_Implication>length of time to cure</span></span></span>.",
            "Target Summary": "Antibiotics for COPD exacerbations showed large and consistent beneficial effects across outcomes of patients admitted to an ICU. However, for outpatients and inpatients the results were inconsistent. The risk for treatment failure was significantly reduced in both inpatients and outpatients when all trials (1957 to 2012) were included but not when the analysis for outpatients was restricted to currently used antibiotics. Also, antibiotics had no statistically significant effect on mortality and length of hospital stay in inpatients and almost no data on patient-reported outcomes exist. These inconsistent effects call for research into clinical signs and biomarkers that help identify patients who benefit from antibiotics and patients who experience no effect, and in whom downsides of antibiotics (side effects, costs and multi-resistance) could be avoided.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD006251",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Extrinsic_Information>There is insufficient evidence to assess the effectiveness of occupational safety and health interventions for preventing occupational injuries in the construction industry.</span></span></span> <span class=Omission_of_Key_Facts><span class=Length><span class=Inaccurate_Emphasis>There is an urgent need for high quality, methodologically sound studies to evaluate the effectiveness and cost-effectiveness of occupational Safety and Health interventions.</span></span></span>",
            "Target Summary": "The vast majority of technical, human and organisational interventions that are recommended by standard texts of safety, consultants and safety courses have not been adequately evaluated. There is no evidence that introducing regulations for reducing fatal and non-fatal injuries are effective as such. There is neither evidence that regionally oriented safety campaigns, training, inspections nor the introduction of occupational health services are effective at reducing non-fatal injuries in construction companies. There is low-quality evidence that company-oriented safety interventions such as a multifaceted safety campaign and a multifaceted drug workplace programme can reduce non-fatal injuries among construction workers. Additional strategies are needed to increase the compliance of employers and workers to the safety measures that are prescribed by regulation. Continuing company-oriented interventions among management and construction workers, such as a targeted safety campaign or a drug-free workplace programme, seem to have an effect in reducing injuries in the longer term.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD003266",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Incorrect_Implication>There is insufficient evidence to support the use of <span class=Lack_of_Focus>erythropoietin to treat predialysis patients with CKD.</span></span></span> Further <span class=Length>randomised controlled trials are needed to determine the efficacy and safety of this intervention.</span>",
            "Target Summary": "Treatment with rHu EPO in pre-dialysis patients corrects anaemia, avoids the requirement for blood transfusions and also improves quality of life and exercise capacity. We were unable to assess the effects of rHu EPO on progression of renal disease, delay in the onset of dialysis or adverse events. Based on the current evidence, decisions on the putative benefits in terms of quality of life are worth the extra costs of pre-dialysis rHu EPO need careful evaluation.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000116",
            "ESE Summary": "There is insufficient evidence to support or refute the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>cardiotocography plus ST</span></span></span> in high-risk labour to reduce <span class=Omission_of_Key_Facts><span class=Redundancy><span class=Overgeneralization>mortality, morbidity, or morbidity</span></span></span>. Further research is needed. \r\n[Note: The four citations in the awaiting classification section of the review may alter the conclusions of the study once assessed.]",
            "Target Summary": "These findings provide some modest support for the use of fetal ST waveform analysis when a decision has been made to undertake continuous electronic fetal heart rate monitoring during labour. However, the advantages need to be considered along with the disadvantages of needing to use an internal scalp electrode, after membrane rupture, for ECG waveform recordings.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD002008",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus>There is <span class=Extrinsic_Information>insufficient evidence</span> to support the use of nutritional interventions in patients with cancer.</span></span> <span class=Length>Further trials are needed to determine whether nutritional interventions are beneficial and, if so, which interventions are <span class=Overgeneralization>most effective</span>.</span>",
            "Target Summary": "Evidence of variable quality suggests that dietary advice with or without oral nutritional supplements may improve weight, body composition and grip strength. We found no evidence of benefit of dietary advice or oral nutritional supplements given alone or in combination on survival. Studies addressing the impact of nutritional interventions on nutritional, functional and patient-centred outcomes are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003427",
            "ESE Summary": "Prophylactic penicillin in children with sickle cell disease <span class=Lack_of_Focus Length><span class=Extrinsic_Information>reduces the risk of <span class=Population_Mismatch>S.pneumoniae</span> and septicemia</span></span>, but <span class=Excessive_Detail>there is <span class=Omission_of_Key_Facts><span class=Incorrect_Implication>no evidence of an effect on mortality</span></span></span>.",
            "Target Summary": "Prophylactic penicillin significantly reduces risk of pneumococcal infection in children with homozygous sickle cell disease, and is associated with minimal adverse reactions. Further research may help to determine the ideal age to safely withdraw penicillin.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD008253",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Length><span class=Extrinsic_Information>Betamethasone nasal drops are effective in reducing polyp size in people with cystic fibrosis.</span></span></span> However, <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Overgeneralization>there is a need for further randomised controlled trials.</span></span></span>",
            "Target Summary": "This review suggests topical steroids for nasal polyposis in patients with cystic fibrosis have no demonstrable effect on subjective nasal symptom scores. They have some effect in reducing the size of the polyps, but due to the small sample size, poor study completion rates and lack of follow-up, the study is at high risk of bias and evidence for efficacy is limited. Overall there is no clear evidence for using topical steroids in people with cystic fibrosis and nasal polyposis.\nA well-designed randomised controlled trial of adequate power and long-term follow-up is needed. Validated measures of symptoms and physical findings should be performed and quality of life issues addressed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000948",
            "ESE Summary": "There is <span class=Extrinsic_Information>insufficient evidence from randomised controlled trials</span> to determine the <span class=Overgeneralization>relative benefits and harms</span> of <span class=Omission_of_Key_Facts><span class=Length>orotracheal versus nasotracheal intubation</span></span> in neonates requiring ventilatory support.",
            "Target Summary": "Post extubation atelectasis may be more frequent after nasal intubation, particularly in very low birth weight infants. One route of intubation does not seem to be preferable to the other. There is a need for further randomized controlled trials containing larger numbers of infants.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 0,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003120",
            "ESE Summary": "<span class=Lack_of_Focus>There is some evidence that <span class=Omission_of_Key_Facts><span class=Overgeneralization>Ginkgo biloba is an effective treatment for mild to moderate dementia.</span></span></span> However, the evidence is not strong enough to recommend its use as a treatment for <span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Overgeneralization>other types of dementia.</span></span></span>",
            "Target Summary": "Ginkgo biloba appears to be safe in use with no excess side effects compared with placebo. Many of the early trials used unsatisfactory methods, were small, and publication bias cannot be excluded. The evidence that Ginkgo biloba has predictable and clinically significant benefit for people with dementia or cognitive impairment is inconsistent and unreliable.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 2,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003581",
            "ESE Summary": "<span class=Lack_of_Focus>There is <span class=Omission_of_Key_Facts><span class=Extrinsic_Information>insufficient evidence to support or refute the use of preterm birth prevention programs</span></span> in the county of Los Angeles.</span>",
            "Target Summary": "There is no evidence, either supporting or refuting the use of bed rest at home or in hospital, to prevent preterm birth. Although bed rest in hospital or at home is widely used as the first step of treatment, there is no evidence that this practice could be beneficial. Due to the potential adverse effects that bed rest could have on women and their families, and the increased costs for the healthcare system, clinicians should not routinely advise women to rest in bed to prevent preterm birth. Potential benefits and harms should be discussed with women facing an increased risk of preterm birth. Appropriate research is mandatory. Future trials should evaluate both the effectiveness of bed rest, and the effectiveness of the prescription of bed rest, to prevent preterm birth.\n[Note: The two citations in the awaiting classification section of the review may alter the conclusions of the review once assessed.]",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003200",
            "ESE Summary": "<span class=Overgeneralization>There is some evidence to support the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>graded exercise therapy</span></span> in the management of <span class=Population_Mismatch><span class=Lack_of_Focus>chronic fatigue syndrome</span></span>.</span> However, <span class=Inaccurate_Emphasis>the evidence is not strong enough to recommend its use as a standard treatment for <span class=Omission_of_Key_Facts><span class=Redundancy>CFS</span></span>.</span> Further research is needed.",
            "Target Summary": "There is encouraging evidence that some patients may benefit from exercise therapy and no evidence that exercise therapy may worsen outcomes on average. However the treatment may be less acceptable to patients than other management approaches, such as rest or pacing. Patients with CFS who are similar to those in these trials should be offered exercise therapy, and their progress monitored Further high quality randomised studies are needed.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD000536",
            "ESE Summary": "<span class=Overgeneralization>There is insufficient evidence to determine whether <span class=Omission_of_Key_Facts>anticoagulants given to patients undergoing peripheral arterial bypass surgery improve survival or reduce mortality</span>.</span> There is a need for larger randomised controlled trials to evaluate the effects of anticoabulants on mortality and morbidity in patients undergoing bypass surgery.",
            "Target Summary": "Patients undergoing infrainguinal venous graft are more likely to benefit from treatment with VKA than platelet inhibitors. Patients receiving an artificial graft benefit from platelet inhibitors (aspirin). However, the evidence is not conclusive. Randomised controlled trials with larger patient numbers are needed in the future to compare antithrombotic therapies with either placebo or antiplatelet therapies.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD000146",
            "ESE Summary": "Nicotine replacement therapy is effective in promoting smoking cessation in people with a high level of nicotine dependence. <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Extrinsic_Information>Adequately powered trials with low risk of bias are needed.</span></span></span>",
            "Target Summary": "All of the commercially available forms of NRT (gum, transdermal patch, nasal spray, inhaler and sublingual tablets/lozenges) can help people who make a quit attempt to increase their chances of successfully stopping smoking. NRTs increase the rate of quitting by 50 to 70%, regardless of setting. The effectiveness of NRT appears to be largely independent of the intensity of additional support provided to the individual. Provision of more intense levels of support, although beneficial in facilitating the likelihood of quitting, is not essential to the success of NRT.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD007986",
            "ESE Summary": "There is <span class=Extrinsic_Information>insufficient evidence to support or refute the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>omega-6 fatty acids</span></span></span> in children with <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>ADHD</span></span>.",
            "Target Summary": "Overall, there is little evidence that PUFA supplementation provides any benefit for the symptoms of ADHD in children and adolescents. The majority of data showed no benefit of PUFA supplementation, although there were some limited data that did show an improvement with combined omega-3 and omega-6 supplementation.\nIt is important that future research addresses current weaknesses in this area, which include small sample sizes, variability of selection criteria, variability of the type and dosage of supplementation, short follow-up times and other methodological weaknesses.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD001815",
            "ESE Summary": "<span class=Extrinsic_Information>There is insufficient evidence to recommend the use of <span class=Omission_of_Key_Facts><span class=Lack_of_Focus>antibiotics</span></span> in the treatment of preterm infants with <span class=Omission_of_Key_Facts>feeding intolerance</span>.</span>",
            "Target Summary": "There is insufficient evidence to recommend the use of erythromycin in low or high doses for preterm infants with or at risk of feeding intolerance. Future research is needed to determine if there is a more precise dose range where erythromycin might be effective as a prokinetic agent in preterm infants > 32 weeks' GA.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004447",
            "ESE Summary": "There is <span class=Extrinsic_Information Overgeneralization>insufficient evidence to determine whether or not <span class=Omission_of_Key_Facts><span class=Redundancy Length>IGF-I deficiency or deficiency</span></span> is associated with short stature in people with X-linked hypophosphatemia.</span> Further research is required to determine if <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Excessive_Detail><span class=Intrinsic_Information Incorrect_Implication>IGF-1 deficiency is an underlying cause of short stature and whether IGF-2 deficiency is a contributory factor in the short stature of people with this condition.</span></span></span>",
            "Target Summary": "We have found no conclusive evidence to indicate that the use of recombinant human growth hormone therapy in children with X-linked hypophosphatemia is associated with changes in longitudinal growth, mineral metabolism, endocrine, renal function, bone mineral density, and body proportions.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 2
                },
                "Conciseness": {
                    "Redundancy": 1,
                    "Length": 1,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 1
                },
                "Faithfulness": {
                    "Intrinsic_Information": 1,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD003700",
            "ESE Summary": "<span class=Omission_of_Key_Facts><span class=Lack_of_Focus><span class=Inaccurate_Emphasis>There is insufficient evidence</span> to recommend the use of vitamin A as a treatment for pneumonia in children.</span></span>",
            "Target Summary": "The evidence does not suggest a significant reduction in mortality, measures of morbidity, nor an effect on the clinical course of pneumonia with vitamin A adjunctive treatment in children with non-measles pneumonia. However, not all studies measured all outcomes, which limited the number of studies that could be incorporated into the meta-analyses, so that there may have been a lack of statistical power to detect statistically significant differences.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 1,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 1
                }
            }
        },
        {
            "ReviewID": "CD003412",
            "ESE Summary": "<span class=Lack_of_Focus Length><span class=Extrinsic_Information>Imiquimod 5% cream appears to be effective in the treatment of superficial BCC.</span></span> <span class=Omission_of_Key_Facts><span class=Lack_of_Focus Length><span class=Ambiguity>It is unclear whether it has an effect on other tumours.</span></span></span>",
            "Target Summary": "Overall there has been very little good quality research on treatments for BCC. Most trials have only evaluated BCCs in low risk locations. Surgery and radiotherapy appear to be the most effective treatments with surgery showing the lowest failure rates. Although cosmetic outcomes appear good with PDT, long-term follow-up data are needed. Other treatments might have some use but few have been compared to surgery. An ongoing study comparing imiquimod to surgery should clarify whether imiquimod is a useful option.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 0,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 2,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 1,
                    "Ambiguity": 1,
                    "Overgeneralization": 0,
                    "Incorrect_Implication": 0,
                    "Inaccurate_Emphasis": 0
                }
            }
        },
        {
            "ReviewID": "CD004979",
            "ESE Summary": "There is insufficient evidence to determine whether <span class=Omission_of_Key_Facts><span class=Incorrect_Implication><span class=Lack_of_Focus>oral or intramuscular antibiotics</span> are equivalent</span></span> in the treatment of <span class=Population_Mismatch><span class=Lack_of_Focus><span class=Overgeneralization>acute pneumonia in children</span></span></span>.",
            "Target Summary": "Oral therapy appears to be an effective and safe alternative to parenteral antibiotics in hospitalised children with severe pneumonia who do not have any serious signs or symptoms.",
            "errors": {
                "Completeness": {
                    "Population_Mismatch": 1,
                    "Intervention_Mismatch": 0,
                    "Outcome_Mismatch": 0,
                    "Omission_of_Key_Facts": 1
                },
                "Conciseness": {
                    "Redundancy": 0,
                    "Length": 0,
                    "Lack_of_Focus": 2,
                    "Excessive_Detail": 0
                },
                "Faithfulness": {
                    "Intrinsic_Information": 0,
                    "Extrinsic_Information": 0,
                    "Ambiguity": 0,
                    "Overgeneralization": 1,
                    "Incorrect_Implication": 1,
                    "Inaccurate_Emphasis": 0
                }
            }
        }
    ]
}